
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E5985CB9275F6933B85CB004DC31781.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="ploscomp">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7909705/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLoS Computational Biology">
<meta name="citation_title" content="Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes">
<meta name="citation_author" content="Karoline Horgmo Jæger">
<meta name="citation_author_institution" content="Simula Research Laboratory, Oslo, Norway">
<meta name="citation_author" content="Samuel Wall">
<meta name="citation_author_institution" content="Simula Research Laboratory, Oslo, Norway">
<meta name="citation_author" content="Aslak Tveito">
<meta name="citation_author_institution" content="Simula Research Laboratory, Oslo, Norway">
<meta name="citation_author_institution" content="Department of Informatics, University of Oslo, Oslo, Norway">
<meta name="citation_publication_date" content="2021 Feb 16">
<meta name="citation_volume" content="17">
<meta name="citation_issue" content="2">
<meta name="citation_firstpage" content="e1008089">
<meta name="citation_doi" content="10.1371/journal.pcbi.1008089">
<meta name="citation_pmid" content="33591962">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7909705/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7909705/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7909705/pdf/pcbi.1008089.pdf">
<meta name="description" content="Short QT (SQT) syndrome is a genetic cardiac disorder characterized by an abbreviated QT interval of the patient’s electrocardiogram. The syndrome is associated with increased risk of arrhythmia and sudden cardiac death and can arise from a number ...">
<meta name="og:title" content="Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Short QT (SQT) syndrome is a genetic cardiac disorder characterized by an abbreviated QT interval of the patient’s electrocardiogram. The syndrome is associated with increased risk of arrhythmia and sudden cardiac death and can arise from a number ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7909705/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="7909705">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pcbi.1008089"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pcbi.1008089.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC7909705%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/7909705/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/7909705/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC7909705/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-ploscomp.png" alt="PLOS Computational Biology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS Computational Biology" title="Link to PLOS Computational Biology" shape="default" href="https://doi.org/10.1371/journal.pcbi.1008089" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS Comput Biol</button></div>. 2021 Feb 16;17(2):e1008089. doi: <a href="https://doi.org/10.1371/journal.pcbi.1008089" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pcbi.1008089</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22PLoS%20Comput%20Biol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20Comput%20Biol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20Comput%20Biol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20Comput%20Biol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%C3%A6ger%20KH%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Karoline Horgmo Jæger</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Karoline Horgmo Jæger</span></h3>
<div class="p">
<sup>1</sup>Simula Research Laboratory, Oslo, Norway</div>
<div>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%C3%A6ger%20KH%22%5BAuthor%5D" class="usa-link"><span class="name western">Karoline Horgmo Jæger</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wall%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Samuel Wall</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Samuel Wall</span></h3>
<div class="p">
<sup>1</sup>Simula Research Laboratory, Oslo, Norway</div>
<div>Funding acquisition, Validation, Visualization, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wall%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Samuel Wall</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tveito%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Aslak Tveito</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Aslak Tveito</span></h3>
<div class="p">
<sup>1</sup>Simula Research Laboratory, Oslo, Norway</div>
<div class="p">
<sup>2</sup>Department of Informatics, University of Oslo, Oslo, Norway</div>
<div>Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Validation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tveito%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aslak Tveito</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>
</div>
<div class="cg p">Editor: <span class="name western">Daniel A Beard</span><sup>3</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>Simula Research Laboratory, Oslo, Norway</div>
<div id="aff002">
<sup>2</sup>Department of Informatics, University of Oslo, Oslo, Norway</div>
<div id="edit1">
<sup>3</sup>University of Michigan, UNITED STATES</div>
<div class="author-notes p">
<div class="fn" id="coi001"><p>I have read the journal’s policy and the authors of this manuscript have the following competing interests: KJ, SW and AT have financial relationships with Organos Inc, and the company may benefit from commercialization of the results of this research.</p></div>
<div class="fn" id="cor001">
<sup>✉</sup><p class="display-inline">* E-mail: <span>karolihj@simula.no</span></p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Karoline Horgmo Jæger</span></strong>: <span class="role">Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Samuel Wall</span></strong>: <span class="role">Funding acquisition, Validation, Visualization, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Aslak Tveito</span></strong>: <span class="role">Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Validation, Writing – review &amp; editing</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Daniel A Beard</span></strong>: <span class="role">Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2020 Jun 18; Accepted 2020 Dec 20; Collection date 2021 Feb.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2021 Jæger et al</div>
<p>This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC7909705  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33591962/" class="usa-link">33591962</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Short QT (SQT) syndrome is a genetic cardiac disorder characterized by an abbreviated QT interval of the patient’s electrocardiogram. The syndrome is associated with increased risk of arrhythmia and sudden cardiac death and can arise from a number of ion channel mutations. Cardiomyocytes derived from induced pluripotent stem cells generated from SQT patients (SQT hiPSC-CMs) provide promising platforms for testing pharmacological treatments directly in human cardiac cells exhibiting mutations specific for the syndrome. However, a difficulty is posed by the relative immaturity of hiPSC-CMs, with the possibility that drug effects observed in SQT hiPSC-CMs could be very different from the corresponding drug effect <em>in vivo</em>. In this paper, we apply a multistep computational procedure for translating measured drug effects from these cells to human QT response. This process first detects drug effects on individual ion channels based on measurements of SQT hiPSC-CMs and then uses these results to estimate the drug effects on ventricular action potentials and QT intervals of adult SQT patients. We find that the procedure is able to identify IC<sub>50</sub> values in line with measured values for the four drugs quinidine, ivabradine, ajmaline and mexiletine. In addition, the predicted effect of quinidine on the adult QT interval is in good agreement with measured effects of quinidine for adult patients. Consequently, the computational procedure appears to be a useful tool for helping predicting adult drug responses from pure <em>in vitro</em> measurements of patient derived cell lines.</p></section><section class="abstract" id="abstract2"><h2>Author summary</h2>
<p>A number of cardiac disorders originate from genetic mutations affecting the function of ion channels populating the membrane of cardiomyocytes. One example is short QT syndrome, associated with increased risk of arrhythmias and sudden cardiac death. Cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs) provide a promising platform for testing potential pharmacological treatments for such disorders, as human cardiomyocytes exhibiting specific mutations can be generated and exposed to drugs <em>in vitro</em>. However, the electrophysiological properties of hiPSC-CMs differ significantly from those of adult native cardiomyocytes. Therefore, drug effects observed for hiPSC-CMs could possibly be very different from corresponding drug effects for adult cells <em>in vivo</em>. In this study, we apply a computational framework for translating drug effects observed for hiPSC-CMs derived from a short QT patient to drug effects for adult short QT cardiomyocytes. For one of the considered drugs, the effect on adult QT intervals has been measured and these measurements turn out to be in good agreement with the response estimated by the computational procedure. Thus, the computational framework shows promise for being a useful tool for predicting adult drug responses from measurements of hiPSC-CMs, allowing earlier identification of compounds to accurately treat cardiac diseases.</p></section><section id="sec001"><h2 class="pmc_sec_title">1 Introduction</h2>
<p>Short QT (SQT) syndrome is a cardiac channelopathy characterized by an abnormally short duration of the QT interval of the patient’s electrocardiogram (ECG) [<a href="#pcbi.1008089.ref001" class="usa-link" aria-describedby="pcbi.1008089.ref001">1</a>–<a href="#pcbi.1008089.ref003" class="usa-link" aria-describedby="pcbi.1008089.ref003">3</a>]. The syndrome is associated with increased risk of atrial fibrillation, ventricular arrhythmias and sudden cardiac death [<a href="#pcbi.1008089.ref004" class="usa-link" aria-describedby="pcbi.1008089.ref004">4</a>, <a href="#pcbi.1008089.ref005" class="usa-link" aria-describedby="pcbi.1008089.ref005">5</a>] and was first described by Gussak et al. in 2000 [<a href="#pcbi.1008089.ref001" class="usa-link" aria-describedby="pcbi.1008089.ref001">1</a>]. The first identified SQT subtype, termed SQT1, results from an increase in the transmembrane potassium current, <em>I</em><sub>Kr</sub>, caused by a mutation in the <em>I</em><sub>Kr</sub> encoding gene KCNH2 [<a href="#pcbi.1008089.ref006" class="usa-link" aria-describedby="pcbi.1008089.ref006">6</a>]. Later, several additional subtypes of SQT syndrome have been identified, originating from mutations in other genes, including gain of function alterations in genes encoding the potassium channels responsible for the <em>I</em><sub>Ks</sub> and <em>I</em><sub>K1</sub> currents and loss of function alterations in genes encoding calcium channels [<a href="#pcbi.1008089.ref002" class="usa-link" aria-describedby="pcbi.1008089.ref002">2</a>, <a href="#pcbi.1008089.ref003" class="usa-link" aria-describedby="pcbi.1008089.ref003">3</a>].</p>
<p>Because of the lethal risks associated with the syndrome, there is an urgent need for effective pharmacological therapies. One modern approach is to identify compounds that can make the electrophysiological properties of cardiomyocytes (CMs) populated with SQT mutated channels more similar to the electrophysiological properties of CMs populated with wild type (WT), unmutated, channels (see, e.g., [<a href="#pcbi.1008089.ref007" class="usa-link" aria-describedby="pcbi.1008089.ref007">7</a>–<a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>]). For SQT1, which is characterized by an increased <em>I</em><sub>Kr</sub> current, drugs inhibiting the <em>I</em><sub>Kr</sub> current have been proposed as possible candidates (see, e.g., [<a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>, <a href="#pcbi.1008089.ref012" class="usa-link" aria-describedby="pcbi.1008089.ref012">12</a>]). However, the effect of a drug on WT <em>I</em><sub>Kr</sub> channels can be very different from the effect on mutated channels. For example, the <em>I</em><sub>Kr</sub> blockers sotalol and ibutilide have been shown to be ineffective for SQT1 patients [<a href="#pcbi.1008089.ref012" class="usa-link" aria-describedby="pcbi.1008089.ref012">12</a>]. This may be explained by the fact that these drugs primarily affect the inactivated state of the <em>I</em><sub>Kr</sub> channels, and the SQT1 mutation impairs the inactivation of the channels [<a href="#pcbi.1008089.ref006" class="usa-link" aria-describedby="pcbi.1008089.ref006">6</a>, <a href="#pcbi.1008089.ref013" class="usa-link" aria-describedby="pcbi.1008089.ref013">13</a>, <a href="#pcbi.1008089.ref014" class="usa-link" aria-describedby="pcbi.1008089.ref014">14</a>]. On the other hand, quinidine, which affects both the open and inactivated states of <em>I</em><sub>Kr</sub> channels has proven to be more effective for SQT1 patients [<a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>]. These examples demonstrate that investigations into drug effects on specific SQT mutations are needed in order to find appropriate pharmacological treatments.</p>
<p>A promising prospect in the quest for suitable drugs for SQT syndrome is the development of human induced pluripotent stem cells (hiPSCs) (see, e.g., [<a href="#pcbi.1008089.ref016" class="usa-link" aria-describedby="pcbi.1008089.ref016">16</a>–<a href="#pcbi.1008089.ref019" class="usa-link" aria-describedby="pcbi.1008089.ref019">19</a>]). These cells can be generated from individual patients and differentiated into a large number of different cell types, including CMs. Thus, cells can be generated from SQT patients, allowing for investigations of drug effects for CMs populated by ion channels affected by the patients’ specific mutations. Indeed, in [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>], several drugs have been tested on hiPSC-derived CMs (hiPSC-CMs) from an SQT1 patient, revealing possible promising drugs.</p>
<p>However, a difficulty with using hiPSC-CMs in drug testing applications is that the electrophysiological properties of hiPSC-CMs differ significantly from the electrophysiological properties of adult CMs (see, e.g., [<a href="#pcbi.1008089.ref020" class="usa-link" aria-describedby="pcbi.1008089.ref020">20</a>, <a href="#pcbi.1008089.ref021" class="usa-link" aria-describedby="pcbi.1008089.ref021">21</a>]). In general, hiPSC-CMs are recognized as electrophysiologically immature, with properties more similar to those of fetal CMs. These differences imply that the drug response observed for hiPSC-CMs might not be the same as the corresponding drug response for adult native CMs.</p>
<p>Mathematical modeling has been proposed as a possible tool to help translate the drug response of hiPSC-CMs to the drug response of adult CMs (see, e.g., [<a href="#pcbi.1008089.ref022" class="usa-link" aria-describedby="pcbi.1008089.ref022">22</a>–<a href="#pcbi.1008089.ref025" class="usa-link" aria-describedby="pcbi.1008089.ref025">25</a>]). The development of mathematical models of the dynamics underlying human cardiac action potentials is an active field of research, and a large number of models have been developed, including models for adult undiseased ventricular CMs [<a href="#pcbi.1008089.ref026" class="usa-link" aria-describedby="pcbi.1008089.ref026">26</a>, <a href="#pcbi.1008089.ref027" class="usa-link" aria-describedby="pcbi.1008089.ref027">27</a>], atrial CMs [<a href="#pcbi.1008089.ref028" class="usa-link" aria-describedby="pcbi.1008089.ref028">28</a>, <a href="#pcbi.1008089.ref029" class="usa-link" aria-describedby="pcbi.1008089.ref029">29</a>], hiPSC-CMs [<a href="#pcbi.1008089.ref030" class="usa-link" aria-describedby="pcbi.1008089.ref030">30</a>, <a href="#pcbi.1008089.ref031" class="usa-link" aria-describedby="pcbi.1008089.ref031">31</a>] and CMs affected by mutations [<a href="#pcbi.1008089.ref032" class="usa-link" aria-describedby="pcbi.1008089.ref032">32</a>, <a href="#pcbi.1008089.ref033" class="usa-link" aria-describedby="pcbi.1008089.ref033">33</a>]. In these models, changes in the membrane potential are represented by individual transmembrane ionic currents (see, e.g., <a href="#pcbi.1008089.e001" class="usa-link">(1)</a> below), and the models can therefore be useful for investigating how drug effects on individual ion channels affect the composite dynamics of the full action potential. Furthermore, the action potential models can be combined with spatial models of electric conduction (see, e.g., [<a href="#pcbi.1008089.ref034" class="usa-link" aria-describedby="pcbi.1008089.ref034">34</a>–<a href="#pcbi.1008089.ref038" class="usa-link" aria-describedby="pcbi.1008089.ref038">38</a>]) to provide insight into drug effects on cardiac conduction properties and mechanisms of arrhythmia.</p>
<p>In previous studies, we have applied a procedure based on mathematical action potential modeling to estimate drug effects on individual ion channels from measurements of hiPSC-CMs and predict adult CM drug responses [<a href="#pcbi.1008089.ref022" class="usa-link" aria-describedby="pcbi.1008089.ref022">22</a>, <a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>]. This procedure is based on the assumption that the function of individual proteins, e.g. ion channels, is the same for hiPSC-CMs and adult CMs, and that only the density of the proteins differs between hiPSC-CMs and adult CMs (see Fig 2 below). From this assumption, it follows that the effect of a drug on an individual ion channel is the same for hiPSC-CMs and adult CMs. Assuming that we have correctly identified the drug effect on individual channels in the hiPSC-CM case, we can therefore directly translate this effect to the adult case by inserting the inferred mechanisms into a model for adult cells.</p>
<p>The aim of the present study is to use this computational procedure to predict drug effects for adult SQT1 CMs based on measurements of drug effects on the action potential of SQT1 hiPSC-CMs from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>] and to extend these results into prediction of patient QT changes. Our overall computational pipeline is depicted in <a href="#pcbi.1008089.g001" class="usa-link">Fig 1</a>. We consider the four drugs quinidine, ajmaline, mexilietine and ivabradine, shown to potentially be useful for SQT1 patients in [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>] and show predicted drug responses for the drugs on the ventricular action potential and QT interval of adult patients. We validate our pipeline using data for quinidine, where measurements of the drug effect on the QT interval have been conducted for adult patients [<a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>]. The predicted drug response turns out to be in good agreement with the measured drug effect, indicating that the computational procedure could be useful for predicting adult drug responses from measurements of hiPSC-CMs.</p>
<figure class="fig xbox font-sm" id="pcbi.1008089.g001"><h3 class="obj_head">Fig 1. Illustration of the computational pipeline.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7909705_pcbi.1008089.g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f485/7909705/b7f37035bb9c/pcbi.1008089.g001.jpg" loading="lazy" height="743" width="762" alt="Fig 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/pcbi.1008089.g001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>1) Biomarkers from the cardiac AP are taken from hiPSC-CMs under drug testing. 2) These biomarkers from dose escalation studies are inverted into an SQT1 model of the AP of hiPSC-CMs. Inversion into a matched model provides determination of drug effects on specific channels [<a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>]. 3) The drug effects determined in 2 are inserted into a model of adult CMs with the same SQT1 mutation to give a prediction of drug effect in mature CMs [<a href="#pcbi.1008089.ref022" class="usa-link" aria-describedby="pcbi.1008089.ref022">22</a>]. 4) The adult CM model is converted into pseudo-ECG waveforms for prediction of QT segment changes in SQT1 patients under the estimated effect of the drug.</p></figcaption></figure></section><section id="sec002"><h2 class="pmc_sec_title">2 Methods</h2>
<p>In this section, we describe the methods applied in this study. We start by describing the basic modeling assumptions underlying the approaches used for computational identification of drug effects and mapping of drug effects from hiPSC-CMs to adult CMs. Then, we describe details of the applied action potential model and inversion procedure. Finally, we describe the approach used to estimate the QT interval in the adult case. Note that the majority of these methods are to a large extent based on the methods described in [<a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>].</p>
<section id="sec003"><h3 class="pmc_sec_title">2.1 Action potential models</h3>
<p>In this section, we describe the framework for modeling the action potentials of hiPSC-CMs and adult CMs, with and without the SQT1 mutation, and the relationship between these models. Three of the main modeling assumptions are illustrated in <a href="#pcbi.1008089.g002" class="usa-link">Fig 2</a>, building on the approaches of [<a href="#pcbi.1008089.ref022" class="usa-link" aria-describedby="pcbi.1008089.ref022">22</a>, <a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>]. In the next subsections we will explain these assumptions and demonstrate how they affect the action potential modeling.</p>
<figure class="fig xbox font-sm" id="pcbi.1008089.g002"><h4 class="obj_head">Fig 2. Illustration of the assumptions underlying the computational maturation approach.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7909705_pcbi.1008089.g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f485/7909705/d7d4e39edc73/pcbi.1008089.g002.jpg" loading="lazy" height="901" width="786" alt="Fig 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/pcbi.1008089.g002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>1) The density of different types of ion channels (and other membrane or intracellular proteins) may differ between hiPSC-CMs and adult CMs, but the function of the individual channels is the same. In the model, the density difference is represented by the parameter λ. 2) The SQT1 mutation affects the individual <em>I</em><sub>Kr</sub> channels in exactly the same manner for hiPSC-CMs and adult CMs. In the model, the mutation is represented by an adjusted model for the open probability, <em>o</em><sub>Kr</sub>. 3) The effect of a drug on a single protein is the same for hiPSC-CMs and adult CMs. In the model, the drug effect is represented by the parameter <em>ε</em>.</p></figcaption></figure><section id="sec004"><h4 class="pmc_sec_title">2.1.1 Action potential modeling framework</h4>
<p>In the action potential model, the membrane potential, <em>v</em> (in mV), is governed by an equation of the form
</p>
<table class="disp-formula p" id="pcbi.1008089.e001"><tr>
<td class="formula"><math id="M1" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><mfrac><mrow><mi>d</mi><mi>v</mi></mrow><mrow><mi>d</mi><mi>t</mi></mrow></mfrac><mo>=</mo><mo>-</mo><munder><mo>∑</mo><mi>j</mi></munder><msub><mi>I</mi><mi>j</mi></msub><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(1)</td>
</tr></table>
<p>
where <em>I</em><sub><em>j</em></sub> are different membrane current densities. These current densities can be expressed on the form
</p>
<table class="disp-formula p" id="pcbi.1008089.e002"><tr>
<td class="formula"><math id="M2" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msub><mi>I</mi><mi>j</mi></msub><mo>=</mo><mfrac><msub><mi>N</mi><mi>j</mi></msub><mrow><mi>A</mi><msub><mi>C</mi><mi>m</mi></msub></mrow></mfrac><msub><mi>i</mi><mi>j</mi></msub><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(2)</td>
</tr></table>
<p>
where <em>N</em><sub><em>j</em></sub> is the number of proteins of type <em>j</em> on the membrane, <em>A</em> is the area of the membrane, <em>C</em><sub><em>m</em></sub> is the specific membrane capacitance, and <em>i</em><sub><em>j</em></sub> is the average current through a single protein of type <em>j</em>. For currents through voltage-gated ion channels, this <em>i</em><sub><em>j</em></sub> is typically given on the form
</p>
<table class="disp-formula p" id="pcbi.1008089.e003"><tr>
<td class="formula"><math id="M3" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msub><mi>i</mi><mi>j</mi></msub><mo>=</mo><msub><mi>g</mi><mrow><mn>0</mn><mo>,</mo><mi>j</mi></mrow></msub><msub><mi>o</mi><mi>j</mi></msub><mrow><mo>(</mo><mi>v</mi><mo>-</mo><msub><mi>E</mi><mi>j</mi></msub><mo>)</mo></mrow><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(3)</td>
</tr></table>
<p>
where <em>g</em><sub>0,<em>j</em></sub> is the conductance through a single open channel, <em>o</em><sub><em>j</em></sub> is the open probability of the channel, and <em>E</em><sub><em>j</em></sub> is the equilibrium potential of the channel. In this case, it is common to introduce combined parameters of the form
</p>
<table class="disp-formula p" id="pcbi.1008089.e004"><tr>
<td class="formula"><math id="M4" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msub><mi>g</mi><mi>j</mi></msub><mo>=</mo><mfrac><msub><mi>N</mi><mi>j</mi></msub><mrow><mi>A</mi><msub><mi>C</mi><mi>m</mi></msub></mrow></mfrac><msub><mi>g</mi><mrow><mn>0</mn><mo>,</mo><mi>j</mi></mrow></msub><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(4)</td>
</tr></table>
<p>
and write <a href="#pcbi.1008089.e002" class="usa-link">(2)</a> on the form
</p>
<table class="disp-formula p" id="pcbi.1008089.e005"><tr>
<td class="formula"><math id="M5" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msub><mi>I</mi><mi>j</mi></msub><mo>=</mo><msub><mi>g</mi><mi>j</mi></msub><msub><mi>o</mi><mi>j</mi></msub><mrow><mo>(</mo><mi>v</mi><mo>-</mo><msub><mi>E</mi><mi>j</mi></msub><mo>)</mo></mrow><mo>.</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(5)</td>
</tr></table></section><section id="sec005"><h4 class="pmc_sec_title">2.1.2 Assumption 1: Functional invariance of wild type (WT) ion channels during maturation</h4>
<p>A number of electrophysiological properties have been shown to differ between hiPSC-CMs and adult CMs (see, e.g., [<a href="#pcbi.1008089.ref020" class="usa-link" aria-describedby="pcbi.1008089.ref020">20</a>, <a href="#pcbi.1008089.ref021" class="usa-link" aria-describedby="pcbi.1008089.ref021">21</a>]). In addition, the electrophysiological properties of different samples of WT hiPSC-CMs often vary significantly (see, e.g., [<a href="#pcbi.1008089.ref039" class="usa-link" aria-describedby="pcbi.1008089.ref039">39</a>, <a href="#pcbi.1008089.ref040" class="usa-link" aria-describedby="pcbi.1008089.ref040">40</a>]). We assume that these differences in electrophysiological properties (both between samples of hiPSC-CMs and between adult CMs and hiPSC-CMs) are due to:</p>
<ol class="list" style="list-style-type:decimal">
<li><p>Differences in the geometry of the cells,</p></li>
<li><p>Differences in the number of membrane proteins, like ion channels, pumps and exchangers,</p></li>
<li><p>Differences in the number of intracellular proteins, like calcium buffers, ryanodine receptors and SERCA pumps.</p></li>
</ol>
<p>However, we assume that the function of the individual membrane and intracellular proteins is the same for the different WT cases.</p>
<p>Considering the model <a href="#pcbi.1008089.e001" class="usa-link">(1)</a> and <a href="#pcbi.1008089.e002" class="usa-link">(2)</a>, these assumptions imply that the density <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pcbi.1008089.e006"><math id="M6"><mrow><msub><mi>ρ</mi><mi>j</mi></msub><mo>=</mo><mfrac><msub><mi>N</mi><mi>j</mi></msub><mi>A</mi></mfrac></mrow></math></span> may differ between cells, but that <em>i</em><sub><em>j</em></sub> remains the same. Parameterizing the model to a specific set of measurements can then be accomplished by adjustments of the densities represented by adjustment factors λ<sub><em>j</em></sub>, such that
</p>
<table class="disp-formula p" id="pcbi.1008089.e007"><tr>
<td class="formula"><math id="M7" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msub><mi>ρ</mi><mi>j</mi></msub><mo>=</mo><mrow><mo>(</mo><mn>1</mn><mo>+</mo><msub><mo>λ</mo><mi>j</mi></msub><mo>)</mo></mrow><msubsup><mi>ρ</mi><mi>j</mi><mo>*</mo></msubsup><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(6)</td>
</tr></table>
<p>
where <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pcbi.1008089.e008"><math id="M8"><msubsup><mi>ρ</mi><mi>j</mi><mo>*</mo></msubsup></math></span> is the default density of proteins of type <em>j</em>. Incorporating these adjustment factors into the model <a href="#pcbi.1008089.e001" class="usa-link">(1)</a>, specific adult and hiPSC-CM versions of the model are given by
</p>
<table class="disp-formula p" id="pcbi.1008089.e009"><tr>
<td class="formula"><math id="M9" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mfrac><mrow><mi>d</mi><mi>v</mi></mrow><mrow><mi>d</mi><mi>t</mi></mrow></mfrac></mtd><mtd><mrow><mo>=</mo><mo>-</mo><munder><mo>∑</mo><mi>j</mi></munder><mrow><mo>(</mo><mn>1</mn><mo>+</mo><msubsup><mo>λ</mo><mi>j</mi><mi mathvariant="normal">A</mi></msubsup><mo>)</mo></mrow><msub><mi>I</mi><mi>j</mi></msub><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(7)</td>
</tr></table>
<table class="disp-formula p" id="pcbi.1008089.e010"><tr>
<td class="formula"><math id="M10" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mfrac><mrow><mi>d</mi><mi>v</mi></mrow><mrow><mi>d</mi><mi>t</mi></mrow></mfrac></mtd><mtd><mrow><mo>=</mo><mo>-</mo><munder><mo>∑</mo><mi>j</mi></munder><mrow><mo>(</mo><mn>1</mn><mo>+</mo><msubsup><mo>λ</mo><mi>j</mi><mtext>hiPSC</mtext></msubsup><mo>)</mo></mrow><msub><mi>I</mi><mi>j</mi></msub><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(8)</td>
</tr></table>
<p>
respectively, where <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pcbi.1008089.e011"><math id="M11"><msubsup><mo>λ</mo><mi>j</mi><mi mathvariant="normal">A</mi></msubsup></math></span> and <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pcbi.1008089.e012"><math id="M12"><msubsup><mo>λ</mo><mi>j</mi><mtext>hiPSC</mtext></msubsup></math></span> specify the adjustment factors for the protein densities in the two cases. For currents through ion channels, these adjustment factors can be incorporated by adjusting the conductances, <em>g</em><sub><em>j</em></sub> (see <a href="#pcbi.1008089.e004" class="usa-link">(4)</a> and <a href="#pcbi.1008089.e005" class="usa-link">(5)</a>). Similar adjustment factors can be set up for the density of intracellular proteins and the cell geometry, see [<a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>]. A list of the maturation-dependent parameter values of the base model are given in Table IV of the <a href="#pcbi.1008089.s001" class="usa-link">S1 Appendix</a>.</p></section><section id="sec006"><h4 class="pmc_sec_title">2.1.3 Assumption 2: Functional invariance of mutated ion channels during maturation</h4>
<p>We assume that a mutation affects an individual ion channel in exactly the same manner for hiPSC-CMs and adult CMs. SQT1 is known to affect the <em>I</em><sub>Kr</sub> current [<a href="#pcbi.1008089.ref003" class="usa-link" aria-describedby="pcbi.1008089.ref003">3</a>, <a href="#pcbi.1008089.ref041" class="usa-link" aria-describedby="pcbi.1008089.ref041">41</a>], and we assume that the effect on the current can be represented by adjusting the model for the open probability, <em>o</em><sub>Kr</sub> (see <a href="#pcbi.1008089.e003" class="usa-link">(3)</a>). More specifically, we adjust the voltage dependence of the steady state inactivation gate, <em>x</em><sub>Kr2</sub>, by shifting the inactivation towards more positive potentials, as described for the SQT1 mutation N588K in [<a href="#pcbi.1008089.ref003" class="usa-link" aria-describedby="pcbi.1008089.ref003">3</a>]. Because we assume that the mutation affects an individual <em>I</em><sub>Kr</sub> channel in the same manner for hiPSC-CMs and adult CMs, we apply the same adjustment of the model for <em>o</em><sub>Kr</sub> in the hiPSC and adult SQT1 cases. In addition, we assume that the SQT1 mutation can be represented solely by this adjustment of <em>o</em><sub>Kr</sub>, and that the density of proteins, including the density of <em>I</em><sub>Kr</sub> channels, is the same in the WT and SQT1 cases.</p></section><section id="sec007"><h4 class="pmc_sec_title">2.1.4 Assumption 3: Identical drug effects for identical proteins</h4>
<p>The third assumption illustrated in <a href="#pcbi.1008089.g002" class="usa-link">Fig 2</a> is that since the function of a single ion channel is the same for hiPSC-CMs and adult CMs, the effect of a drug on an individual ion channel will also be identical for hiPSC-CMs and adult CMs. This means that if we are able to determine the effect of a drug on an individual channel in the hiPSC-CM case, we can find the effect of the same drug in the adult case by incorporating the same single channel drug effect in the adult version of the model.</p>
<p>Following [<a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>], we use a simple IC<sub>50</sub>-based modeling approach to represent the effect of a drug. That is, we assume that the average single channel current through a channel <em>j</em> in the presence of the drug dose <em>D</em> is given by
</p>
<table class="disp-formula p" id="pcbi.1008089.e013"><tr>
<td class="formula"><math id="M13" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msub><mi>i</mi><mi>j</mi></msub><mrow><mo>(</mo><mi>D</mi><mo>)</mo></mrow><mo>=</mo><mfrac><mn>1</mn><mrow><mn>1</mn><mo>+</mo><msub><mi>ε</mi><mi>j</mi></msub><mi>D</mi></mrow></mfrac><msub><mi>i</mi><mi>j</mi></msub><mrow><mo>(</mo><mn>0</mn><mo>)</mo></mrow><mo>.</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(9)</td>
</tr></table>
<p>Here, <em>i</em><sub><em>j</em></sub>(0) is the average single channel current when no drug is present and <em>ε</em><sub><em>j</em></sub> (in <em>μ</em>M<sup>−1</sup>) represents the effect of the drug, defined as
</p>
<table class="disp-formula p" id="pcbi.1008089.e014"><tr>
<td class="formula"><math id="M14" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msub><mi>ε</mi><mi>j</mi></msub><mo>=</mo><mfrac><mn>1</mn><msubsup><mtext>IC</mtext><mrow><mn>50</mn></mrow><mi>j</mi></msubsup></mfrac><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(10)</td>
</tr></table>
<p>
where <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pcbi.1008089.e015"><math id="M15"><msubsup><mtext>IC</mtext><mrow><mn>50</mn></mrow><mi>j</mi></msubsup></math></span> (in <em>μ</em>M) is the drug concentration that blocks the current <em>j</em> by 50%. Incorporating drug effects into the hiPSC-CM and adult CM models <a href="#pcbi.1008089.e009" class="usa-link">(7)</a> and <a href="#pcbi.1008089.e010" class="usa-link">(8)</a>, we obtain
</p>
<table class="disp-formula p" id="pcbi.1008089.e016"><tr>
<td class="formula"><math id="M16" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mfrac><mrow><mi>d</mi><mi>v</mi></mrow><mrow><mi>d</mi><mi>t</mi></mrow></mfrac></mtd><mtd><mrow><mo>=</mo><mo>-</mo><munder><mo>∑</mo><mi>j</mi></munder><mfrac><mrow><mn>1</mn><mo>+</mo><msubsup><mo>λ</mo><mi>j</mi><mi mathvariant="normal">A</mi></msubsup></mrow><mrow><mn>1</mn><mo>+</mo><msub><mi>ε</mi><mi>j</mi></msub><mi>D</mi></mrow></mfrac><msub><mi>I</mi><mi>j</mi></msub><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(11)</td>
</tr></table>
<table class="disp-formula p" id="pcbi.1008089.e017"><tr>
<td class="formula"><math id="M17" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mfrac><mrow><mi>d</mi><mi>v</mi></mrow><mrow><mi>d</mi><mi>t</mi></mrow></mfrac></mtd><mtd><mrow><mo>=</mo><mo>-</mo><munder><mo>∑</mo><mi>j</mi></munder><mfrac><mrow><mn>1</mn><mo>+</mo><msubsup><mo>λ</mo><mi>j</mi><mtext>hiPSC</mtext></msubsup></mrow><mrow><mn>1</mn><mo>+</mo><msub><mi>ε</mi><mi>j</mi></msub><mi>D</mi></mrow></mfrac><msub><mi>I</mi><mi>j</mi></msub><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(12)</td>
</tr></table>
<p>
where we note that <em>ε</em><sub><em>j</em></sub> is the same in the two versions of the model.</p>
<p>In this study, we will use this modeling framework to estimate the drug effect (in the form of <em>ε</em> values) of drugs based on action potential measurements of hiPSC-CMs with the SQT1 mutation N588K. Next, we will insert the estimated <em>ε</em> values into a model for adult ventricular cells with the same mutation to estimate the effect of the drug for an adult patient.</p></section><section id="sec008"><h4 class="pmc_sec_title">2.1.5 Adult and hiPSC-CM base model variability</h4>
<p>In our computations, we use action potential measurements of hiPSC-CMs to predict drug effects for adult patients. In this procedure, we need to fit the hiPSC-CM base model <a href="#pcbi.1008089.e010" class="usa-link">(8)</a> to match data of specific samples of hiPSC-CMs. The properties of these hiPSC-CMs tend to vary between experiments, also in the control case (see, e.g., the biomarkers for the zero dose cases in Fig 7). Therefore, we let the values of the adjustment factors, <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pcbi.1008089.e018"><math id="M18"><msubsup><mo>λ</mo><mi>j</mi><mtext>hiPSC</mtext></msubsup></math></span>, vary for each experiment (that is, for each considered drug). The adjustment factors are, however, assumed to be the same in the control case and for all doses of a specific drug. Following [<a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>], in the adult case, we consider only one default case defined by the parameters <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pcbi.1008089.e019"><math id="M19"><msubsup><mo>λ</mo><mi>j</mi><mi mathvariant="normal">A</mi></msubsup></math></span>. In other words, the adult base model is assumed to be the same in all cases, regardless of the variability in the parameters <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pcbi.1008089.e020"><math id="M20"><msubsup><mo>λ</mo><mi>j</mi><mtext>hiPSC</mtext></msubsup></math></span>.</p></section><section id="sec009"><h4 class="pmc_sec_title">2.1.6 Base model formulation</h4>
<p>In order to represent the action potentials of adult ventricular CMs and hiPSC-CMs (both with and without the SQT1 mutation N588K), we use a slightly modified version of the base model formulation from [<a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>], following the form <a href="#pcbi.1008089.e001" class="usa-link">(1)</a> and <a href="#pcbi.1008089.e002" class="usa-link">(2)</a>. Three main adjustments have been incorporated into the current version of the model. First, we have modified the steady-state values of the gating variables of the <em>I</em><sub>Kr</sub> current to better fit measured <em>I</em><sub>Kr</sub> currents in the WT and SQT1 cases from [<a href="#pcbi.1008089.ref014" class="usa-link" aria-describedby="pcbi.1008089.ref014">14</a>] (see Fig 5). Second, we have extended the temperature-dependence of the model by including Q<sub>10</sub> values for a number of the currents, following [<a href="#pcbi.1008089.ref042" class="usa-link" aria-describedby="pcbi.1008089.ref042">42</a>, <a href="#pcbi.1008089.ref043" class="usa-link" aria-describedby="pcbi.1008089.ref043">43</a>]. This was done because we consider two different temperatures in our computations. In the adult case, we assume body temperature (310 K), while for the hiPSC-CM case, we assume room temperature (296 K) since the considered hiPSC-CM data (from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>]) are obtained at room temperature. Third, we have incorporated a dynamic model for the intracellular Na<sup>+</sup> concentration. This was done in order to make the frequency dependent QT interval changes more physiologically realistic (see Fig 11). The full base model formulation is found in the <a href="#pcbi.1008089.s001" class="usa-link">S1 Appendix</a>. The system of ordinary differential equations (ODEs) defined by the base model is solved using the <em>ode15s</em> solver in MATLAB. The MATLAB code for the base model is found in <a href="#pcbi.1008089.s003" class="usa-link">S1 Code</a>.</p></section><section id="sec010"><h4 class="pmc_sec_title">2.1.7 Stimulation protocol</h4>
<p>In the adult case, we use 1 Hz pacing unless otherwise specified. Furthermore, we run each simulation for at least 500 pacing cycles after each parameter change in order to obtain new stable solutions before recording the action potentials (and pseudo-ECGs, see Section 2.4 below).</p>
<p>In the hiPSC-CMs case, we use 0.2 Hz pacing, as specified in [<a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>]. As a compromise between the need to obtain new stable solutions after each parameter change and the need for reducing the computing time of the inversion procedure, we run the simulation for 30 pacing cycles before measuring the action potential for each iteration in the continuation method used for optimization (see Section 2.3.2). However, the parameter changes between each iteration of the continuation method are expected to be quite small and we update the initial conditions between each of the 20 iterations. Therefore, the final solutions of the inversion are expected to be quite close to the steady state solutions for the applied parameters. This has also been confirmed by numerical experiments. For example, the APD90 value for the inversion of data for 10 <em>μ</em>M of quinidine was 323.7 ms using 30 pacing cycles from the states saved in the second-to-last continuation iteration. When the simulation was allowed to continue for 500 pacing cycles, the APD90 value changed by only 0.5% to 325.5 ms.</p></section><section id="sec011"><h4 class="pmc_sec_title">2.1.8 Parameterization of default adult and hiPSC-CM base models</h4>
<p>In order to parameterize the default adult and hiPSC-CM versions of the base model for WT and SQT1, the model parameters are adjusted by hand. For the hiPSC-CM case, adjustments are made to the conductance of all membrane currents. The purpose of the adjustments is to obtain a model in rough agreement with some measured current densities and AP characteristics for WT and SQT1 hiPSC-CMs from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>] to use as a suitable starting point for the inversions of hiPSC-CM data. A comparison of the AP characteristics and current densities from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>] to the corresponding values for the default WT and SQT1 versions of the hiPSC-CM model are given in <a href="#pcbi.1008089.s005" class="usa-link">S1 Fig</a> of the Supporting Information.</p>
<p>In the adult case, the base model parameters are fitted to information about the heart rate dependent value of the QTp interval (see Section 2.4) measured for adults with and without the SQT1 mutation from [<a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>]. Because the intracellular Na<sup>+</sup> and Ca<sup>+</sup> dynamics are important for the frequency response of action potential models [<a href="#pcbi.1008089.ref027" class="usa-link" aria-describedby="pcbi.1008089.ref027">27</a>], the conductance of the currents responsible for the balance of intracellular Ca<sup>2+</sup> and Na<sup>+</sup> concentrations are adjusted (i.e., the conductance of <em>I</em><sub>CaL</sub>, <em>I</em><sub>bCa</sub>, <em>I</em><sub>pCa</sub>, <em>I</em><sub>NaCa</sub>, <em>I</em><sub>Na</sub>, and <em>I</em><sub>NaK</sub>) in order to fit the model to the heart rate dependent QTp interval. In addition, to achieve the measured difference between WT and SQT1 QTp intervals, the conductance of the different repolarizing currents <em>I</em><sub>Kr</sub>, <em>I</em><sub>Ks</sub>, and <em>I</em><sub>bCl</sub> are adjusted. We also attempt to make the current densities during an action potential relatively close to the current densities of the well-established adult ventricular AP models of Grandi et al. and O’Hara et al. [<a href="#pcbi.1008089.ref026" class="usa-link" aria-describedby="pcbi.1008089.ref026">26</a>, <a href="#pcbi.1008089.ref027" class="usa-link" aria-describedby="pcbi.1008089.ref027">27</a>]. A comparison of some of the main current densities between the adult WT base model and the Grandi et al. and the O’Hara et al. models are given in <a href="#pcbi.1008089.s006" class="usa-link">S2 Fig</a> of the Supporting Information.</p></section></section><section id="sec012"><h3 class="pmc_sec_title">2.2 Inversion of <em>I</em><sub>Kr</sub> measurements</h3>
<p>In order to represent the WT and SQT1 <em>I</em><sub>Kr</sub> currents, parameters of the model for the <em>I</em><sub>Kr</sub> open probability are fitted to data of WT and SQT1 <em>I</em><sub>Kr</sub> currents from [<a href="#pcbi.1008089.ref014" class="usa-link" aria-describedby="pcbi.1008089.ref014">14</a>]. In this data, it is revealed that the steady state inactivation of the current is shifted towards higher potentials in the SQT1 (N588K) case compared to the WT case (see the right panel of Fig 5 below). Therefore, we assume that the mutation can be represented in the model by an adjusted model for the steady state value of the inactivation gate, <em>x</em><sub>Kr2</sub>. To find a model matching the data as well as possible, we introduce six free parameters <em>c</em><sub>1</sub> − <em>c</em><sub>6</sub> in the steady state activation and inactivation gates of the <em>I</em><sub>Kr</sub> current on the form:
</p>
<table class="disp-formula p" id="pcbi.1008089.e021"><tr>
<td class="formula"><math id="M21" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msub><mi>x</mi><mrow><mtext>Kr</mtext><mn>1</mn><mo>,</mo><mi>∞</mi></mrow></msub><mrow><mo>(</mo><mi>v</mi><mo>)</mo></mrow></mrow></mtd><mtd><mrow><mo>=</mo><mfrac><mn>1</mn><mrow><mn>1</mn><mo>+</mo><mo form="prefix">exp</mo><mo>(</mo><mrow><mo>(</mo><mi>v</mi><mo>+</mo><msub><mi>c</mi><mn>1</mn></msub><mo>)</mo></mrow><mo>/</mo><msub><mi>c</mi><mn>2</mn></msub><mo>)</mo></mrow></mfrac><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(13)</td>
</tr></table>
<table class="disp-formula p" id="pcbi.1008089.e022"><tr>
<td class="formula"><math id="M22" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msub><mi>x</mi><mrow><mtext>Kr</mtext><mn>2</mn><mo>,</mo><mi>∞</mi></mrow></msub><mrow><mo>(</mo><mi>v</mi><mo>)</mo></mrow></mrow></mtd><mtd><mrow><mo>=</mo><mfrac><mn>1</mn><mrow><mn>1</mn><mo>+</mo><mo form="prefix">exp</mo><mo>(</mo><mrow><mo>(</mo><mi>v</mi><mo>+</mo><msub><mi>c</mi><mn>3</mn></msub><mo>)</mo></mrow><mo>/</mo><msub><mi>c</mi><mn>4</mn></msub><mo>)</mo></mrow></mfrac></mrow></mtd><mtd columnalign="left"><mrow><mtext>for</mtext><mspace width="4pt"></mspace><mtext>WT,</mtext></mrow></mtd></mtr></mtable></math></td>
<td class="label">(14)</td>
</tr></table>
<table class="disp-formula p" id="pcbi.1008089.e023"><tr>
<td class="formula"><math id="M23" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msub><mi>x</mi><mrow><mtext>Kr</mtext><mn>2</mn><mo>,</mo><mi>∞</mi></mrow></msub><mrow><mo>(</mo><mi>v</mi><mo>)</mo></mrow></mrow></mtd><mtd><mrow><mo>=</mo><mfrac><mn>1</mn><mrow><mn>1</mn><mo>+</mo><mo form="prefix">exp</mo><mo>(</mo><mrow><mo>(</mo><mi>v</mi><mo>+</mo><msub><mi>c</mi><mn>3</mn></msub><mo>+</mo><msub><mi>c</mi><mn>5</mn></msub><mo>)</mo></mrow><mo>/</mo><mrow><mo>(</mo><msub><mi>c</mi><mn>4</mn></msub><mo>·</mo><msub><mi>c</mi><mn>6</mn></msub><mo>)</mo></mrow><mo>)</mo></mrow></mfrac></mrow></mtd><mtd columnalign="left"><mrow><mtext>for</mtext><mspace width="4pt"></mspace><mtext>SQT1</mtext><mo>.</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(15)</td>
</tr></table>
<p>See <a href="#pcbi.1008089.s001" class="usa-link">S1 Appendix</a> for a description of the full <em>I</em><sub>Kr</sub> model formulation. To find optimal values of the six parameters <em>c</em><sub>1</sub> − <em>c</em><sub>6</sub>, we run simulations of the voltage clamp protocol applied in [<a href="#pcbi.1008089.ref014" class="usa-link" aria-describedby="pcbi.1008089.ref014">14</a>]. That is, we first fix the membrane potential at -80 mV and run a simulation to steady state. Then, we increase the membrane potential to a value between -50 mV and 100 mV and compare the current after 2 seconds of simulation to the corresponding current reported in [<a href="#pcbi.1008089.ref014" class="usa-link" aria-describedby="pcbi.1008089.ref014">14</a>]. In addition, we compare the steady state values of the inactivation gate <em>x</em><sub>Kr2</sub> directly to the steady state inactivation measurements reported in [<a href="#pcbi.1008089.ref014" class="usa-link" aria-describedby="pcbi.1008089.ref014">14</a>].</p>
<p>In the simulations trying to adjust the <em>I</em><sub>Kr</sub> model to measurements from [<a href="#pcbi.1008089.ref014" class="usa-link" aria-describedby="pcbi.1008089.ref014">14</a>], we adjust the temperature and intracellular and extracellular potassium concentrations in the model to match those reported for the experiments, that is <em>T</em> = 37°C, [K<sup>+</sup>]<sub><em>i</em></sub> = 130 mM, [K<sup>+</sup>]<sub><em>e</em></sub> = 4 mM.</p>
<p>We find the optimal parameters <em>c</em> = (<em>c</em><sub>1</sub>, …, <em>c</em><sub>6</sub>) by minimizing a cost function of the form
</p>
<table class="disp-formula p" id="pcbi.1008089.e024"><tr>
<td class="formula"><math id="M24" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msub><mi>H</mi><mtext>Kr</mtext></msub><mrow><mo>(</mo><mi>c</mi><mo>)</mo></mrow><mo>=</mo><msqrt><mrow><munder><mo>∑</mo><mi>i</mi></munder><msup><mrow><mo>(</mo><msup><mi>I</mi><mi>d</mi></msup><mrow><mo>(</mo><msub><mi>v</mi><mi>i</mi></msub><mo>)</mo></mrow><mo>-</mo><msup><mi>I</mi><mi>b</mi></msup><mrow><mo>(</mo><mi>c</mi><mo>,</mo><msub><mi>v</mi><mi>i</mi></msub><mo>)</mo></mrow><mo>)</mo></mrow><mn>2</mn></msup></mrow></msqrt><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(16)</td>
</tr></table>
<p>
using the Nelder-Mead algorithm [<a href="#pcbi.1008089.ref044" class="usa-link" aria-describedby="pcbi.1008089.ref044">44</a>]. Here, <em>v</em><sub><em>i</em></sub> are each of the values of the membrane potential considered in the data set, <em>I</em><sup><em>d</em></sup>(<em>v</em><sub><em>i</em></sub>) are each of the measured data points for relative <em>I</em><sub>Kr</sub> currents, and <em>I</em><sup><em>b</em></sup>(<em>c</em>, <em>v</em><sub><em>i</em></sub>) are the corresponding currents computed for the model specified by the parameters <em>c</em>.</p></section><section id="sec013"><h3 class="pmc_sec_title">2.3 Inversion of action potential measurements</h3>
<p>The inversion of data of SQT1 hiPSC-CMs exposed to various drugs is performed using the inversion procedure described in [<a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>]. In the inversion, the adjustment factors λ<sub>Kr</sub>, λ<sub>CaL</sub>, λ<sub>Na</sub>, λ<sub>K1</sub>, λ<sub>f</sub>, λ<sub>NaCa</sub>, λ<sub>NaK</sub>, and λ<sub>bCl</sub> for the currents <em>I</em><sub>Kr</sub>, <em>I</em><sub>CaL</sub>, <em>I</em><sub>Na</sub>, <em>I</em><sub>K1</sub>, <em>I</em><sub>f</sub>, <em>I</em><sub>NaCa</sub>, <em>I</em><sub>NaK</sub>, and <em>I</em><sub>bCl</sub>, and the combined adjustment factor λ<sub>B</sub>, adjusting all the intracellular calcium buffers as in [<a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>] are treated as free parameters. In addition, we assume that the drugs affect the <em>I</em><sub>Kr</sub>, <em>I</em><sub>CaL</sub> or <em>I</em><sub>Na</sub> currents for quinidine, ajmaline and mexiletine and the <em>I</em><sub>Kr</sub>, <em>I</em><sub>f</sub> or <em>I</em><sub>Na</sub> currents for ivabradine. Therefore, we introduce the drug parameters <em>ε</em><sub>Kr</sub>, <em>ε</em><sub>f</sub> and <em>ε</em><sub>Na</sub> for ivabradine and <em>ε</em><sub>Kr</sub>, <em>ε</em><sub>CaL</sub>, and <em>ε</em><sub>Na</sub> for the remaining drugs. For a given drug, these twelve parameters are fitted to data simultaneously using information about both the control case and each drug dose included in the data set as explained below.</p>
<section id="sec014"><h4 class="pmc_sec_title">2.3.1 Cost function definition</h4>
<p>In the inversion procedure, we wish to minimize a cost function of the form
</p>
<table class="disp-formula p" id="pcbi.1008089.e025"><tr>
<td class="formula"><math id="M25" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><mi>H</mi><mrow><mo>(</mo><mo>λ</mo><mo>,</mo><mi>ε</mi><mo>)</mo></mrow><mo>=</mo><munder><mo>∑</mo><mi>d</mi></munder><munder><mo>∑</mo><mi>i</mi></munder><msub><mi>w</mi><mrow><mi>d</mi><mo>,</mo><mi>i</mi></mrow></msub><msup><mrow><mo>(</mo><msub><mi>H</mi><mi>i</mi></msub><mrow><mo>(</mo><mo>λ</mo><mo>,</mo><mi>ε</mi><mo>,</mo><msub><mi>D</mi><mi>d</mi></msub><mo>)</mo></mrow><mo>)</mo></mrow><mn>2</mn></msup><mo>+</mo><msub><mi>H</mi><mtext>reg</mtext></msub><mrow><mo>(</mo><mo>λ</mo><mo>,</mo><mi>ε</mi><mo>)</mo></mrow><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(17)</td>
</tr></table>
<p>
where <em>D</em><sub><em>d</em></sub> represent each of the drug doses included in the data set (including the control case, <em>D</em><sub>0</sub> = 0), <em>H</em><sub><em>i</em></sub> represent the different cost function terms included in the cost function, <em>w</em><sub><em>d</em>,<em>i</em></sub> are weights for each of the cost function terms and doses and <em>H</em><sub>reg</sub> is a regularization term (see <a href="#pcbi.1008089.e028" class="usa-link">(19)</a> below). The cost function consists of terms of the form
</p>
<table class="disp-formula p" id="pcbi.1008089.e026"><tr>
<td class="formula"><math id="M26" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msub><mi>H</mi><mi>i</mi></msub><mrow><mo>(</mo><mo>λ</mo><mo>,</mo><mi>ε</mi><mo>,</mo><msub><mi>D</mi><mi>d</mi></msub><mo>)</mo></mrow><mo>=</mo><mfrac><mrow><mrow><mo>|</mo></mrow><msub><mi>R</mi><mi>i</mi></msub><mrow><mo>(</mo><mo>λ</mo><mo>,</mo><mi>ε</mi><mo>,</mo><msub><mi>D</mi><mi>d</mi></msub><mo>)</mo></mrow><mo>-</mo><msubsup><mi>R</mi><mi>i</mi><mo>*</mo></msubsup><mrow><mo>(</mo><msub><mi>D</mi><mi>d</mi></msub><mo>)</mo></mrow><mrow><mo>|</mo></mrow></mrow><mrow><mrow><mo>|</mo></mrow><msubsup><mi>R</mi><mi>i</mi><mo>*</mo></msubsup><mrow><mo>(</mo><msub><mi>D</mi><mi>d</mi></msub><mo>)</mo></mrow><mrow><mo>|</mo></mrow></mrow></mfrac><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(18)</td>
</tr></table>
<p>
where <em>R</em><sub><em>i</em></sub>(λ, <em>ε</em>, <em>D</em><sub><em>d</em></sub>) is a biomarker computed from the solution of the model specified by λ and <em>ε</em> for the drug dose <em>D</em><sub><em>d</em></sub>, and <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pcbi.1008089.e027"><math id="M27"><mrow><msubsup><mi>R</mi><mi>i</mi><mo>*</mo></msubsup><mrow><mo>(</mo><msub><mi>D</mi><mi>d</mi></msub><mo>)</mo></mrow></mrow></math></span> is the corresponding measured biomarker of the data we are trying to invert.</p>
<p><strong>Considered biomarkers</strong>. We consider each of the biomarkers, <em>R</em><sub><em>i</em></sub>, included in the data sets from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>], i.e., APD50, APD90, APA, dvdt and RMP. These biomarkers are illustrated in the left panel of <a href="#pcbi.1008089.g003" class="usa-link">Fig 3</a>. Here, the maximal upstroke velocity, dvdt (in mV/ms), is defined as the maximum value of the derivative of the membrane potential with respect to time, the resting membrane potential, RMP (in mV), is defined as the minimum value of the membrane potential, the action potential amplitude, APA (in mV), is defined as the difference between maximum and minimum values of the membrane potential, and the APD50 and APD90 values are defined as the time (in ms) from the time point of the maximum upstroke velocity to the time point where the membrane potential first reaches a value below 50% or 90%, respectively, of the action potential amplitude. All biomarkers are computed directly from the model solution, found using an adaptive time step in MATLAB’s ODE solver <em>ode15s</em>.</p>
<figure class="fig xbox font-sm" id="pcbi.1008089.g003"><h5 class="obj_head">Fig 3. Illustration of considered biomarkers.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7909705_pcbi.1008089.g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f485/7909705/d092ae4e3e21/pcbi.1008089.g003.jpg" loading="lazy" height="367" width="750" alt="Fig 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/pcbi.1008089.g003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Left: Illustration of the five biomarkers included in the cost function of the inversion procedure: The action potential durations (in ms) at 90% and 50% repolarization (APD90 and APD50, respectively), the maximal upstroke velocity (dvdt, in mV/ms), the action potential amplitude (APA, in mV) and the resting membrane potential (RMP, in mV). Right: Illustration of the QTp interval (in ms) computed from a pseudo-ECG waveform. The QTp interval is defined as the time from the onset of the QRS complex to the peak of the T-wave.</p></figcaption></figure><p><strong>Cost function weights</strong>. We use the weight 3 for <em>H</em><sub>APA</sub>, the weight 6 for <em>H</em><sub>APD90</sub> and the weight 1 for the remaining terms. In addition, the weights for the control case, <em>w</em><sub>0,<em>j</em></sub>, and the weight for <em>H</em><sub>APD90</sub> for the largest dose are multiplied by the total number of doses included in the data set. The term <em>H</em><sub>RMP</sub> is only included for the drug quinidine because it was not specified in the data set for the remaining drugs [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>]. The specific weights used for the cost function terms are chosen to prevent large errors for single biomarkers and to give an overall acceptable fit.</p>
<p><strong>Regularization term</strong>. The regularization term, <em>H</em><sub>reg</sub>(λ, <em>ε</em>), is defined as
</p>
<table class="disp-formula p" id="pcbi.1008089.e028"><tr>
<td class="formula"><math id="M28" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msub><mi>H</mi><mtext>reg</mtext></msub><mrow><mo>(</mo><mo>λ</mo><mo>,</mo><mi>ε</mi><mo>)</mo></mrow><mo>=</mo><msub><mi>w</mi><mo>λ</mo></msub><munder><mo>∑</mo><mrow><mi>j</mi><mo>∈</mo><msub><mi>S</mi><mo>λ</mo></msub></mrow></munder><msubsup><mo>λ</mo><mi>j</mi><mn>2</mn></msubsup><mo>+</mo><msub><mi>w</mi><mi>ε</mi></msub><munder><mo>∑</mo><mrow><mi>j</mi><mo>∈</mo><msub><mi>S</mi><mi>ε</mi></msub></mrow></munder><msup><mrow><mo>(</mo><mover accent="true"><mi>D</mi><mo>˜</mo></mover><msub><mi>ε</mi><mi>j</mi></msub><mo>)</mo></mrow><mn>2</mn></msup><mo>.</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(19)</td>
</tr></table>
<p>Here, the first term is defined to make the inversion procedure avoid solutions with unrealistically large perturbations of some of the currents, and the second term is defined to make the inversion select small drug perturbations if small and large perturbations result in almost indistinguishable solutions (<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pcbi.1008089.e029"><math id="M29"><mover accent="true"><mi>D</mi><mo>˜</mo></mover></math></span> is the median of the considered drug doses of the data set). In our computations, we set the weights for the terms to <em>w</em><sub>λ</sub> = 1 and <em>w</em><sub><em>ε</em></sub> = 0.001. We let the set <em>S</em><sub><em>ε</em></sub> consist of all the currents we assume may be affected by the drug and the set <em>S</em><sub>λ</sub> consist of the <em>I</em><sub>Kr</sub> and <em>I</em><sub>CaL</sub> currents. Note that we here assume that λ<sub><em>j</em></sub> = 0 defines the starting point of the inversion procedure (i.e., the default hiPSC-CM base model parameterization).</p></section><section id="sec015"><h4 class="pmc_sec_title">2.3.2 Optimization method</h4>
<p>We apply the continuation-based optimization algorithm from [<a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>] to minimize the cost function <a href="#pcbi.1008089.e025" class="usa-link">(17)</a>. A simple example application of the continuation algorithm with two free parameters fitted to a single AP waveform is illustrated in <a href="#pcbi.1008089.g004" class="usa-link">Fig 4</a>. In short, the algorithm consists of introducing a parameter, <em>θ</em>, which is gradually increased from 0 to 1 in <em>M</em> iterations (or <em>θ</em>-steps). For each <em>θ</em>-step, we seek the optimal parameters fitting a temporary objective that is, as <em>θ</em> is increased, gradually adjusted from the default model solution to the actual data we are trying to invert. More specifically, for a given <em>θ</em> ∈ [0, 1], we try to minimize the cost function <a href="#pcbi.1008089.e025" class="usa-link">(17)</a> and <a href="#pcbi.1008089.e026" class="usa-link">(18)</a> with the biomarkers given by
</p>
<table class="disp-formula p" id="pcbi.1008089.e030"><tr>
<td class="formula"><math id="M30" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msubsup><mi>R</mi><mi>i</mi><mo>*</mo></msubsup><mrow><mo>(</mo><mi>θ</mi><mo>)</mo></mrow><mo>=</mo><mrow><mo>(</mo><mn>1</mn><mo>-</mo><mi>θ</mi><mo>)</mo></mrow><msub><mi>R</mi><mi>i</mi></msub><mrow><mo>(</mo><mn>0</mn><mo>)</mo></mrow><mo>+</mo><mi>θ</mi><msubsup><mi>R</mi><mi>i</mi><mo>*</mo></msubsup><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(20)</td>
</tr></table>
<p>
where <em>R</em><sub><em>i</em></sub>(0) are the biomarkers of the default model used as a starting point for the optimization, <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pcbi.1008089.e031"><math id="M31"><msubsup><mi>R</mi><mi>i</mi><mo>*</mo></msubsup></math></span> are the biomarkers of the data and <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pcbi.1008089.e032"><math id="M32"><mrow><msubsup><mi>R</mi><mi>i</mi><mo>*</mo></msubsup><mrow><mo>(</mo><mi>θ</mi><mo>)</mo></mrow></mrow></math></span> define a temporary objective. The purpose of gradually stepping from the default model solution to the data in this manner is that we know the optimal solution for <em>θ</em> = 0, and for each <em>θ</em>-step, we assume that the optimal parameters are quite close to the optimal parameters of the last step. Therefore, we can keep the space in which to search for optimal parameters quite small in each iteration.</p>
<figure class="fig xbox font-sm" id="pcbi.1008089.g004"><h5 class="obj_head">Fig 4. Illustration of the continuation algorithm used for optimization in the inversion method.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7909705_pcbi.1008089.g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f485/7909705/b7f9b265082b/pcbi.1008089.g004.jpg" loading="lazy" height="900" width="750" alt="Fig 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/pcbi.1008089.g004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>A) The problem is defined by a default model and some data we are trying to invert by finding an optimal model parameterization fitting the data. B) In the continuation algorithm, we seek temporary optimal parameters in <em>M</em> iterations (<em>θ</em>-steps). The objective for each <em>θ</em>-step is gradually changed from the default model to the data we are trying to invert. C) In each <em>θ</em>-step, we look for optimal parameters for the temporary objective by drawing <em>N</em><sub>G</sub> random guesses in the vicinity of the optimal parameters from the previous <em>θ</em>-step. For each random guess, we run <em>N</em><sub>NM</sub> Nelder-Mead iterations, and from the result, we select the best fit as the new optimal parameters. D) The final parameterization is given by the optimal parameters found in the last <em>θ</em>-step.</p></figcaption></figure><p>In our computations, we use <em>M</em> = 20 continuation iterations (<em>θ</em>-steps) with <em>N</em><sub>G</sub> = 100 or 200 randomly chosen initial guesses for the first fifteen and the last five iterations, respectively. The initial guesses for λ are chosen within 20% above or below the optimal values from the previous iteration, and the initial guesses for <em>ε</em><sub><em>m</em></sub> are chosen within [<em>ε</em><sub><em>m</em>−1</sub>/5, 5<em>ε</em><sub><em>m</em>−1</sub>], where <em>ε</em><sub><em>m</em>−1</sub> is the optimal <em>ε</em> from the previous iteration. From these initial guesses we run <em>N</em><sub>NM</sub> = 30 or 60 iterations of the Nelder-Mead algorithm [<a href="#pcbi.1008089.ref044" class="usa-link" aria-describedby="pcbi.1008089.ref044">44</a>] for the first fifteen and the last five iterations, respectively.</p>
<p>We have chosen to use the continuation-based optimization algorithm because we have previous experience from [<a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>] using this algorithm for this type of optimization problems. Furthermore, in <a href="#pcbi.1008089.s008" class="usa-link">S4 Fig</a> of the Supporting Information, we show a comparison of the continuation method with other optimization methods. The other methods are provided in MATLAB’s Global Optimization Toolbox [<a href="#pcbi.1008089.ref045" class="usa-link" aria-describedby="pcbi.1008089.ref045">45</a>]. We compare the methods for cases using simulated data and thus the exact minimum is known. This allows for comparison of the methods and it turns out that the continuation method compares well with the other methods, especially when the number of free parameters increases.</p></section></section><section id="sec016"><h3 class="pmc_sec_title">2.4 Computation of pseudo-ECG and QT interval</h3>
<p>In order to estimate drug effects on adult QT intervals, we apply a simple pseudo-ECG calculation applied in a number of earlier studies (e.g., [<a href="#pcbi.1008089.ref046" class="usa-link" aria-describedby="pcbi.1008089.ref046">46</a>–<a href="#pcbi.1008089.ref050" class="usa-link" aria-describedby="pcbi.1008089.ref050">50</a>]). The calculation follows a two-step procedure.</p>
<section id="sec017"><h4 class="pmc_sec_title">Step 1</h4>
<p>The membrane potential and membrane currents along a strand of cylindrical cells are computed using the cable equation as explained i detail in [<a href="#pcbi.1008089.ref035" class="usa-link" aria-describedby="pcbi.1008089.ref035">35</a>]. In this step, cells are connected to each other by gap junctions, each cell is assumed to be isopotential, and the extracellular potential is assumed to be constant in space. The membrane potential <em>v</em><sub><em>k</em></sub> in each cell <em>k</em> is modeled by
</p>
<table class="disp-formula p" id="pcbi.1008089.e033"><tr>
<td class="formula"><math id="M33" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><mn>2</mn><mi>π</mi><mi>r</mi><mi>L</mi><msub><mi>R</mi><mtext>CG</mtext></msub><msub><mi>C</mi><mi>m</mi></msub><mo>(</mo><mfrac><mrow><mi>d</mi><msub><mi>v</mi><mi>k</mi></msub></mrow><mrow><mi>d</mi><mi>t</mi></mrow></mfrac><mo>+</mo><msubsup><mi>I</mi><mrow><mtext>ion</mtext></mrow><mi>k</mi></msubsup><mo>)</mo><mo>=</mo><mi>π</mi><msup><mi>r</mi><mn>2</mn></msup><mo>(</mo><msubsup><mi>σ</mi><mi>i</mi><mrow><mi>k</mi><mo>-</mo><mn>1</mn><mo>/</mo><mn>2</mn></mrow></msubsup><mfrac><mrow><msub><mi>v</mi><mrow><mi>k</mi><mo>-</mo><mn>1</mn></mrow></msub><mo>-</mo><msub><mi>v</mi><mi>k</mi></msub></mrow><mi>L</mi></mfrac><mo>+</mo><msubsup><mi>σ</mi><mi>i</mi><mrow><mi>k</mi><mo>+</mo><mn>1</mn><mo>/</mo><mn>2</mn></mrow></msubsup><mfrac><mrow><msub><mi>v</mi><mrow><mi>k</mi><mo>+</mo><mn>1</mn></mrow></msub><mo>-</mo><msub><mi>v</mi><mi>k</mi></msub></mrow><mi>L</mi></mfrac><mo>)</mo><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(21)</td>
</tr></table>
<p>
where <em>r</em> is the cell radius, <em>L</em> is the cell length, <em>R</em><sub>CG</sub> is the ratio between the capacitive and the geometrical cell areas (see, e.g., [<a href="#pcbi.1008089.ref035" class="usa-link" aria-describedby="pcbi.1008089.ref035">35</a>]), <em>C</em><sub><em>m</em></sub> is the specific cell capacitance and <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pcbi.1008089.e034"><math id="M34"><msubsup><mi>σ</mi><mi>i</mi><mrow><mi>k</mi><mo>-</mo><mn>1</mn><mo>/</mo><mn>2</mn></mrow></msubsup></math></span> is the averaged intracellular conductivity between cells <em>k</em> − 1 and <em>k</em>. This averaged intracellular conductivity is given by
</p>
<table class="disp-formula p" id="pcbi.1008089.e035"><tr>
<td class="formula"><math id="M35" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msub><mi>σ</mi><mi>i</mi></msub><mo>=</mo><mfrac><mn>1</mn><mrow><msub><mi>R</mi><mtext>myo</mtext></msub><mo>+</mo><mfrac><msub><mi>R</mi><mi>g</mi></msub><mi>L</mi></mfrac></mrow></mfrac><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(22)</td>
</tr></table>
<p>
where <em>R</em><sub>myo</sub> is the myoplasmic resistance and <em>R</em><sub><em>g</em></sub> is the gap junction resistance. Furthermore, <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pcbi.1008089.e036"><math id="M36"><msubsup><mi>I</mi><mrow><mtext>ion</mtext></mrow><mi>k</mi></msubsup></math></span> is the sum of the ionic current densities of the cell, modeled by the base model (i.e., ∑<sub><em>j</em></sub>
<em>I</em><sub><em>j</em></sub> in <a href="#pcbi.1008089.e001" class="usa-link">(1)</a>).</p>
<p>The ODE system defined by <a href="#pcbi.1008089.e033" class="usa-link">(21)</a> is solved using the <em>ode15s</em> solver in MATLAB, and the solution is used to compute the membrane currents
</p>
<table class="disp-formula p" id="pcbi.1008089.e037"><tr>
<td class="formula"><math id="M37" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msubsup><mi>I</mi><mi>m</mi><mrow><mi>k</mi><mo>,</mo><mi>n</mi></mrow></msubsup><mo>=</mo><mi>π</mi><msup><mi>r</mi><mn>2</mn></msup><mo>(</mo><msubsup><mi>σ</mi><mi>i</mi><mrow><mi>k</mi><mo>-</mo><mn>1</mn><mo>/</mo><mn>2</mn></mrow></msubsup><mfrac><mrow><msubsup><mi>v</mi><mrow><mi>k</mi><mo>-</mo><mn>1</mn></mrow><mi>n</mi></msubsup><mo>-</mo><msubsup><mi>v</mi><mrow><mi>k</mi></mrow><mi>n</mi></msubsup></mrow><mi>L</mi></mfrac><mo>+</mo><msubsup><mi>σ</mi><mi>i</mi><mrow><mi>k</mi><mo>+</mo><mn>1</mn><mo>/</mo><mn>2</mn></mrow></msubsup><mfrac><mrow><msubsup><mi>v</mi><mrow><mi>k</mi><mo>+</mo><mn>1</mn></mrow><mi>n</mi></msubsup><mo>-</mo><msubsup><mi>v</mi><mrow><mi>k</mi></mrow><mi>n</mi></msubsup></mrow><mi>L</mi></mfrac><mo>)</mo><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(23)</td>
</tr></table>
<p>
originating from each cell <em>i</em> at each time point <em>n</em>.</p></section><section id="sec018"><h4 class="pmc_sec_title">Step 2</h4>
<p>The extracellular potential originating from the cell strand is computed for each time step <em>n</em> using the so-called point-source approximation (see, e.g., [<a href="#pcbi.1008089.ref046" class="usa-link" aria-describedby="pcbi.1008089.ref046">46</a>, <a href="#pcbi.1008089.ref051" class="usa-link" aria-describedby="pcbi.1008089.ref051">51</a>]),
</p>
<table class="disp-formula p" id="pcbi.1008089.e038"><tr>
<td class="formula"><math id="M38" display="block"><mtable displaystyle="true"><mtr><mtd columnalign="right"><mrow><msubsup><mi>u</mi><mi>e</mi><mi>n</mi></msubsup><mo>=</mo><mfrac><mn>1</mn><mrow><mn>4</mn><mi>π</mi><msub><mi>σ</mi><mi>e</mi></msub></mrow></mfrac><munder><mo>∑</mo><mi>k</mi></munder><mfrac><msubsup><mi>I</mi><mi>m</mi><mrow><mi>k</mi><mo>,</mo><mi>n</mi></mrow></msubsup><mrow><mrow><mo>|</mo><mi>r</mi><mo>-</mo></mrow><msub><mi>r</mi><mi>k</mi></msub><mrow><mo>|</mo></mrow></mrow></mfrac><mo>,</mo></mrow></mtd></mtr></mtable></math></td>
<td class="label">(24)</td>
</tr></table>
<p>
where <em>σ</em><sub><em>e</em></sub> is the extracellular conductivity and |<em>r</em> − <em>r</em><sub><em>k</em></sub>| is the Euclidean distance between the point at which we are measuring the extracellular potential, <em>r</em>, and the center of cell number <em>k</em>, <em>r</em><sub><em>k</em></sub>.</p></section><section id="sec019"><h4 class="pmc_sec_title">Parameter values</h4>
<p>The parameters of the pseudo-ECG simulations are based on the parameters of earlier computations of pseudo-ECGs (e.g., [<a href="#pcbi.1008089.ref035" class="usa-link" aria-describedby="pcbi.1008089.ref035">35</a>, <a href="#pcbi.1008089.ref046" class="usa-link" aria-describedby="pcbi.1008089.ref046">46</a>, <a href="#pcbi.1008089.ref049" class="usa-link" aria-describedby="pcbi.1008089.ref049">49</a>]). We consider a cell stand of 100 cells of length <em>L</em> = 150<em>μ</em>m and radius <em>r</em> = 10<em>μ</em>m. We let the cell strand exhibit transmural heterogeneity of ion channel density, with an endocardial region consisting of the first 25 cells, a midmyocardial region for the next 35 cells and an epicardial region in the last 40 cells. The default adult base model defines the ion channel density in the epicardial region. In the endocardial region, the <em>I</em><sub>to</sub> and <em>I</em><sub>Ks</sub> channel densities are reduced to 1% and 31%, respectively, compared to the epicardial region. Similarly, in the midmyocardial region, the <em>I</em><sub>to</sub> and <em>I</em><sub>Ks</sub> channel densities are reduced to 85% and 11%, respectively, compared to the epicardial region.</p>
<p>Furthermore, we set <em>C</em><sub><em>m</em></sub> = 1<em>μ</em>F/cm<sup>2</sup>, <em>R</em><sub>CG</sub> = 2, <em>R</em><sub>myo</sub> = 0.15 kΩcm, and <em>R</em><sub><em>g</em></sub> = 0.0015 kΩcm<sup>2</sup>, resulting in a conduction velocity along the cell strand of approximately 52 cm/s, close to experimentally measured conduction velocities from literature (∼50 cm/s [<a href="#pcbi.1008089.ref052" class="usa-link" aria-describedby="pcbi.1008089.ref052">52</a>]). Stimulation is applied for the first two cells of the endocardial region, and the extracellular potential is measured 2 cm from the end of the epicardial region. Because we in this study only are interested in the time course of the ECG and not the amplitude in mV, we do not assign a specific value for <em>σ</em><sub><em>e</em></sub> and report the computed pseudo-ECG without numbers on the <em>u</em><sub><em>e</em></sub>-axis.</p></section><section id="sec020"><h4 class="pmc_sec_title">Definition of the QT interval</h4>
<p>After computing a pseudo-ECG using the described approach, the QT interval is computed from the ECG waveforms. The QT interval is often defined as the time from the start of the QRS interval to the end of the T-wave (see <a href="#pcbi.1008089.g003" class="usa-link">Fig 3</a>). However, in the study [<a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>], which we will use for comparison to the computational results, an alternative definition of the so-called QTp interval is applied, defined as the time from the start of the QRS complex to the peak of the T-wave, as illustrated in the right panel of <a href="#pcbi.1008089.g003" class="usa-link">Fig 3</a>. We will therefore use this definition in this study. Note that for the SQT1 case, the computed T-wave is inverted to have the opposite sign of the QRS complex (see Fig 6). In that case, we define the peak of the T-wave as the time point when the minimum, i.e. the maximum absolute deviation of the T-wave, is reached.</p></section></section></section><section id="sec021"><h2 class="pmc_sec_title">3 Results</h2>
<p>In this section, we describe the results of our applications of the above mentioned methods. First, we set up the default hiPSC-CM and adult base models for WT and SQT1 based on measurements of WT and SQT1 <em>I</em><sub>Kr</sub> currents from [<a href="#pcbi.1008089.ref014" class="usa-link" aria-describedby="pcbi.1008089.ref014">14</a>]. Next, we apply the inversion procedure to identify the effect of four drugs on individual ion channels based on action potential measurements of SQT1 hiPSC-CMs from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>]. Finally, we estimate the corresponding drug effect for adult patients with short QT syndrome using these identified drug effects.</p>
<section id="sec022"><h3 class="pmc_sec_title">3.1 Computational representation of the SQT1 mutation</h3>
<p>In order to represent the SQT1 mutation N588K in the model, we first adjust the model of the open probability of the <em>I</em><sub>Kr</sub> current to data for WT and SQT1 <em>I</em><sub>Kr</sub> currents from [<a href="#pcbi.1008089.ref014" class="usa-link" aria-describedby="pcbi.1008089.ref014">14</a>] as described in Section 2.2. The optimal values for the model given on the form <a href="#pcbi.1008089.e021" class="usa-link">(13)</a>–<a href="#pcbi.1008089.e023" class="usa-link">(15)</a> returned by the inversion procedure are <em>c</em><sub>1</sub> = −2.7, <em>c</em><sub>2</sub> = −15.3, <em>c</em><sub>3</sub> = 70, <em>c</em><sub>4</sub> = 20.9, <em>c</em><sub>5</sub> = −62, <em>c</em><sub>6</sub> = 1.85. In <a href="#pcbi.1008089.g005" class="usa-link">Fig 5</a>, the fitted model solutions of <em>I</em><sub>Kr</sub> in the WT and SQT1 cases are compared to the data from [<a href="#pcbi.1008089.ref014" class="usa-link" aria-describedby="pcbi.1008089.ref014">14</a>]. In the right panel, we observe that the inactivation is shifted towards higher values of the membrane potential in the SQT1 case.</p>
<figure class="fig xbox font-sm" id="pcbi.1008089.g005"><h4 class="obj_head">Fig 5. Representation of the SQT1 mutation N588K in the <em>I</em><sub>Kr</sub> model.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7909705_pcbi.1008089.g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f485/7909705/0bfda311c211/pcbi.1008089.g005.jpg" loading="lazy" height="282" width="665" alt="Fig 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/pcbi.1008089.g005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Left panel: Steady state <em>I</em><sub>Kr</sub> currents obtained at different fixed values of the membrane potential divided by the currents obtained at <em>v</em> = 0 mV. The results obtained for the fitted WT and SQT1 <em>I</em><sub>Kr</sub> models are compared to corresponding data from [<a href="#pcbi.1008089.ref014" class="usa-link" aria-describedby="pcbi.1008089.ref014">14</a>]. Right panel: Comparison of the steady state inactivation gate in the WT and SQT1 models of <em>I</em><sub>Kr</sub> and steady state inactivation data from [<a href="#pcbi.1008089.ref014" class="usa-link" aria-describedby="pcbi.1008089.ref014">14</a>]. In the SQT1 case, the inactivation is shifted towards higher values of the membrane potential. Data used in this figure can be found in <a href="#pcbi.1008089.s004" class="usa-link">S1 Data</a>.</p></figcaption></figure><p>The WT and SQT1 versions of the <em>I</em><sub>Kr</sub> model fitted to measurements from [<a href="#pcbi.1008089.ref014" class="usa-link" aria-describedby="pcbi.1008089.ref014">14</a>] are inserted into the base model formulation. The parameters, λ<sup>hiPSC</sup>, for the hiPSC-CM versions of the model are then fitted to action potential measurements of WT and SQT1 hiPSC-CMs from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>]. In addition, the parameters of adult versions of the base model are fitted to information about the QTp interval for adults with and without the SQT1 mutation from [<a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>]. These adjustments are made by hand-tuning the parameters of the default hiPSC-CM and adult versions of the base model from [<a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>], as described in Section 2.1.8.</p>
<p>The action potentials of the resulting models are plotted in the upper panel of <a href="#pcbi.1008089.g006" class="usa-link">Fig 6</a>, along with the computed pseudo-ECG for the adult case. The pseudo-ECG is computed using the approach described in Section 2.4. Note that the only difference between the WT and SQT1 versions of the models is a difference in the steady state inactivation gate of the <em>I</em><sub>Kr</sub> current (see <a href="#pcbi.1008089.e023" class="usa-link">(15)</a>), and that the remaining model parameters (including the density of <em>I</em><sub>Kr</sub> channels) are the same in the WT and SQT1 cases. Note also that the adjustment of the <em>I</em><sub>Kr</sub> steady state inactivation gate is exactly the same in the hiPSC-CM and adult versions of the model (following assumption 2 in <a href="#pcbi.1008089.g002" class="usa-link">Fig 2</a>), but that the geometry of the cell and the density of different types of membrane and intracellular proteins are different between the models for hiPSC-CMs and adult CMs (following assumption 1 in <a href="#pcbi.1008089.g002" class="usa-link">Fig 2</a>).</p>
<figure class="fig xbox font-sm" id="pcbi.1008089.g006"><h4 class="obj_head">Fig 6. Properties of the base models for hiPSC-CMs and adult ventricular CMs in the WT and SQT1 cases.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7909705_pcbi.1008089.g006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f485/7909705/ec18affd7542/pcbi.1008089.g006.jpg" loading="lazy" height="410" width="800" alt="Fig 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/pcbi.1008089.g006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Upper panel: Comparison of the action potentials computed for the WT and SQT1 versions of the hiPSC-CM (left) and adult (center) models, in addition to the pseudo-ECG for the adult model (right). The only difference between the formulations of the WT and SQT1 models is a shift in the inactivation gate of <em>I</em><sub>Kr</sub> as illustrated in the right panel of <a href="#pcbi.1008089.g005" class="usa-link">Fig 5</a>. Lower panel: APD90 values and QTp intervals computed using the WT and SQT1 versions of the models. The computed APD90 values for hiPSC-CMs are compared to data from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>], and the computed QTp intervals for adults are compared to data from [<a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>]. Data used in this figure can be found in <a href="#pcbi.1008089.s004" class="usa-link">S1 Data</a>.</p></figcaption></figure><p>In the lower panel of <a href="#pcbi.1008089.g006" class="usa-link">Fig 6</a>, we report the APD90 values of the WT and SQT1 models in the hiPSC-CM and adult cases. In addition, we report the QTp interval computed from the pseudo-ECG (see <a href="#pcbi.1008089.g003" class="usa-link">Fig 3</a>). In the hiPSC-CM case, we compare the APD90 values of the model to the corresponding values reported in [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>]. The APD90 value is reduced from 324 ms in the WT case to 188 ms in the SQT1 case, in good agreement with the values reported in [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>]. In the adult case, the APD90 value is similarly reduced from 272 ms to 189 ms. Furthermore, the QTp interval is reduced from 292 ms in the WT case to 200 ms in the SQT1 case, close to reported QTp values from [<a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>]. Moreover, in Figure 1 of [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>], an ECG from the SQT1 patient whose skin fibroblasts were used to generate the SQT1 hiPSC-CMs of the study is reported. Considering the signal recorded in lead V3 (as in [<a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>]), the QTp interval can be estimated to be about 170 ms. Correcting for heart rate using Bazett’s formula and assuming a heart rate of 60 beats per minute (as is used in the simulation) the QTp interval is about 190 ms, similar to the value reported in [<a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>] and close to the value given by the model (200 ms). We also note that in the computed pseudo-ECG, the T-wave is positive in the WT case and negative in the SQT1 case. A note on this property is found in the <a href="#pcbi.1008089.s002" class="usa-link">S2 Appendix</a>.</p></section><section id="sec023"><h3 class="pmc_sec_title">3.2 Computational identification of drug response from membrane potential measurements of SQT1 hiPSC-CMs</h3>
<p>In [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>], action potential biomarkers are reported from measurements of hiPSC-CMs with the SQT1 mutation N588K exposed to drugs attempting to make the properties of the SQT1 cells more similar to those of WT cells. In this paper, we wish to use this data to estimate the corresponding drug responses for adult SQT1 patients. In order to make these predictions, we first need to identify the effect of the drugs on individual ion channels in the hiPSC-CM case, based on the data provided in [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>]. These drug effects are predicted using the inversion procedure described in Section 2.3 using the SQT1 hiPSC-CM model from <a href="#pcbi.1008089.g006" class="usa-link">Fig 6</a> as a starting point for the inversion.</p>
<p><a href="#pcbi.1008089.g007" class="usa-link">Fig 7</a> shows how well the biomarkers of the fitted SQT1 hiPSC-CM model match the corresponding biomarkers reported in the data. We observe that the biomarkers of the fitted models are quite similar to the values of the data. In particular, the model seems to capture the APD90 increase resulting from the drugs quite well. In the lower panel of <a href="#pcbi.1008089.g008" class="usa-link">Fig 8</a>, the action potentials of the SQT1 hiPSC-CM models fitted to the data are plotted for the control case and for each of the drug doses, along with the action potential of the default base model for WT hiPSC-CM. We observe that each of the drugs increases the action potential duration, but not enough to fully recapture the WT hiPSC-CM action potential length.</p>
<figure class="fig xbox font-sm" id="pcbi.1008089.g007"><h4 class="obj_head">Fig 7. Comparison of measured and computed action potential biomarkers.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7909705_pcbi.1008089.g007.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f485/7909705/fd87b066a8a6/pcbi.1008089.g007.jpg" loading="lazy" height="839" width="800" alt="Fig 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/pcbi.1008089.g007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>We consider the biomarkers reported in the data from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>] (green) and computed from the fitted SQT1 hiPSC-CM models returned by the inversion procedure described in Section 2.3 (purple) for the drugs quinidine, ivabradine, ajmaline and mexiletine. Note that the definition of each of the biomarkers are illustrated in <a href="#pcbi.1008089.g003" class="usa-link">Fig 3</a> and that RMP data are only included for the quinidine case. Data are shown as the mean ± SEM (standard error of the mean). Data used in this figure can be found in <a href="#pcbi.1008089.s004" class="usa-link">S1 Data</a>.</p></figcaption></figure><figure class="fig xbox font-sm" id="pcbi.1008089.g008"><h4 class="obj_head">Fig 8. Result of the inversion procedure applied to data for the drugs quinidine, ivabradine, ajmaline and mexiletine from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>].</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7909705_pcbi.1008089.g008.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f485/7909705/8aa7be72499e/pcbi.1008089.g008.jpg" loading="lazy" height="406" width="800" alt="Fig 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/pcbi.1008089.g008/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Upper panel: Predicted drug effect on individual ion channels in the form of <em>ε</em>-values returned by the inversion procedure. Lower panel: Action potentials of the fitted SQT1 hiPSC-CM models in the control case and for doses of each drug. For comparison, we also show the action potential of the WT hiPSC-CM model. Action potential characteristics of the fitted models in the lower panel are compared to data from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>] in <a href="#pcbi.1008089.g007" class="usa-link">Fig 7</a>. Data used in this figure can be found in <a href="#pcbi.1008089.s004" class="usa-link">S1 Data</a>.</p></figcaption></figure><p>The upper panel of <a href="#pcbi.1008089.g008" class="usa-link">Fig 8</a> reports the drug effects identified by the inversion procedure in the form of <em>ε</em> values. Recall that <em>ε</em><sub><em>j</em></sub> is defined as <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pcbi.1008089.e039"><math id="M39"><mrow><mn>1</mn><mo>/</mo><msubsup><mtext>IC</mtext><mrow><mn>50</mn></mrow><mi>j</mi></msubsup></mrow></math></span>, where <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pcbi.1008089.e040"><math id="M40"><msubsup><mtext>IC</mtext><mrow><mn>50</mn></mrow><mi>j</mi></msubsup></math></span> is the drug concentration that blocks the current <em>j</em> by 50%. In other words, a high <em>ε</em> value corresponds to a significant drug effect. We observe that the inversion procedure predicts that all four drugs have a significant effect on the <em>I</em><sub>Kr</sub> current. In addition, ajmaline is estimated to considerably block the <em>I</em><sub>CaL</sub> current, and mexiletine is estimated to block <em>I</em><sub>Na</sub>.</p>
<p>In [<a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>], measured drug effects on SQT1 <em>I</em><sub>Kr</sub> currents are reported for the maximum dose of each of the considered drugs. In order to get an impression of the accuracy of the IC<sub>50</sub> values estimated by the inversion procedure, we compare the block percentages reported in [<a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>] to the corresponding block percentages estimated by the computational procedure. The results are displayed in <a href="#pcbi.1008089.g009" class="usa-link">Fig 9</a>, and we observe that the estimated block percentages seem to be in good agreement with the measured values.</p>
<figure class="fig xbox font-sm" id="pcbi.1008089.g009"><h4 class="obj_head">Fig 9. Comparison of reported and estimated block percentages for <em>I</em><sub>Kr</sub>.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7909705_pcbi.1008089.g009.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f485/7909705/953e2952f1a6/pcbi.1008089.g009.jpg" loading="lazy" height="406" width="750" alt="Fig 9"></a></p>
<div class="p text-right font-secondary"><a href="figure/pcbi.1008089.g009/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>We consider the reported block percentages for 10 <em>μ</em>M quinidine, 10 <em>μ</em>M ivabradine, 30 <em>μ</em>M ajmaline and 100 <em>μ</em>M mexiletine from [<a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>] and the block percentages estimated based on the IC<sub>50</sub> values identified in the inversion procedure. Data are shown as the mean ± SEM. Data used in this figure can be found in <a href="#pcbi.1008089.s004" class="usa-link">S1 Data</a>.</p></figcaption></figure></section><section id="sec024"><h3 class="pmc_sec_title">3.3 Estimation of drug response for adult SQT1 patients</h3>
<p>Following assumption 3 in <a href="#pcbi.1008089.g002" class="usa-link">Fig 2</a>, we assume that the effect of a drug on a single ion channel is the same for hiPSC-CMs and adult CMs. Using this assumption, we can estimate the effect of the drugs quinidine, ivabradine, ajmaline and mexiletine for adult SQT1 CMs by inserting the <em>ε</em> values identified in <a href="#pcbi.1008089.g008" class="usa-link">Fig 8</a> into the adult SQT1 base model. In <a href="#pcbi.1008089.g010" class="usa-link">Fig 10</a>, we report the resulting estimated adult drug effects. In the upper panel, we show the ventricular action potentials for the SQT1 case with no drug and with each of the considered drug doses present. In addition, we show the action potential in the WT case. The lower panel of <a href="#pcbi.1008089.g010" class="usa-link">Fig 10</a> displays the adult QTp intervals computed from pseudo-ECG simulations as explained in Section 2.4. We observe that the drugs increase the QTp interval for the SQT1 case to be more similar to the WT QTp interval. For 10 <em>μ</em>M of quinidine, the QTp interval is estimated to increase from 200 ms to 257 ms. Similarly, the QTp interval is predicted to increase to 238 ms for 10 <em>μ</em>M of ivabradine, and 221 ms for 100 <em>μ</em>M of mexiletine. For comparison, the WT QTp interval is 292 ms. For 30 <em>μ</em>M of ajmaline, the QTp interval is predicted to increase to only 209 ms. This is probably caused by the fact that ajmaline is estimated to have considerable effect on both the depolarizing current <em>I</em><sub>CaL</sub> and the repolarizing current <em>I</em><sub>Kr</sub>, and that these two drug effects cancel each other out in the adult model.</p>
<figure class="fig xbox font-sm" id="pcbi.1008089.g010"><h4 class="obj_head">Fig 10. Estimated drug effects for adult patients with the SQT1 mutation.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7909705_pcbi.1008089.g010.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f485/7909705/b13cb68b5d4e/pcbi.1008089.g010.jpg" loading="lazy" height="376" width="800" alt="Fig 10"></a></p>
<div class="p text-right font-secondary"><a href="figure/pcbi.1008089.g010/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The figure displays the estimated drug effect of quinidine, ivabradine, ajmaline and mexiletine for adult patients with the SQT1 mutation (and a heart rate of 60 beats/min) based on the result of the inversion of hiPSC-CM data reported in <a href="#pcbi.1008089.g008" class="usa-link">Fig 8</a>. Upper panel: Estimated drug effect on the adult ventricular action potential. Lower panel: Estimated drug effect on the QTp interval. See <a href="#pcbi.1008089.g003" class="usa-link">Fig 3</a> for an illustration of the definition of the QTp interval. Note that the blue lines represent the adult WT case. Data used in this figure can be found in <a href="#pcbi.1008089.s004" class="usa-link">S1 Data</a>.</p></figcaption></figure><p>The effect of the drug quinidine on the QTp interval of adult SQT1 patients is reported for a number of different heart rates in [<a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>]. In <a href="#pcbi.1008089.g011" class="usa-link">Fig 11</a>, we compare the predicted adult drug response of quinidine from our computational procedure to the measured responses in [<a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>]. In the study [<a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>], mean serum concentration was reported as 2.1 mg/L. Applying the molecular weight of quinidine of 324.4 g/mol [<a href="#pcbi.1008089.ref053" class="usa-link" aria-describedby="pcbi.1008089.ref053">53</a>], we consider the drug concentration 6.5 <em>μ</em>M in the computational model. Moreover, we use the <em>ε</em> values identified based on measurements of SQT1 hiPSC-CMs from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>] (see <a href="#pcbi.1008089.g008" class="usa-link">Fig 8</a>). The QTp intervals are computed for different pacing frequencies using the pseudo-ECG approach described in Section 2.4. In <a href="#pcbi.1008089.g011" class="usa-link">Fig 11</a>, we observe that the QTp intervals predicted by the model for different heart rates fit well with the measured data in both the WT case, in the SQT1 case and in the SQT1 case with quinidine.</p>
<figure class="fig xbox font-sm" id="pcbi.1008089.g011"><h4 class="obj_head">Fig 11. Comparison of measured and estimated adult QTp intervals.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7909705_pcbi.1008089.g011.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f485/7909705/8b48d8c38e1b/pcbi.1008089.g011.jpg" loading="lazy" height="620" width="750" alt="Fig 11"></a></p>
<div class="p text-right font-secondary"><a href="figure/pcbi.1008089.g011/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>We compare the QTp intervals (see <a href="#pcbi.1008089.g003" class="usa-link">Fig 3</a>) estimated by the computational procedure and the measured QTp intervals from [<a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>] for different heart rates. We consider the WT case, the SQT1 case and the SQT1 case with cells exposed to 6.5 <em>μ</em>M quinidine. The drug effect estimated by the procedure is based on measured drug effects for SQT1 hiPSC-CMs from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>]. Data used in this figure can be found in <a href="#pcbi.1008089.s004" class="usa-link">S1 Data</a>.</p></figcaption></figure></section></section><section id="sec025"><h2 class="pmc_sec_title">4 Discussion</h2>
<p>In this paper, we have applied the computational procedure introduced in [<a href="#pcbi.1008089.ref022" class="usa-link" aria-describedby="pcbi.1008089.ref022">22</a>, <a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>] to data of hiPSC-CMs derived from an SQT1 patient, found in [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>]. In this procedure, we first identified the drug response on individual ion channels based on measurements of drug effects for SQT1 hiPSC-CMs and then estimated the drug effect for an adult SQT1 patient by inserting these single channel drug effects into a model for adult cells.</p>
<section id="sec026"><h3 class="pmc_sec_title">4.1 Computational representation of the SQT mutation</h3>
<p>Short QT syndrome is characterized by an abnormally short duration of the QT interval, and several different genetic mutations have proven to give rise to different subtypes of the syndrome [<a href="#pcbi.1008089.ref001" class="usa-link" aria-describedby="pcbi.1008089.ref001">1</a>–<a href="#pcbi.1008089.ref003" class="usa-link" aria-describedby="pcbi.1008089.ref003">3</a>]. SQT1–SQT3 are caused by gain of function mutations in the potassium channels responsible for the <em>I</em><sub>Kr</sub>, <em>I</em><sub>Ks</sub> and <em>I</em><sub>K1</sub> currents, respectively, while SQT4–SQT6 are associated with loss of function mutations in genes encoding calcium channels. Furthermore, SQT7 and SQT8 have been characterized by a loss of function mutation in a gene encoding sodium channels and a mutation in a gene encoding the cardiac Cl/HCO<sub>3</sub> exchangers AE3, respectively [<a href="#pcbi.1008089.ref054" class="usa-link" aria-describedby="pcbi.1008089.ref054">54</a>]. Because of the different effects of different mutations, it is likely that pharmacological treatment of SQT syndrome must be tailored to the individual subtypes. Furthermore, in order to study the effects of mutations computationally, different mathematical representations are needed for the mechanistic causes of the shortening.</p>
<p>In this study, we have considered the SQT1 subtype, caused by a mutation (N588K) leading to increased <em>I</em><sub>Kr</sub> currents. Based on measurements of WT and mutated <em>I</em><sub>Kr</sub> currents [<a href="#pcbi.1008089.ref014" class="usa-link" aria-describedby="pcbi.1008089.ref014">14</a>], we represented the mutation by shifting the inactivation of the channels towards more positive potentials (see <a href="#pcbi.1008089.e023" class="usa-link">(15)</a> and <a href="#pcbi.1008089.g005" class="usa-link">Fig 5</a>). This computational representation of the mutation follows the same lines as [<a href="#pcbi.1008089.ref049" class="usa-link" aria-describedby="pcbi.1008089.ref049">49</a>, <a href="#pcbi.1008089.ref055" class="usa-link" aria-describedby="pcbi.1008089.ref055">55</a>, <a href="#pcbi.1008089.ref056" class="usa-link" aria-describedby="pcbi.1008089.ref056">56</a>], which used similar adjustments of the model for the <em>I</em><sub>Kr</sub>, <em>I</em><sub>Ks</sub> and <em>I</em><sub>K1</sub> open probabilities to represent the SQT1, SQT2 and SQT3 subtypes, respectively.</p>
<p>In the base model used in this study (see <a href="#pcbi.1008089.s001" class="usa-link">S1 Appendix</a>), as well as in other commonly used action potential models (e.g., [<a href="#pcbi.1008089.ref026" class="usa-link" aria-describedby="pcbi.1008089.ref026">26</a>, <a href="#pcbi.1008089.ref027" class="usa-link" aria-describedby="pcbi.1008089.ref027">27</a>, <a href="#pcbi.1008089.ref030" class="usa-link" aria-describedby="pcbi.1008089.ref030">30</a>, <a href="#pcbi.1008089.ref057" class="usa-link" aria-describedby="pcbi.1008089.ref057">57</a>]), the open probability of voltage-gated ion channels are governed by gating variables following the Hodgkin-Huxley formalism. However, more detailed and versatile models for the open probability have been introduced in the form of more complicated Markov models (see, e.g., [<a href="#pcbi.1008089.ref058" class="usa-link" aria-describedby="pcbi.1008089.ref058">58</a>, <a href="#pcbi.1008089.ref059" class="usa-link" aria-describedby="pcbi.1008089.ref059">59</a>] for a comparison of the two formalisms). Such Markov models have been suggested to give a more realistic representation of both the effect of mutations and the effect of drugs (see, e.g., [<a href="#pcbi.1008089.ref060" class="usa-link" aria-describedby="pcbi.1008089.ref060">60</a>–<a href="#pcbi.1008089.ref062" class="usa-link" aria-describedby="pcbi.1008089.ref062">62</a>]), and was applied in computational studies of SQT1 in [<a href="#pcbi.1008089.ref048" class="usa-link" aria-describedby="pcbi.1008089.ref048">48</a>, <a href="#pcbi.1008089.ref063" class="usa-link" aria-describedby="pcbi.1008089.ref063">63</a>, <a href="#pcbi.1008089.ref064" class="usa-link" aria-describedby="pcbi.1008089.ref064">64</a>] and SQT3 in [<a href="#pcbi.1008089.ref065" class="usa-link" aria-describedby="pcbi.1008089.ref065">65</a>]. On the other hand, complex Markov models are associated with a significant increase in the number of free parameters to determine in the models, and we have therefore chosen to use a more simplified Hodgkin-Huxley formalism in this study.</p>
<p>The WT and SQT1 versions of the <em>I</em><sub>Kr</sub> current were inserted into the base models for hiPSC-CMs and adult CMs to define WT and SQT1 versions of these action potential models. The resulting computed action potentials displayed a clear action potential shortening for the SQT1 case for both hiPSC-CMs and adult CMs (see <a href="#pcbi.1008089.g006" class="usa-link">Fig 6</a>). The computed pseudo-ECGs for the adult case also displayed a clear reduction in the duration of the QT interval for SQT1. Furthermore, the APD90 values of the hiPSC-CM model and the QT intervals of the adult model appeared to fit well with measured data for WT and SQT1 from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>].</p></section><section id="sec027"><h3 class="pmc_sec_title">4.2 Computational identification of drug effects from membrane potential measurements of SQT1 hiPSC-CMs</h3>
<p>Because of the possibly lethal risks associated with SQT syndrome, there is an urgent need for efficient therapies, including pharmacological treatment. In [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>], a number of drug candidates were tested on hiPSC-CMs generated from an SQT1 patient, and the drugs quinidine, ivabradine, ajmailine and mexiletine seemed to be the most promising for increasing the action potential duration of the SQT1 hiPSC-CMs. Other drugs shown to block WT <em>I</em><sub>Kr</sub> (sotalol, ranolazine, flecainide, amiodarone) did not seem to work as well for hiPSC-CMs affected by the SQT1 mutation. This highlights the need for mutation-specific investigations of drug effects. Here we have tried to extend such investigations computationally, and have used the measurements from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>] to estimate the effect of quinidine, ivabradine, ajmaline and mexiletine for adult SQT1 patients using the computational procedure introduced in [<a href="#pcbi.1008089.ref022" class="usa-link" aria-describedby="pcbi.1008089.ref022">22</a>, <a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>].</p>
<section id="sec028"><h4 class="pmc_sec_title">4.2.1 Identifiability of model parameters</h4>
<p>In [<a href="#pcbi.1008089.ref022" class="usa-link" aria-describedby="pcbi.1008089.ref022">22</a>, <a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>], drug effects were identified in an inversion procedure based on optical measurements of the membrane potential and cytosolic calcium concentration of hiPSC-CMs in a microphysiological system [<a href="#pcbi.1008089.ref066" class="usa-link" aria-describedby="pcbi.1008089.ref066">66</a>]. In the present study, we have used a different type of data in the inversion procedure, i.e., membrane potential measurements from patch-clamp recordings. This alternative data type could have both advantages and disadvantages compared to the optical measurements used in [<a href="#pcbi.1008089.ref022" class="usa-link" aria-describedby="pcbi.1008089.ref022">22</a>, <a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>]. A disadvantage is that we only have measurements of the membrane potential and not any information about the calcium transient. Information about the calcium transient has been shown to potentially improve the identification of parameters in mathematical action potential models [<a href="#pcbi.1008089.ref022" class="usa-link" aria-describedby="pcbi.1008089.ref022">22</a>, <a href="#pcbi.1008089.ref067" class="usa-link" aria-describedby="pcbi.1008089.ref067">67</a>, <a href="#pcbi.1008089.ref068" class="usa-link" aria-describedby="pcbi.1008089.ref068">68</a>]. However, an advantage of the patch-clamp recordings is that we can obtain information about the actual value of the membrane potential instead of just relative pixel intensities from optical measurements of voltage sensitive dyes. Therefore, we can get information about the resting membrane potential, the action potential amplitude and the upstroke velocity, which could all be useful for the identification of parameters. For example, the upstroke velocity is difficult to obtain from optical measurements of the action potential, which makes it very hard to identify drug effects on the fast sodium current, <em>I</em><sub>Na</sub>, unless additional data, e.g. extracellular measurements are included (see, e.g., [<a href="#pcbi.1008089.ref069" class="usa-link" aria-describedby="pcbi.1008089.ref069">69</a>]). Note also that identification of drug effects on <em>I</em><sub>Na</sub> from measurements of hiPSC-CMs could be hampered by the fact that the diastolic membrane potential of hiPSC-CMs often is depolarized compared to that of adult CMs (see, e.g., [<a href="#pcbi.1008089.ref021" class="usa-link" aria-describedby="pcbi.1008089.ref021">21</a>, <a href="#pcbi.1008089.ref039" class="usa-link" aria-describedby="pcbi.1008089.ref039">39</a>]). This can lead to inactivation of the Na<sup>+</sup> channels, making the upstroke of the action potential to a lager extent driven by <em>I</em><sub>CaL</sub> as opposed to <em>I</em><sub>Na</sub>, like for pacemaker cells [<a href="#pcbi.1008089.ref021" class="usa-link" aria-describedby="pcbi.1008089.ref021">21</a>, <a href="#pcbi.1008089.ref070" class="usa-link" aria-describedby="pcbi.1008089.ref070">70</a>]. In the current study, however, we consider measurements of hiPSC-CMs with a resting membrane potential of about −80 mV, indicating that <em>I</em><sub>Na</sub> is important for determining the upstroke velocity of these cells.</p>
<p>With information about the upstroke velocity, it should therefore be possible to identify <em>I</em><sub>Na</sub>. However, full identification of all model parameters based on membrane potential measurements is very challenging, and in some cases several combinations of parameter values result in virtually identical action potentials (see, e.g., [<a href="#pcbi.1008089.ref068" class="usa-link" aria-describedby="pcbi.1008089.ref068">68</a>, <a href="#pcbi.1008089.ref071" class="usa-link" aria-describedby="pcbi.1008089.ref071">71</a>, <a href="#pcbi.1008089.ref072" class="usa-link" aria-describedby="pcbi.1008089.ref072">72</a>]). In order to investigate which currents were identifiable in the SQT1 hiPSC-CM base model, we applied the singular value decomposition approach from [<a href="#pcbi.1008089.ref073" class="usa-link" aria-describedby="pcbi.1008089.ref073">73</a>]. The result of this analysis is given in <a href="#pcbi.1008089.s007" class="usa-link">S3 Fig</a> of the Supporting Information. In short, the analysis reveals that the <em>I</em><sub>Na</sub>, <em>I</em><sub>CaL</sub>, and <em>I</em><sub>Kr</sub> currents are the most identifiable currents of the model. This means that we expect the identifiability of the three main currents investigated for drug effects to be relatively high. In <a href="#pcbi.1008089.s008" class="usa-link">S4 Fig</a> of the Supporting Information, we also show examples of the inversion method applied to simulated data. This enables us to assess the accuracy of our approach, and we observe that we are able to find the correct solution using the continuation method in examples where adjustment factors, λ, for these three currents and up to two additional currents are treated as free parameters. Similar experiments have shown similar results (see, e.g., Figure 6 in [<a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>]) and although this does not prove that we are able to get the correct parameterization of the model in all cases, it indicates that the method is useful. A general proof of uniqueness of a minimum is most likely not possible unless strong regularization terms are added.</p>
<p>For the <em>I</em><sub>f</sub>-blocking drug ivabradine, we also estimate drug effects on <em>I</em><sub>f</sub>, but we note that the identifiability of this current is not very high according to the singular value decomposition analysis and that the estimated drug effect for <em>I</em><sub>f</sub> consequently is associated with a large degree of uncertainty. The λ-values found for the remaining parameters in the inversion procedure are also associated with a degree of uncertainty. However, these parameters are not used directly in the prediction of drug effects in the adult case (see Section 2.1).</p>
<p>It should also be noted that the hand-tuned parameterizations chosen as a starting point for the inversions of hiPSC-CM data and as the default adult base models are associated with uncertainty. In the hiPSC-CM case, some of the current densities are adjusted to measurements of hiPSC-CMs from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>] (see <a href="#pcbi.1008089.s005" class="usa-link">S1 Fig</a>), but for the remaining parameter values, it is possible that other combinations of parameters would give equally good or better fits to the data. Similarly, for the adult case, we have fitted the model to information about the heart rate dependent QTp interval from [<a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>]. In addition, we have attempted to make the size of some of the main currents similar to the size of the currents in the models [<a href="#pcbi.1008089.ref026" class="usa-link" aria-describedby="pcbi.1008089.ref026">26</a>, <a href="#pcbi.1008089.ref027" class="usa-link" aria-describedby="pcbi.1008089.ref027">27</a>] (see <a href="#pcbi.1008089.s006" class="usa-link">S2 Fig</a>). However, it is possible that the chosen parameterization is not unique or that better parameterizations exist.</p></section><section id="sec029"><h4 class="pmc_sec_title">4.2.2 Identified drug effects</h4>
<p>Using the computational inversion procedure described in Section 2.3, we estimated drug effects on major ion channels based on action potential measurements of SQT1 hiPSC-CMs. For quinidine, ajmaline and mexiletine, we considered drug effects on the currents <em>I</em><sub>Kr</sub>, <em>I</em><sub>CaL</sub> and <em>I</em><sub>Na</sub>, and for ivabradine, we considered drug effects on the currents <em>I</em><sub>Kr</sub>, <em>I</em><sub>f</sub> and <em>I</em><sub>Na</sub>, because these currents have been shown to be affected by ivabradine [<a href="#pcbi.1008089.ref074" class="usa-link" aria-describedby="pcbi.1008089.ref074">74</a>–<a href="#pcbi.1008089.ref076" class="usa-link" aria-describedby="pcbi.1008089.ref076">76</a>].</p>
<p>Each of the considered drugs had a considerable effect on the <em>I</em><sub>Kr</sub> current, with predicted IC<sub>50</sub> values of 8.1 <em>μ</em>M for quinidine, 12.6 <em>μ</em>M for ivabradine, 69 <em>μ</em>M for ajmaline and 280 <em>μ</em>M for mexiletine (see <a href="#pcbi.1008089.g008" class="usa-link">Fig 8</a>). The effect of a drug can be very different for WT <em>I</em><sub>Kr</sub> channels compared to that of mutated <em>I</em><sub>Kr</sub> channels (see, e.g., [<a href="#pcbi.1008089.ref077" class="usa-link" aria-describedby="pcbi.1008089.ref077">77</a>, <a href="#pcbi.1008089.ref078" class="usa-link" aria-describedby="pcbi.1008089.ref078">78</a>]). For instance, in [<a href="#pcbi.1008089.ref077" class="usa-link" aria-describedby="pcbi.1008089.ref077">77</a>], the IC<sub>50</sub> value of quinidine was found to be 0.6 <em>μ</em>M for WT <em>I</em><sub>Kr</sub> channels and 2.2 <em>μ</em>M for the SQT1 mutation N588K. Consequently, it is not reasonable to compare the IC<sub>50</sub> values identified for the SQT1 case to IC<sub>50</sub> values found in WT <em>I</em><sub>Kr</sub> experiments. However, we observe that the identified IC<sub>50</sub> value for quinidine is quite close to the IC<sub>50</sub> value reported for the SQT1 case in [<a href="#pcbi.1008089.ref077" class="usa-link" aria-describedby="pcbi.1008089.ref077">77</a>] (8.1 <em>μ</em>M vs 2.2 <em>μ</em>M). Furthermore, the predicted block percentage for 10 <em>μ</em>M of quinidine is very close to the measured block percentage reported in [<a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>] (see <a href="#pcbi.1008089.g009" class="usa-link">Fig 9</a>). The block percentages for the remaining drugs are also quite close to the percentages reported in [<a href="#pcbi.1008089.ref011" class="usa-link" aria-describedby="pcbi.1008089.ref011">11</a>], indicating reasonable identified IC<sub>50</sub> values for SQT1 <em>I</em><sub>Kr</sub>. For ivabradine, the identified IC<sub>50</sub> value for <em>I</em><sub>Kr</sub> (12.6 <em>μ</em>M) is also in good agreement with the IC<sub>50</sub> value of 10.3 <em>μ</em>M reported for <em>I</em><sub>Kr</sub> affected by the SQT1 (N588K) mutation in [<a href="#pcbi.1008089.ref074" class="usa-link" aria-describedby="pcbi.1008089.ref074">74</a>].</p>
<p>In addition, for ajmaline, the inversion procedure identified an IC<sub>50</sub> value of 47 <em>μ</em>M for <em>I</em><sub>CaL</sub>. This is comparable to what was measured in [<a href="#pcbi.1008089.ref079" class="usa-link" aria-describedby="pcbi.1008089.ref079">79</a>] (70.8 <em>μ</em>M). The inversion procedure also identified a significant block of <em>I</em><sub>Na</sub> for the drug mexiletine (see <a href="#pcbi.1008089.g008" class="usa-link">Fig 8</a>). This is reasonable, since mexiletine is known as an <em>I</em><sub>Na</sub> blocker [<a href="#pcbi.1008089.ref080" class="usa-link" aria-describedby="pcbi.1008089.ref080">80</a>]. However, the identified IC<sub>50</sub> value of 200 <em>μ</em>M is larger than IC<sub>50</sub> values found in literature (7.6 <em>μ</em>M–43 <em>μ</em>M) [<a href="#pcbi.1008089.ref081" class="usa-link" aria-describedby="pcbi.1008089.ref081">81</a>–<a href="#pcbi.1008089.ref083" class="usa-link" aria-describedby="pcbi.1008089.ref083">83</a>]. Similarly, ivabradine is an <em>I</em><sub>f</sub> blocker with an IC<sub>50</sub> value found to be about 2 <em>μ</em>M in [<a href="#pcbi.1008089.ref075" class="usa-link" aria-describedby="pcbi.1008089.ref075">75</a>], but the computational procedure underestimates the drug effect to an IC<sub>50</sub> value of about 42 <em>μ</em>M. This discrepancy is not unexpected, since the identifiability of <em>I</em><sub>f</sub> is predicted to be low (see <a href="#pcbi.1008089.s007" class="usa-link">S3 Fig</a>). The IC<sub>50</sub> value for <em>I</em><sub>Na</sub> block of ivabradine, was estimated to 86 <em>μ</em>M, closer to, but still a bit higher than the measured IC<sub>50</sub> value of 30 <em>μ</em>M reported in [<a href="#pcbi.1008089.ref076" class="usa-link" aria-describedby="pcbi.1008089.ref076">76</a>]. Possible effects of ajmaline on <em>I</em><sub>Na</sub>, of quinidine on <em>I</em><sub>CaL</sub> and <em>I</em><sub>Na</sub> and of mexiletine on <em>I</em><sub>CaL</sub> are also underestimated by the inversion procedure compared to the IC<sub>50</sub> values reported in [<a href="#pcbi.1008089.ref083" class="usa-link" aria-describedby="pcbi.1008089.ref083">83</a>]. This could indicate that the biomarkers considered in the inversion procedure (see Figs <a href="#pcbi.1008089.g003" class="usa-link">3</a> and <a href="#pcbi.1008089.g007" class="usa-link">7</a>) are not enough to properly characterize these less pronounced drug effects or that the applied base model formulation or simplified drug modeling are not sufficient to represent these effects. It also could be that the regularization term used for the <em>ε</em> values can cause underestimation due to its pressure on finding the minimum effect in the chosen fit. It should also be noted that IC<sub>50</sub> values identified in different experiments tend to vary considerably.</p></section></section><section id="sec030"><h3 class="pmc_sec_title">4.3 Computational maturation of drug response</h3>
<p>Using the single channel drug effects identified from membrane potential measurements of hiPSC-CM, we estimated the drug effects in the adult case based on the three assumptions explained in <a href="#pcbi.1008089.g002" class="usa-link">Fig 2</a>. First, we assumed that the density of different types of ion channels (and other membrane and intracellular proteins) differ between hiPSC-CMs and adult CMs, but that the function of a single channel is the same for adult CMs and hiPSC-CMs. This means that a set of parameters representing the density of different types of proteins, e.g., ion channel conductances (see <a href="#pcbi.1008089.e004" class="usa-link">(4)</a>), are different between the hiPSC-CM and adult CM models, but that the models for, e.g., the open probability of the channels are the same in both versions of the model. Second, we assumed that a mutation affects the function of an ion channel in exactly the same manner for hiPSC-CMs and adult CMs. Therefore, we used the same adjustment of the open probability of the <em>I</em><sub>Kr</sub> current (see <a href="#pcbi.1008089.g005" class="usa-link">Fig 5</a>) to represent the SQT1 mutation N588K for both hiPSC-CMs and adult CMs (see <a href="#pcbi.1008089.g006" class="usa-link">Fig 6</a>). Third, we assumed that a drug affects a single ion channel in exactly the same manner for hiPSC-CMs and adult CMs, and we could therefore estimate the drug effect in the adult case based on the drug effect identified for hiPSC-CMs.</p>
<p>This modeling framework was used in [<a href="#pcbi.1008089.ref022" class="usa-link" aria-describedby="pcbi.1008089.ref022">22</a>, <a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>] to predict side effects of drugs for adult WT CMs based on measurements of WT hiPSC-CMs. However, the procedure can also take the effect of mutations into account (as specified in the second assumption of <a href="#pcbi.1008089.g002" class="usa-link">Fig 2</a>), and in the present study, we have used the procedure to estimate drug effects on the ventricular action potential and the QT interval of adult SQT1 patients based on measurements of hiPSC-CMs generated from an SQT1 patient.</p>
<section id="sec031"><h4 class="pmc_sec_title">4.3.1 Estimation of the QT interval</h4>
<p>Because the effect of one of the drugs considered in this study has been investigated for adult SQT1 patients in the form of measured QT intervals of patients’ ECGs, we wished to be able to compare the drug responses predicted by our computational procedure to these measured QT intervals. However, the mathematical base model from [<a href="#pcbi.1008089.ref023" class="usa-link" aria-describedby="pcbi.1008089.ref023">23</a>] only represents the adult ventricular action potential and cannot be directly used to compute the adult QT interval. On the other hand, it is generally recognized that there is a clear link between the duration of the ventricular action potential and the QT interval of a patient’s ECG. For example, in [<a href="#pcbi.1008089.ref084" class="usa-link" aria-describedby="pcbi.1008089.ref084">84</a>], a simple linear relationship between the APD90 value and the QT interval was observed. Conversely, in the computational study [<a href="#pcbi.1008089.ref085" class="usa-link" aria-describedby="pcbi.1008089.ref085">85</a>], it was shown that there was not a direct linear realtionship between drug effects on the action potential duration and drug effects on the QT interval. For example, drugs blocking the <em>I</em><sub>Na</sub> current gave rise to prolongations of the computed QT intervals, even though no prolongation was observed for the action potential duration. In this study, we have chosen to predict the QT interval by computing a pseudo-ECG using a very simple mathematical representation, as applied in several previous studies of drug effects on the QT interval (e.g., [<a href="#pcbi.1008089.ref046" class="usa-link" aria-describedby="pcbi.1008089.ref046">46</a>, <a href="#pcbi.1008089.ref049" class="usa-link" aria-describedby="pcbi.1008089.ref049">49</a>, <a href="#pcbi.1008089.ref050" class="usa-link" aria-describedby="pcbi.1008089.ref050">50</a>]). The applied method appeared to give rise to reasonable pseudo-ECG waveforms and QT intervals (see, e.g., <a href="#pcbi.1008089.g006" class="usa-link">Fig 6</a>), but it is a very simplified representation of the dynamics underlying the ECG, and more realistic spatial modeling, possibly extended to whole-heart simulations including a surrounding torso like in [<a href="#pcbi.1008089.ref085" class="usa-link" aria-describedby="pcbi.1008089.ref085">85</a>–<a href="#pcbi.1008089.ref088" class="usa-link" aria-describedby="pcbi.1008089.ref088">88</a>], could potentially improve the reliability of the computed QT intervals.</p></section><section id="sec032"><h4 class="pmc_sec_title">4.3.2 Predicted adult drug responses for SQT1 patients</h4>
<p>The estimated effects of the four drugs quinidine, ivabradine, ajmaline and mexiletine on the ventricular action potential and QT interval of adult SQT1 patients revealed that all four drugs are expected to lead to an increase in the action potential duration and the QT interval of SQT1 patients (see <a href="#pcbi.1008089.g010" class="usa-link">Fig 10</a>). However, the extent of the prolongation of the QT interval was estimated to be quite different for the different drugs. The most significant prolongation was observed for 10 <em>μ</em>M of quinidine, which was predicted to increase the QTp interval from 200 ms to 257 ms, closer to the WT value of 292 ms. For the drug ivabradine, the procedure also estimated a significant increase in the adult QT interval, and for the drug mexilitine, a smaller, but clearly visible QT interval increase was predicted. For ajmaline, however, the estimated drug effect in the adult case was quite small, even though a significant APD prolongation was observed in the hiPSC-CM case (compare Figs <a href="#pcbi.1008089.g008" class="usa-link">8</a> and <a href="#pcbi.1008089.g010" class="usa-link">10</a>). This is probably explained by the fact that the inversion procedure estimates a significant block of both <em>I</em><sub>Kr</sub> and <em>I</em><sub>CaL</sub> for ajmaline which due to the difference in protein densities between the hiPSC-CM and adult cases cancel each other out in the adult model, but not in the hiPSC-CM model.</p>
<p>It is generally hard to validate the drug responses predicted by the computational procedure because data of drug responses for adult SQT1 patients would be required. However, for the drug quinidine, such experiments are reported in [<a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>] in the form of measured QT intervals for a number of different heart rates. These measurements have been conducted for SQT1 patients without pharmacological treatment, SQT1 patients using the drug quinidine and for healthy adults without the SQT1 mutation [<a href="#pcbi.1008089.ref015" class="usa-link" aria-describedby="pcbi.1008089.ref015">15</a>]. We found that the effect of quinidine for adult patients estimated by the computational procedure fitted well with these measured drug responses (see <a href="#pcbi.1008089.g011" class="usa-link">Fig 11</a>), indicating that the applied computational procedure shows promise for reliably predicting adult drug responses based on measurements of hiPSC-CMs.</p></section></section><section id="sec033"><h3 class="pmc_sec_title">4.4 Conclusions</h3>
<p>In this paper, we have used a computational procedure to predict the effect of the drugs quinidine, ivabradine, ajmaline and mexilitine for clinical biomarkers of adult SQT1 patients, based on measured drug responses for hiPSC-CMs generated from an SQT1 patient. The procedure consists of identifying drug effects on individual ion channels based on membrane potential measurements of drug effects for hiPSC-CMs and then mapping this effect up to the adult case based on the assumption of functional invariance of ion channels during maturation. All four drugs were predicted to lead to increases in the ventricular action potential duration and QT interval, and the drugs quinidine and ivabradine were estimated to be most effective. Furthermore, the effect of quinidine predicted by the computational procedure appeared to be in good agreement with measured effects of the drug. Consequently, we conclude that the computational procedure applied in this study could be a useful tool for estimating adult drug responses based on measurements of hiPSC-CMs, also as new measurements become available, including measurements of alternative drugs or mutations.</p></section></section><section id="sec034"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="pcbi.1008089.s001"><div class="caption p">
<span>S1 Appendix. Base model formulation.</span><p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7909705/bin/pcbi.1008089.s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (237KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="pcbi.1008089.s002"><div class="caption p">
<span>S2 Appendix. A note on the sign of the pseudo-ECG.</span><p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7909705/bin/pcbi.1008089.s002.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (176.5KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="pcbi.1008089.s003"><div class="caption p">
<span>S1 Code. MATLAB code for the different versions of the base model used in this study.</span><p>(ZIP)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7909705/bin/pcbi.1008089.s003.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (18.1KB, zip) </sup>
</div></div></section><section class="sm xbox font-sm" id="pcbi.1008089.s004"><div class="caption p">
<span>S1 Data. Underlying numerical data for figures.</span><p>Excel spreadsheet containing the underlying numerical data of Figs <a href="#pcbi.1008089.g005" class="usa-link">5</a>, <a href="#pcbi.1008089.g006" class="usa-link">6</a>, <a href="#pcbi.1008089.g007" class="usa-link">7</a>, <a href="#pcbi.1008089.g008" class="usa-link">8</a>, <a href="#pcbi.1008089.g009" class="usa-link">9</a>, <a href="#pcbi.1008089.g010" class="usa-link">10</a> and <a href="#pcbi.1008089.g011" class="usa-link">11</a>.</p>
<p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7909705/bin/pcbi.1008089.s004.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (482KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pcbi.1008089.s005"><div class="caption p">
<span>S1 Fig. Comparison of the hiPSC-CM base model to data.</span><p>Comparison of data from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>] for WT and SQT1 hiPSC-CMs to properties of the hiPSC-CM base model for WT and SQT1 used as a starting point for the inversions. The upper two rows compare the resting membrane potential (RMP), action potential amplitude (APA), maximal upstroke velocity (dvdt<sub>max</sub>) and action potential durations at 50% and 90% repolarization (APD50 and APD90). The lower two rows compare the current densities of <em>I</em><sub>Ks</sub>, <em>I</em><sub>to</sub>, <em>I</em><sub>K1</sub>, <em>I</em><sub>CaL</sub> and <em>I</em><sub>NaL</sub> at specific voltages using the voltage clamp procedures described in [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>]. Note that two different WT hiPSC lines (D1 and D2) were considered in [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>]. Note also that the <em>I</em><sub>Kr</sub> current reported in [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>] was not compared to the model because the measurements of <em>I</em><sub>Kr</sub> in [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>] were conducted using Cs<sup>+</sup> ions instead of K<sup>+</sup> ions, which could influence the properties of the current, making the measurements less appropriate for direct comparison to the model current [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref089" class="usa-link" aria-describedby="pcbi.1008089.ref089">89</a>].</p>
<p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7909705/bin/pcbi.1008089.s005.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (8.1KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="pcbi.1008089.s006"><div class="caption p">
<span>S2 Fig. Comparison the adult base model to other AP models.</span><p>Comparison of the action potential and some of the main currents in the adult WT base model used in this study against the action potential and currents from the Grandi et al. and O’Hara et al. models [<a href="#pcbi.1008089.ref027" class="usa-link" aria-describedby="pcbi.1008089.ref027">27</a>, <a href="#pcbi.1008089.ref090" class="usa-link" aria-describedby="pcbi.1008089.ref090">90</a>]. The currents and action potentials are computed in a simulation using 1 Hz pacing, and the epicardial version of the models are used for all three models.</p>
<p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7909705/bin/pcbi.1008089.s006.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (133.1KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="pcbi.1008089.s007"><div class="caption p">
<span>S3 Fig. Singular value decomposition analysis.</span><p>Singular value decomposition analysis of the SQT1 hiPSC-CM base model, using the method from [<a href="#pcbi.1008089.ref073" class="usa-link" aria-describedby="pcbi.1008089.ref073">73</a>]. The identifiability of each current is indicated in the orange panel, and a value close to 1 indicates a high degree of identifiability. The cost function used to define the unidentifiable space is the same as that used in the inversions. The identifiability threshold, <em>δ</em>, was set to 0.1. For details on the analysis, we refer to [<a href="#pcbi.1008089.ref073" class="usa-link" aria-describedby="pcbi.1008089.ref073">73</a>].</p>
<p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7909705/bin/pcbi.1008089.s007.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (159.1KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="pcbi.1008089.s008"><div class="caption p">
<span>S4 Fig. Comparison of optimization methods.</span><p>Comparison of the continuation method and a number of other optimization methods from MATLAB’s Global Optimization Toolbox [<a href="#pcbi.1008089.ref045" class="usa-link" aria-describedby="pcbi.1008089.ref045">45</a>]. We use the same cost function as in the inversions of the paper, except that we include no regularization terms and only consider a single AP (not several doses). The data is defined by simulated solutions generated using λ = −0.5 for all considered currents (see the legends). The titles above each column specify the considered number of free parameters, and the plots show the evolution of the optimal parameter values during the iterations of the algorithms. We impose the bounds −1 ≤ λ ≤ 0 and a maximum time limit of 5 hours for all methods, except that the bounds are adjusted to −0.7 ≤ λ ≤ 0.3 for the surrogate optimization algorithm, to avoid automatically finding the correct solution, λ = −0.5, in the first iteration of the algorithm.</p>
<p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7909705/bin/pcbi.1008089.s008.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (117KB, pdf) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Data Availability</h2>
<p>All relevant data are within the manuscript and its <a href="#sec034" class="usa-link">Supporting information</a> files.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>KJ, SW and AT was supported by the Research Council of Norway funded IDENTIPHY project #309871/E50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pcbi.1008089.ref001">
<span class="label">1.</span><cite>
Gussak I, Brugada P, Brugada J, Wright RS, Kopecky SL, Chaitman BR, et al. Idiopathic short QT interval: a new clinical syndrome?
Cardiology. 2000;94(2):99–102. 10.1159/000047299
</cite> [<a href="https://doi.org/10.1159/000047299" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11173780/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiology&amp;title=Idiopathic%20short%20QT%20interval:%20a%20new%20clinical%20syndrome?&amp;author=I%20Gussak&amp;author=P%20Brugada&amp;author=J%20Brugada&amp;author=RS%20Wright&amp;author=SL%20Kopecky&amp;volume=94&amp;issue=2&amp;publication_year=2000&amp;pages=99-102&amp;pmid=11173780&amp;doi=10.1159/000047299&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref002">
<span class="label">2.</span><cite>
Campuzano O, Sarquella-Brugada G, Cesar S, Arbelo E, Brugada J, Brugada R. Recent advances in short QT syndrome. Frontiers in Cardiovascular Medicine. 2018;5:149. 10.3389/fcvm.2018.00149
</cite> [<a href="https://doi.org/10.3389/fcvm.2018.00149" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6215807/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30420954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Cardiovascular%20Medicine&amp;title=Recent%20advances%20in%20short%20QT%20syndrome&amp;author=O%20Campuzano&amp;author=G%20Sarquella-Brugada&amp;author=S%20Cesar&amp;author=E%20Arbelo&amp;author=J%20Brugada&amp;volume=5&amp;publication_year=2018&amp;pages=149&amp;pmid=30420954&amp;doi=10.3389/fcvm.2018.00149&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref003">
<span class="label">3.</span><cite>
Patel C, Yan GX, Antzelevitch C. Short QT syndrome: from bench to bedside. Circulation: Arrhythmia and Electrophysiology. 2010;3(4):401–408. 10.1161/CIRCEP.109.921056
</cite> [<a href="https://doi.org/10.1161/CIRCEP.109.921056" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2933105/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20716721/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation:%20Arrhythmia%20and%20Electrophysiology&amp;title=Short%20QT%20syndrome:%20from%20bench%20to%20bedside&amp;author=C%20Patel&amp;author=GX%20Yan&amp;author=C%20Antzelevitch&amp;volume=3&amp;issue=4&amp;publication_year=2010&amp;pages=401-408&amp;pmid=20716721&amp;doi=10.1161/CIRCEP.109.921056&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref004">
<span class="label">4.</span><cite>
Gaita F, Giustetto C, Bianchi F, Wolpert C, Schimpf R, Riccardi R, et al. Short QT syndrome: a familial cause of sudden death. Circulation. 2003;108(8):965–970. 10.1161/01.CIR.0000085071.28695.C4
</cite> [<a href="https://doi.org/10.1161/01.CIR.0000085071.28695.C4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12925462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Short%20QT%20syndrome:%20a%20familial%20cause%20of%20sudden%20death&amp;author=F%20Gaita&amp;author=C%20Giustetto&amp;author=F%20Bianchi&amp;author=C%20Wolpert&amp;author=R%20Schimpf&amp;volume=108&amp;issue=8&amp;publication_year=2003&amp;pages=965-970&amp;pmid=12925462&amp;doi=10.1161/01.CIR.0000085071.28695.C4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref005">
<span class="label">5.</span><cite>
Schimpf R, Wolpert C, Gaita F, Giustetto C, Borggrefe M. Short QT syndrome. Cardiovascular Research. 2005;67(3):357–366. 10.1016/j.cardiores.2005.03.026
</cite> [<a href="https://doi.org/10.1016/j.cardiores.2005.03.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15890322/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=Short%20QT%20syndrome&amp;author=R%20Schimpf&amp;author=C%20Wolpert&amp;author=F%20Gaita&amp;author=C%20Giustetto&amp;author=M%20Borggrefe&amp;volume=67&amp;issue=3&amp;publication_year=2005&amp;pages=357-366&amp;pmid=15890322&amp;doi=10.1016/j.cardiores.2005.03.026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref006">
<span class="label">6.</span><cite>
Brugada R, Hong K, Dumaine R, Cordeiro J, Gaita F, Borggrefe M, et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation. 2004;109(1):30–35. 10.1161/01.CIR.0000109482.92774.3A
</cite> [<a href="https://doi.org/10.1161/01.CIR.0000109482.92774.3A" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14676148/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Sudden%20death%20associated%20with%20short-QT%20syndrome%20linked%20to%20mutations%20in%20HERG&amp;author=R%20Brugada&amp;author=K%20Hong&amp;author=R%20Dumaine&amp;author=J%20Cordeiro&amp;author=F%20Gaita&amp;volume=109&amp;issue=1&amp;publication_year=2004&amp;pages=30-35&amp;pmid=14676148&amp;doi=10.1161/01.CIR.0000109482.92774.3A&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref007">
<span class="label">7.</span><cite>
Abriel H, Rougier JS. <em>β</em>-Blockers in Congenital Short-QT Syndrome as Ion Channel Blockers. Journal of Cardiovascular Electrophysiology. 2013;24(10):1172–1174. 10.1111/jce.12204
</cite> [<a href="https://doi.org/10.1111/jce.12204" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23890274/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cardiovascular%20Electrophysiology&amp;title=%CE%B2-Blockers%20in%20Congenital%20Short-QT%20Syndrome%20as%20Ion%20Channel%20Blockers&amp;author=H%20Abriel&amp;author=JS%20Rougier&amp;volume=24&amp;issue=10&amp;publication_year=2013&amp;pages=1172-1174&amp;pmid=23890274&amp;doi=10.1111/jce.12204&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref008">
<span class="label">8.</span><cite>
Mazzanti A, Maragna R, Vacanti G, Kostopoulou A, Marino M, Monteforte N, et al. Hydroquinidine prevents life-threatening arrhythmic events in patients with short QT syndrome. Journal of the American College of Cardiology. 2017;70(24):3010–3015. 10.1016/j.jacc.2017.10.025
</cite> [<a href="https://doi.org/10.1016/j.jacc.2017.10.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29241489/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20College%20of%20Cardiology&amp;title=Hydroquinidine%20prevents%20life-threatening%20arrhythmic%20events%20in%20patients%20with%20short%20QT%20syndrome&amp;author=A%20Mazzanti&amp;author=R%20Maragna&amp;author=G%20Vacanti&amp;author=A%20Kostopoulou&amp;author=M%20Marino&amp;volume=70&amp;issue=24&amp;publication_year=2017&amp;pages=3010-3015&amp;pmid=29241489&amp;doi=10.1016/j.jacc.2017.10.025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref009">
<span class="label">9.</span><cite>
El-Battrawy I, Lan H, Cyganek L, Zhao Z, Li X, Buljubasic F, et al. Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes. Journal of the American Heart Association. 2018;7(7):e007394. 10.1161/JAHA.117.007394
</cite> [<a href="https://doi.org/10.1161/JAHA.117.007394" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5907581/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29574456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Heart%20Association&amp;title=Modeling%20Short%20QT%20Syndrome%20Using%20Human-Induced%20Pluripotent%20Stem%20Cell%E2%80%93Derived%20Cardiomyocytes&amp;author=I%20El-Battrawy&amp;author=H%20Lan&amp;author=L%20Cyganek&amp;author=Z%20Zhao&amp;author=X%20Li&amp;volume=7&amp;issue=7&amp;publication_year=2018&amp;pages=e007394&amp;pmid=29574456&amp;doi=10.1161/JAHA.117.007394&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref010">
<span class="label">10.</span><cite>
El-Battrawy I, Besler J, Liebe V, Schimpf R, Tülümen E, Rudic B, et al. Long-Term Follow-Up of Patients With Short QT Syndrome: Clinical Profile and Outcome. Journal of the American Heart Association. 2018;7(23):e010073. 10.1161/JAHA.118.010073
</cite> [<a href="https://doi.org/10.1161/JAHA.118.010073" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6405569/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30571592/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Heart%20Association&amp;title=Long-Term%20Follow-Up%20of%20Patients%20With%20Short%20QT%20Syndrome:%20Clinical%20Profile%20and%20Outcome&amp;author=I%20El-Battrawy&amp;author=J%20Besler&amp;author=V%20Liebe&amp;author=R%20Schimpf&amp;author=E%20T%C3%BCl%C3%BCmen&amp;volume=7&amp;issue=23&amp;publication_year=2018&amp;pages=e010073&amp;pmid=30571592&amp;doi=10.1161/JAHA.118.010073&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref011">
<span class="label">11.</span><cite>
Zhao Z, Li X, El-Battrawy I, Lan H, Zhong R, Xu Q, et al. Drug Testing in Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1. Clinical Pharmacology &amp; Therapeutics. 2019;106(3):642–651. 10.1002/cpt.1449
</cite> [<a href="https://doi.org/10.1002/cpt.1449" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30947366/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Pharmacology%20&amp;%20Therapeutics&amp;title=Drug%20Testing%20in%20Human-Induced%20Pluripotent%20Stem%20Cell%E2%80%93Derived%20Cardiomyocytes%20From%20a%20Patient%20With%20Short%20QT%20Syndrome%20Type%201&amp;author=Z%20Zhao&amp;author=X%20Li&amp;author=I%20El-Battrawy&amp;author=H%20Lan&amp;author=R%20Zhong&amp;volume=106&amp;issue=3&amp;publication_year=2019&amp;pages=642-651&amp;pmid=30947366&amp;doi=10.1002/cpt.1449&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref012">
<span class="label">12.</span><cite>
Gaita F, Giustetto C, Bianchi F, Schimpf R, Haissaguerre M, Calò L, et al. Short QT syndrome: pharmacological treatment. Journal of the American College of Cardiology. 2004;43(8):1494–1499. 10.1016/j.jacc.2004.02.034
</cite> [<a href="https://doi.org/10.1016/j.jacc.2004.02.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15093889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20College%20of%20Cardiology&amp;title=Short%20QT%20syndrome:%20pharmacological%20treatment&amp;author=F%20Gaita&amp;author=C%20Giustetto&amp;author=F%20Bianchi&amp;author=R%20Schimpf&amp;author=M%20Haissaguerre&amp;volume=43&amp;issue=8&amp;publication_year=2004&amp;pages=1494-1499&amp;pmid=15093889&amp;doi=10.1016/j.jacc.2004.02.034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref013">
<span class="label">13.</span><cite>
Cordeiro J, Brugada R, Wu Y, Hong K, Dumaine R. Modulation of <em>I</em><sub>Kr</sub> inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome. Cardiovascular Research. 2005;67(3):498–509. 10.1016/j.cardiores.2005.02.018
</cite> [<a href="https://doi.org/10.1016/j.cardiores.2005.02.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16039272/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=Modulation%20of%20IKr%20inactivation%20by%20mutation%20N588K%20in%20KCNH2:%20a%20link%20to%20arrhythmogenesis%20in%20short%20QT%20syndrome&amp;author=J%20Cordeiro&amp;author=R%20Brugada&amp;author=Y%20Wu&amp;author=K%20Hong&amp;author=R%20Dumaine&amp;volume=67&amp;issue=3&amp;publication_year=2005&amp;pages=498-509&amp;pmid=16039272&amp;doi=10.1016/j.cardiores.2005.02.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref014">
<span class="label">14.</span><cite>
McPate MJ, Duncan RS, Milnes JT, Witchel HJ, Hancox JC. The N588K-HERG K<sup>+</sup> channel mutation in the’short QT syndrome’: mechanism of gain-in-function determined at 37°C. Biochemical and Biophysical Research Communications. 2005;334(2):441–449. 10.1016/j.bbrc.2005.06.112
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2005.06.112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16011830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20and%20Biophysical%20Research%20Communications&amp;title=The%20N588K-HERG%20K+%20channel%20mutation%20in%20the%E2%80%99short%20QT%20syndrome%E2%80%99:%20mechanism%20of%20gain-in-function%20determined%20at%2037%C2%B0C&amp;author=MJ%20McPate&amp;author=RS%20Duncan&amp;author=JT%20Milnes&amp;author=HJ%20Witchel&amp;author=JC%20Hancox&amp;volume=334&amp;issue=2&amp;publication_year=2005&amp;pages=441-449&amp;pmid=16011830&amp;doi=10.1016/j.bbrc.2005.06.112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref015">
<span class="label">15.</span><cite>
Wolpert C, Schimpf R, Giustetto C, Antzelevitch C, Cordeiro J, Dumaine R, et al. Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG. Journal of Cardiovascular Electrophysiology. 2005;16(1):54–58. 10.1046/j.1540-8167.2005.04470.x
</cite> [<a href="https://doi.org/10.1046/j.1540-8167.2005.04470.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1474841/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15673388/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cardiovascular%20Electrophysiology&amp;title=Further%20insights%20into%20the%20effect%20of%20quinidine%20in%20short%20QT%20syndrome%20caused%20by%20a%20mutation%20in%20HERG&amp;author=C%20Wolpert&amp;author=R%20Schimpf&amp;author=C%20Giustetto&amp;author=C%20Antzelevitch&amp;author=J%20Cordeiro&amp;volume=16&amp;issue=1&amp;publication_year=2005&amp;pages=54-58&amp;pmid=15673388&amp;doi=10.1046/j.1540-8167.2005.04470.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref016">
<span class="label">16.</span><cite>
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–676. 10.1016/j.cell.2006.07.024
</cite> [<a href="https://doi.org/10.1016/j.cell.2006.07.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16904174/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Induction%20of%20pluripotent%20stem%20cells%20from%20mouse%20embryonic%20and%20adult%20fibroblast%20cultures%20by%20defined%20factors&amp;author=K%20Takahashi&amp;author=S%20Yamanaka&amp;volume=126&amp;issue=4&amp;publication_year=2006&amp;pages=663-676&amp;pmid=16904174&amp;doi=10.1016/j.cell.2006.07.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref017">
<span class="label">17.</span><cite>
Yoshida Y, Yamanaka S. Induced Pluripotent Stem Cells 10 Years Later. Circulation Research. 2017;120(12):1958–1968. 10.1161/CIRCRESAHA.117.311080
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.117.311080" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28596174/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Induced%20Pluripotent%20Stem%20Cells%2010%20Years%20Later&amp;author=Y%20Yoshida&amp;author=S%20Yamanaka&amp;volume=120&amp;issue=12&amp;publication_year=2017&amp;pages=1958-1968&amp;pmid=28596174&amp;doi=10.1161/CIRCRESAHA.117.311080&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref018">
<span class="label">18.</span><cite>
Di Baldassarre A, Cimetta E, Bollini S, Gaggi G, Ghinassi B. Human-Induced Pluripotent Stem Cell Technology and Cardiomyocyte Generation: Progress and Clinical Applications. Cells. 2018;7(6):48. 10.3390/cells7060048
</cite> [<a href="https://doi.org/10.3390/cells7060048" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6025241/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29799480/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=Human-Induced%20Pluripotent%20Stem%20Cell%20Technology%20and%20Cardiomyocyte%20Generation:%20Progress%20and%20Clinical%20Applications&amp;author=A%20Di%20Baldassarre&amp;author=E%20Cimetta&amp;author=S%20Bollini&amp;author=G%20Gaggi&amp;author=B%20Ghinassi&amp;volume=7&amp;issue=6&amp;publication_year=2018&amp;pages=48&amp;pmid=29799480&amp;doi=10.3390/cells7060048&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref019">
<span class="label">19.</span><cite>
Ye L, Ni X, Zhao ZA, Lei W, Hu S. The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing. Journal of Cardiovascular Translational Research. 2018;11(5):366–374. 10.1007/s12265-018-9811-3
</cite> [<a href="https://doi.org/10.1007/s12265-018-9811-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29845439/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cardiovascular%20Translational%20Research&amp;title=The%20Application%20of%20Induced%20Pluripotent%20Stem%20Cells%20in%20Cardiac%20Disease%20Modeling%20and%20Drug%20Testing&amp;author=L%20Ye&amp;author=X%20Ni&amp;author=ZA%20Zhao&amp;author=W%20Lei&amp;author=S%20Hu&amp;volume=11&amp;issue=5&amp;publication_year=2018&amp;pages=366-374&amp;pmid=29845439&amp;doi=10.1007/s12265-018-9811-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref020">
<span class="label">20.</span><cite>
Hartman ME, Dai DF, Laflamme MA. Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Advanced Drug Delivery Reviews. 2016;96:3–17. 10.1016/j.addr.2015.05.004
</cite> [<a href="https://doi.org/10.1016/j.addr.2015.05.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4644514/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25980938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Advanced%20Drug%20Delivery%20Reviews&amp;title=Human%20pluripotent%20stem%20cells:%20Prospects%20and%20challenges%20as%20a%20source%20of%20cardiomyocytes%20for%20in%20vitro%20modeling%20and%20cell-based%20cardiac%20repair&amp;author=ME%20Hartman&amp;author=DF%20Dai&amp;author=MA%20Laflamme&amp;volume=96&amp;publication_year=2016&amp;pages=3-17&amp;pmid=25980938&amp;doi=10.1016/j.addr.2015.05.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref021">
<span class="label">21.</span><cite>
Garg P, Garg V, Shrestha R, Sanguinetti MC, Kamp TJ, Wu JC. Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes as Models for Cardiac Channelopathies. Circulation Research. 2018;123(2):224–243. 10.1161/CIRCRESAHA.118.311209
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.118.311209" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6136439/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29976690/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Human%20Induced%20Pluripotent%20Stem%20Cell%E2%80%93Derived%20Cardiomyocytes%20as%20Models%20for%20Cardiac%20Channelopathies&amp;author=P%20Garg&amp;author=V%20Garg&amp;author=R%20Shrestha&amp;author=MC%20Sanguinetti&amp;author=TJ%20Kamp&amp;volume=123&amp;issue=2&amp;publication_year=2018&amp;pages=224-243&amp;pmid=29976690&amp;doi=10.1161/CIRCRESAHA.118.311209&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref022">
<span class="label">22.</span><cite>
Tveito A, Jæger KH, Huebsch N, Charrez B, Edwards AG, Wall S, et al. Inversion and computational maturation of drug response using human stem cell derived cardiomyocytes in microphysiological systems. Scientific Reports. 2018;8(1):17626. 10.1038/s41598-018-35858-7
</cite> [<a href="https://doi.org/10.1038/s41598-018-35858-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6279833/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30514966/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=Inversion%20and%20computational%20maturation%20of%20drug%20response%20using%20human%20stem%20cell%20derived%20cardiomyocytes%20in%20microphysiological%20systems&amp;author=A%20Tveito&amp;author=KH%20J%C3%A6ger&amp;author=N%20Huebsch&amp;author=B%20Charrez&amp;author=AG%20Edwards&amp;volume=8&amp;issue=1&amp;publication_year=2018&amp;pages=17626&amp;pmid=30514966&amp;doi=10.1038/s41598-018-35858-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref023">
<span class="label">23.</span><cite>
Jæger KH, Charwat V, Charrez B, Finsberg H, Maleckar MM, Wall S, et al. Improved computational identification of drug response using optical measurements of human stem cell derived cardiomyocytes in microphysiological systems. Frontiers in Pharmacology. 2020;10:1648. 10.3389/fphar.2019.01648
</cite> [<a href="https://doi.org/10.3389/fphar.2019.01648" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7029356/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32116671/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Pharmacology&amp;title=Improved%20computational%20identification%20of%20drug%20response%20using%20optical%20measurements%20of%20human%20stem%20cell%20derived%20cardiomyocytes%20in%20microphysiological%20systems&amp;author=KH%20J%C3%A6ger&amp;author=V%20Charwat&amp;author=B%20Charrez&amp;author=H%20Finsberg&amp;author=MM%20Maleckar&amp;volume=10&amp;publication_year=2020&amp;pages=1648&amp;pmid=32116671&amp;doi=10.3389/fphar.2019.01648&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref024">
<span class="label">24.</span><cite>
Gong JQ, Sobie EA. Population-based mechanistic modeling allows for quantitative predictions of drug responses across cell types. NPJ Systems Biology and Applications. 2018;4(1):11. 10.1038/s41540-018-0047-2
</cite> [<a href="https://doi.org/10.1038/s41540-018-0047-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5825396/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29507757/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=NPJ%20Systems%20Biology%20and%20Applications&amp;title=Population-based%20mechanistic%20modeling%20allows%20for%20quantitative%20predictions%20of%20drug%20responses%20across%20cell%20types&amp;author=JQ%20Gong&amp;author=EA%20Sobie&amp;volume=4&amp;issue=1&amp;publication_year=2018&amp;pages=11&amp;pmid=29507757&amp;doi=10.1038/s41540-018-0047-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref025">
<span class="label">25.</span><cite>
Paci M, Hyttinen J, Rodriguez B, Severi S. Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an <em>in silico</em> electrophysiological study on effects of ionic current block. British Journal of Pharmacology. 2015;172(21):5147–5160. 10.1111/bph.13282
</cite> [<a href="https://doi.org/10.1111/bph.13282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4629192/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26276951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=Human%20induced%20pluripotent%20stem%20cell-derived%20versus%20adult%20cardiomyocytes:%20an%20in%20silico%20electrophysiological%20study%20on%20effects%20of%20ionic%20current%20block&amp;author=M%20Paci&amp;author=J%20Hyttinen&amp;author=B%20Rodriguez&amp;author=S%20Severi&amp;volume=172&amp;issue=21&amp;publication_year=2015&amp;pages=5147-5160&amp;pmid=26276951&amp;doi=10.1111/bph.13282&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref026">
<span class="label">26.</span><cite>
O’Hara T, Virág L, Varró A, Rudy Y. Simulation of the undiseased human cardiac ventricular action potential: Model formulation and experimental validation. PLoS Computational Biology. 2011;7(5):e1002061. 10.1371/journal.pcbi.1002061
</cite> [<a href="https://doi.org/10.1371/journal.pcbi.1002061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3102752/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21637795/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Computational%20Biology&amp;title=Simulation%20of%20the%20undiseased%20human%20cardiac%20ventricular%20action%20potential:%20Model%20formulation%20and%20experimental%20validation&amp;author=T%20O%E2%80%99Hara&amp;author=L%20Vir%C3%A1g&amp;author=A%20Varr%C3%B3&amp;author=Y%20Rudy&amp;volume=7&amp;issue=5&amp;publication_year=2011&amp;pages=e1002061&amp;pmid=21637795&amp;doi=10.1371/journal.pcbi.1002061&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref027">
<span class="label">27.</span><cite>
Grandi E, Pasqualini FS, Bers DM. A novel computational model of the human ventricular action potential and Ca transient. Journal of Molecular and Cellular Cardiology. 2010;48(1):112–121. 10.1016/j.yjmcc.2009.09.019
</cite> [<a href="https://doi.org/10.1016/j.yjmcc.2009.09.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2813400/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19835882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Molecular%20and%20Cellular%20Cardiology&amp;title=A%20novel%20computational%20model%20of%20the%20human%20ventricular%20action%20potential%20and%20Ca%20transient&amp;author=E%20Grandi&amp;author=FS%20Pasqualini&amp;author=DM%20Bers&amp;volume=48&amp;issue=1&amp;publication_year=2010&amp;pages=112-121&amp;pmid=19835882&amp;doi=10.1016/j.yjmcc.2009.09.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref028">
<span class="label">28.</span><cite>
Maleckar MM, Greenstein JL, Trayanova NA, Giles WR. Mathematical simulations of ligand-gated and cell-type specific effects on the action potential of human atrium. Progress in Biophysics and Molecular Biology. 2008;98(2-3):161–170. 10.1016/j.pbiomolbio.2009.01.010
</cite> [<a href="https://doi.org/10.1016/j.pbiomolbio.2009.01.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2836896/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19186188/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Progress%20in%20Biophysics%20and%20Molecular%20Biology&amp;title=Mathematical%20simulations%20of%20ligand-gated%20and%20cell-type%20specific%20effects%20on%20the%20action%20potential%20of%20human%20atrium&amp;author=MM%20Maleckar&amp;author=JL%20Greenstein&amp;author=NA%20Trayanova&amp;author=WR%20Giles&amp;volume=98&amp;issue=2-3&amp;publication_year=2008&amp;pages=161-170&amp;pmid=19186188&amp;doi=10.1016/j.pbiomolbio.2009.01.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref029">
<span class="label">29.</span><cite>
Courtemanche M, Ramirez RJ, Nattel S. Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model. American Journal of Physiology-Heart and Circulatory Physiology. 1998;275(1):H301–H321. 10.1152/ajpheart.1998.275.1.H301
</cite> [<a href="https://doi.org/10.1152/ajpheart.1998.275.1.H301" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9688927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology-Heart%20and%20Circulatory%20Physiology&amp;title=Ionic%20mechanisms%20underlying%20human%20atrial%20action%20potential%20properties:%20insights%20from%20a%20mathematical%20model&amp;author=M%20Courtemanche&amp;author=RJ%20Ramirez&amp;author=S%20Nattel&amp;volume=275&amp;issue=1&amp;publication_year=1998&amp;pages=H301-H321&amp;pmid=9688927&amp;doi=10.1152/ajpheart.1998.275.1.H301&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref030">
<span class="label">30.</span><cite>
Paci M, Hyttinen J, Aalto-Setälä K, Severi S. Computational models of ventricular-and atrial-like human induced pluripotent stem cell derived cardiomyocytes. Annals of Biomedical Engineering. 2013;41(11):2334–2348. 10.1007/s10439-013-0833-3
</cite> [<a href="https://doi.org/10.1007/s10439-013-0833-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23722932/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Biomedical%20Engineering&amp;title=Computational%20models%20of%20ventricular-and%20atrial-like%20human%20induced%20pluripotent%20stem%20cell%20derived%20cardiomyocytes&amp;author=M%20Paci&amp;author=J%20Hyttinen&amp;author=K%20Aalto-Set%C3%A4l%C3%A4&amp;author=S%20Severi&amp;volume=41&amp;issue=11&amp;publication_year=2013&amp;pages=2334-2348&amp;pmid=23722932&amp;doi=10.1007/s10439-013-0833-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref031">
<span class="label">31.</span><cite>
Kernik DC, Morotti S, Wu H, Garg P, Duff HJ, Kurokawa J, et al. A computational model of induced pluripotent stem-cell derived cardiomyocytes incorporating experimental variability from multiple data sources. The Journal of Physiology. 2019;. 10.1113/JP277724
</cite> [<a href="https://doi.org/10.1113/JP277724" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6767694/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31278749/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20Journal%20of%20Physiology&amp;title=A%20computational%20model%20of%20induced%20pluripotent%20stem-cell%20derived%20cardiomyocytes%20incorporating%20experimental%20variability%20from%20multiple%20data%20sources&amp;author=DC%20Kernik&amp;author=S%20Morotti&amp;author=H%20Wu&amp;author=P%20Garg&amp;author=HJ%20Duff&amp;publication_year=2019&amp;pmid=31278749&amp;doi=10.1113/JP277724&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref032">
<span class="label">32.</span><cite>
Vecchietti S, Grandi E, Severi S, Rivolta I, Napolitano C, Priori SG, et al. In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes. American Journal of Physiology-Heart and Circulatory Physiology. 2007;292(1):H56–H65. 10.1152/ajpheart.00270.2006
</cite> [<a href="https://doi.org/10.1152/ajpheart.00270.2006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16980337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology-Heart%20and%20Circulatory%20Physiology&amp;title=In%20silico%20assessment%20of%20Y1795C%20and%20Y1795H%20SCN5A%20mutations:%20implication%20for%20inherited%20arrhythmogenic%20syndromes&amp;author=S%20Vecchietti&amp;author=E%20Grandi&amp;author=S%20Severi&amp;author=I%20Rivolta&amp;author=C%20Napolitano&amp;volume=292&amp;issue=1&amp;publication_year=2007&amp;pages=H56-H65&amp;pmid=16980337&amp;doi=10.1152/ajpheart.00270.2006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref033">
<span class="label">33.</span><cite>
Paci M, Passini E, Severi S, Hyttinen J, Rodriguez B. Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to anti-arrhythmic pharmacological therapy: an in silico approach. Heart Rhythm. 2017;. 10.1016/j.hrthm.2017.07.026
</cite> [<a href="https://doi.org/10.1016/j.hrthm.2017.07.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5668441/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28756098/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heart%20Rhythm&amp;title=Phenotypic%20variability%20in%20LQT3%20human%20induced%20pluripotent%20stem%20cell-derived%20cardiomyocytes%20and%20their%20response%20to%20anti-arrhythmic%20pharmacological%20therapy:%20an%20in%20silico%20approach&amp;author=M%20Paci&amp;author=E%20Passini&amp;author=S%20Severi&amp;author=J%20Hyttinen&amp;author=B%20Rodriguez&amp;publication_year=2017&amp;pmid=28756098&amp;doi=10.1016/j.hrthm.2017.07.026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref034">
<span class="label">34.</span><cite>
Tung L. A bi-domain model for describing ischemic myocardial dc potentials. Massachusetts Institute of Technology; 1978.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=A%20bi-domain%20model%20for%20describing%20ischemic%20myocardial%20dc%20potentials&amp;author=L%20Tung&amp;publication_year=1978&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref035">
<span class="label">35.</span><cite>
Shaw RM, Rudy Y. Ionic mechanisms of propagation in cardiac tissue: roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling. Circulation Research. 1997;81(5):727–741. 10.1161/01.RES.81.5.727
</cite> [<a href="https://doi.org/10.1161/01.RES.81.5.727" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9351447/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Ionic%20mechanisms%20of%20propagation%20in%20cardiac%20tissue:%20roles%20of%20the%20sodium%20and%20L-type%20calcium%20currents%20during%20reduced%20excitability%20and%20decreased%20gap%20junction%20coupling&amp;author=RM%20Shaw&amp;author=Y%20Rudy&amp;volume=81&amp;issue=5&amp;publication_year=1997&amp;pages=727-741&amp;pmid=9351447&amp;doi=10.1161/01.RES.81.5.727&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref036">
<span class="label">36.</span><cite>
Trayanova NA. Whole-heart modeling: Applications to cardiac electrophysiology and electromechanics. Circulation Research. 2011;108(1):113–28. 10.1161/CIRCRESAHA.110.223610
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.110.223610" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3031963/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21212393/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Whole-heart%20modeling:%20Applications%20to%20cardiac%20electrophysiology%20and%20electromechanics&amp;author=NA%20Trayanova&amp;volume=108&amp;issue=1&amp;publication_year=2011&amp;pages=113-28&amp;pmid=21212393&amp;doi=10.1161/CIRCRESAHA.110.223610&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref037">
<span class="label">37.</span><cite>
Tveito A, Jæger KH, Kuchta M, Mardal KA, Rognes ME. A cell-based framework for numerical modeling of electrical conduction in cardiac tissue. Frontiers in Physics. 2017;5:48. 10.3389/fphy.2017.00048</cite> [<a href="https://doi.org/10.3389/fphy.2017.00048" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Physics&amp;title=A%20cell-based%20framework%20for%20numerical%20modeling%20of%20electrical%20conduction%20in%20cardiac%20tissue&amp;author=A%20Tveito&amp;author=KH%20J%C3%A6ger&amp;author=M%20Kuchta&amp;author=KA%20Mardal&amp;author=ME%20Rognes&amp;volume=5&amp;publication_year=2017&amp;pages=48&amp;doi=10.3389/fphy.2017.00048&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref038">
<span class="label">38.</span><cite>
Jæger KH, Edwards AG, McCulloch A, Tveito A. Properties of cardiac conduction in a cell-based computational model. PLoS Computational Biology. 2019;15(5):e1007042. 10.1371/journal.pcbi.1007042
</cite> [<a href="https://doi.org/10.1371/journal.pcbi.1007042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6561587/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31150383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Computational%20Biology&amp;title=Properties%20of%20cardiac%20conduction%20in%20a%20cell-based%20computational%20model&amp;author=KH%20J%C3%A6ger&amp;author=AG%20Edwards&amp;author=A%20McCulloch&amp;author=A%20Tveito&amp;volume=15&amp;issue=5&amp;publication_year=2019&amp;pages=e1007042&amp;pmid=31150383&amp;doi=10.1371/journal.pcbi.1007042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref039">
<span class="label">39.</span><cite>
Hoekstra M, Mummery CL, Wilde A, Bezzina CR, Verkerk AO. Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias. Frontiers in Physiology. 2012;3:346. 10.3389/fphys.2012.00346
</cite> [<a href="https://doi.org/10.3389/fphys.2012.00346" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3449331/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23015789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Physiology&amp;title=Induced%20pluripotent%20stem%20cell%20derived%20cardiomyocytes%20as%20models%20for%20cardiac%20arrhythmias&amp;author=M%20Hoekstra&amp;author=CL%20Mummery&amp;author=A%20Wilde&amp;author=CR%20Bezzina&amp;author=AO%20Verkerk&amp;volume=3&amp;publication_year=2012&amp;pages=346&amp;pmid=23015789&amp;doi=10.3389/fphys.2012.00346&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref040">
<span class="label">40.</span><cite>
Gibson JK, Yue Y, Bronson J, Palmer C, Numann R. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents. Journal of Pharmacological and Toxicological Methods. 2014;70(3):255–267. 10.1016/j.vascn.2014.09.005
</cite> [<a href="https://doi.org/10.1016/j.vascn.2014.09.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25219538/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacological%20and%20Toxicological%20Methods&amp;title=Human%20stem%20cell-derived%20cardiomyocytes%20detect%20drug-mediated%20changes%20in%20action%20potentials%20and%20ion%20currents&amp;author=JK%20Gibson&amp;author=Y%20Yue&amp;author=J%20Bronson&amp;author=C%20Palmer&amp;author=R%20Numann&amp;volume=70&amp;issue=3&amp;publication_year=2014&amp;pages=255-267&amp;pmid=25219538&amp;doi=10.1016/j.vascn.2014.09.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref041">
<span class="label">41.</span><cite>
Hancox JC, Whittaker DG, Du C, Stuart AG, Zhang H. Emerging therapeutic targets in the short QT syndrome. Expert Opinion on Therapeutic Targets. 2018;22(5):439–451. 10.1080/14728222.2018.1470621
</cite> [<a href="https://doi.org/10.1080/14728222.2018.1470621" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29697308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opinion%20on%20Therapeutic%20Targets&amp;title=Emerging%20therapeutic%20targets%20in%20the%20short%20QT%20syndrome&amp;author=JC%20Hancox&amp;author=DG%20Whittaker&amp;author=C%20Du&amp;author=AG%20Stuart&amp;author=H%20Zhang&amp;volume=22&amp;issue=5&amp;publication_year=2018&amp;pages=439-451&amp;pmid=29697308&amp;doi=10.1080/14728222.2018.1470621&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref042">
<span class="label">42.</span><cite>Paci M, Passini E, Klimas A, Severi S, Hyttinen J, Rodriguez B, et al. <em>In silico</em> populations optimized on optogenetic recordings predict drug effects in human induced pluripotent stem cell-derived cardiomyocytes. In: 2018 Computing in Cardiology Conference (CinC). vol. 45. IEEE; 2018. p. 1–4.</cite>
</li>
<li id="pcbi.1008089.ref043">
<span class="label">43.</span><cite>
Shannon TR, Wang F, Puglisi J, Weber C, Bers DM. A mathematical treatment of integrated Ca dynamics within the ventricular myocyte. Biophysical Journal. 2004;87(5):3351–3371. 10.1529/biophysj.104.047449
</cite> [<a href="https://doi.org/10.1529/biophysj.104.047449" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1304803/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15347581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biophysical%20Journal&amp;title=A%20mathematical%20treatment%20of%20integrated%20Ca%20dynamics%20within%20the%20ventricular%20myocyte&amp;author=TR%20Shannon&amp;author=F%20Wang&amp;author=J%20Puglisi&amp;author=C%20Weber&amp;author=DM%20Bers&amp;volume=87&amp;issue=5&amp;publication_year=2004&amp;pages=3351-3371&amp;pmid=15347581&amp;doi=10.1529/biophysj.104.047449&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref044">
<span class="label">44.</span><cite>
Nelder JA, Mead R. A simplex method for function minimization. The Computer Journal. 1965;7(4):308–313. 10.1093/comjnl/7.4.308</cite> [<a href="https://doi.org/10.1093/comjnl/7.4.308" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20Computer%20Journal&amp;title=A%20simplex%20method%20for%20function%20minimization&amp;author=JA%20Nelder&amp;author=R%20Mead&amp;volume=7&amp;issue=4&amp;publication_year=1965&amp;pages=308-313&amp;doi=10.1093/comjnl/7.4.308&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref045">
<span class="label">45.</span><cite>MATLAB Global Optimization Toolbox; Version 4.3.</cite>
</li>
<li id="pcbi.1008089.ref046">
<span class="label">46.</span><cite>
Gima K, Rudy Y. Ionic current basis of electrocardiographic waveforms: a model study. Circulation Research. 2002;90(8):889–896. 10.1161/01.RES.0000016960.61087.86
</cite> [<a href="https://doi.org/10.1161/01.RES.0000016960.61087.86" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1847799/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11988490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Ionic%20current%20basis%20of%20electrocardiographic%20waveforms:%20a%20model%20study&amp;author=K%20Gima&amp;author=Y%20Rudy&amp;volume=90&amp;issue=8&amp;publication_year=2002&amp;pages=889-896&amp;pmid=11988490&amp;doi=10.1161/01.RES.0000016960.61087.86&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref047">
<span class="label">47.</span><cite>
Pueyo E, Husti Z, Hornyik T, Baczkó I, Laguna P, Varró A, et al. Mechanisms of ventricular rate adaptation as a predictor of arrhythmic risk. American Journal of Physiology-Heart and Circulatory Physiology. 2010;298(5):H1577–H1587. 10.1152/ajpheart.00936.2009
</cite> [<a href="https://doi.org/10.1152/ajpheart.00936.2009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20207815/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology-Heart%20and%20Circulatory%20Physiology&amp;title=Mechanisms%20of%20ventricular%20rate%20adaptation%20as%20a%20predictor%20of%20arrhythmic%20risk&amp;author=E%20Pueyo&amp;author=Z%20Husti&amp;author=T%20Hornyik&amp;author=I%20Baczk%C3%B3&amp;author=P%20Laguna&amp;volume=298&amp;issue=5&amp;publication_year=2010&amp;pages=H1577-H1587&amp;pmid=20207815&amp;doi=10.1152/ajpheart.00936.2009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref048">
<span class="label">48.</span><cite>
Adeniran I, McPate MJ, Witchel HJ, Hancox JC, Zhang H. Increased vulnerability of human ventricle to re-entrant excitation in hERG-linked variant 1 short QT syndrome. PLoS Computational Biology. 2011;7(12). 10.1371/journal.pcbi.1002313
</cite> [<a href="https://doi.org/10.1371/journal.pcbi.1002313" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3240585/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22194679/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Computational%20Biology&amp;title=Increased%20vulnerability%20of%20human%20ventricle%20to%20re-entrant%20excitation%20in%20hERG-linked%20variant%201%20short%20QT%20syndrome&amp;author=I%20Adeniran&amp;author=MJ%20McPate&amp;author=HJ%20Witchel&amp;author=JC%20Hancox&amp;author=H%20Zhang&amp;volume=7&amp;issue=12&amp;publication_year=2011&amp;pmid=22194679&amp;doi=10.1371/journal.pcbi.1002313&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref049">
<span class="label">49.</span><cite>
Luo C, Wang K, Zhang H. Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study. Biomedical Engineering Online. 2017;16(1):69. 10.1186/s12938-017-0369-0
</cite> [<a href="https://doi.org/10.1186/s12938-017-0369-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5463381/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28592292/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedical%20Engineering%20Online&amp;title=Effects%20of%20amiodarone%20on%20short%20QT%20syndrome%20variant%203%20in%20human%20ventricles:%20a%20simulation%20study&amp;author=C%20Luo&amp;author=K%20Wang&amp;author=H%20Zhang&amp;volume=16&amp;issue=1&amp;publication_year=2017&amp;pages=69&amp;pmid=28592292&amp;doi=10.1186/s12938-017-0369-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref050">
<span class="label">50.</span><cite>
Trenor B, Gomis-Tena J, Cardona K, Romero L, Rajamani S, Belardinelli L, et al. In silico assessment of drug safety in human heart applied to late sodium current blockers. Channels. 2013;7(4):249–262. 10.4161/chan.24905
</cite> [<a href="https://doi.org/10.4161/chan.24905" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3989354/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23696033/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Channels&amp;title=In%20silico%20assessment%20of%20drug%20safety%20in%20human%20heart%20applied%20to%20late%20sodium%20current%20blockers&amp;author=B%20Trenor&amp;author=J%20Gomis-Tena&amp;author=K%20Cardona&amp;author=L%20Romero&amp;author=S%20Rajamani&amp;volume=7&amp;issue=4&amp;publication_year=2013&amp;pages=249-262&amp;pmid=23696033&amp;doi=10.4161/chan.24905&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref051">
<span class="label">51.</span><cite>
Tveito A, Jæger KH, Lines GT, Paszkowski Ł, Sundnes J, Edwards AG, et al. An evaluation of the accuracy of classical models for computing the membrane potential and extracellular potential for neurons. Frontiers in Computational Neuroscience. 2017;11:27. 10.3389/fncom.2017.00027
</cite> [<a href="https://doi.org/10.3389/fncom.2017.00027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5401906/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28484385/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Computational%20Neuroscience&amp;title=An%20evaluation%20of%20the%20accuracy%20of%20classical%20models%20for%20computing%20the%20membrane%20potential%20and%20extracellular%20potential%20for%20neurons&amp;author=A%20Tveito&amp;author=KH%20J%C3%A6ger&amp;author=GT%20Lines&amp;author=%C5%81%20Paszkowski&amp;author=J%20Sundnes&amp;volume=11&amp;publication_year=2017&amp;pages=27&amp;pmid=28484385&amp;doi=10.3389/fncom.2017.00027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref052">
<span class="label">52.</span><cite>
Weingart R. The actions of ouabain on intercellular coupling and conduction velocity in mammalian ventricular muscle. The Journal of Physiology. 1977;264(2):341–365. 10.1113/jphysiol.1977.sp011672
</cite> [<a href="https://doi.org/10.1113/jphysiol.1977.sp011672" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1307766/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/839458/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20Journal%20of%20Physiology&amp;title=The%20actions%20of%20ouabain%20on%20intercellular%20coupling%20and%20conduction%20velocity%20in%20mammalian%20ventricular%20muscle&amp;author=R%20Weingart&amp;volume=264&amp;issue=2&amp;publication_year=1977&amp;pages=341-365&amp;pmid=839458&amp;doi=10.1113/jphysiol.1977.sp011672&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref053">
<span class="label">53.</span><cite>National Center for Biotechnology Information. PubChem Database. Quinidine, CID = 441074;. <a href="https://pubchem.ncbi.nlm.nih.gov/compound/Quinidine" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubchem.ncbi.nlm.nih.gov/compound/Quinidine</a>.</cite>
</li>
<li id="pcbi.1008089.ref054">
<span class="label">54.</span><cite>
El-Battrawy I, Besler J, Li X, Lan H, Zhao Z, Liebe V, et al. Impact of antiarrhythmic drugs on the outcome of Short QT Syndrome. Frontiers in Pharmacology. 2019;10:771. 10.3389/fphar.2019.00771
</cite> [<a href="https://doi.org/10.3389/fphar.2019.00771" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6688193/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31427960/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Pharmacology&amp;title=Impact%20of%20antiarrhythmic%20drugs%20on%20the%20outcome%20of%20Short%20QT%20Syndrome&amp;author=I%20El-Battrawy&amp;author=J%20Besler&amp;author=X%20Li&amp;author=H%20Lan&amp;author=Z%20Zhao&amp;volume=10&amp;publication_year=2019&amp;pages=771&amp;pmid=31427960&amp;doi=10.3389/fphar.2019.00771&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref055">
<span class="label">55.</span><cite>
Weiss DL, Seemann G, Sachse FB, Dössel O. Modelling of short QT syndrome in a heterogeneous model of the human ventricular wall. EP Europace. 2005;7(s2):S105–S117. 10.1016/j.eupc.2005.04.008</cite> [<a href="https://doi.org/10.1016/j.eupc.2005.04.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16102508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EP%20Europace&amp;title=Modelling%20of%20short%20QT%20syndrome%20in%20a%20heterogeneous%20model%20of%20the%20human%20ventricular%20wall&amp;author=DL%20Weiss&amp;author=G%20Seemann&amp;author=FB%20Sachse&amp;author=O%20D%C3%B6ssel&amp;volume=7&amp;issue=s2&amp;publication_year=2005&amp;pages=S105-S117&amp;pmid=16102508&amp;doi=10.1016/j.eupc.2005.04.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref056">
<span class="label">56.</span><cite>Bartolucci C, Moreno C, de la Cruz A, Lambiase P, Severi S, Valenzuela C. Linking a novel mutation to its short QT phenotype through multiscale computational modelling. In: Computing in Cardiology 2014. IEEE; 2014. p. 1017–1020.</cite>
</li>
<li id="pcbi.1008089.ref057">
<span class="label">57.</span><cite>
ten Tusscher KH, Panfilov AV. Cell model for efficient simulation of wave propagation in human ventricular tissue under normal and pathological conditions. Physics in Medicine and Biology. 2006;51(23):6141. 10.1088/0031-9155/51/23/014
</cite> [<a href="https://doi.org/10.1088/0031-9155/51/23/014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17110776/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Physics%20in%20Medicine%20and%20Biology&amp;title=Cell%20model%20for%20efficient%20simulation%20of%20wave%20propagation%20in%20human%20ventricular%20tissue%20under%20normal%20and%20pathological%20conditions&amp;author=KH%20ten%20Tusscher&amp;author=AV%20Panfilov&amp;volume=51&amp;issue=23&amp;publication_year=2006&amp;pages=6141&amp;pmid=17110776&amp;doi=10.1088/0031-9155/51/23/014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref058">
<span class="label">58.</span><cite>
Rudy Y, Silva JR. Computational biology in the study of cardiac ion channels and cell electrophysiology. Quarterly Reviews of Biophysics. 2006;39(1):57–116. 10.1017/S0033583506004227
</cite> [<a href="https://doi.org/10.1017/S0033583506004227" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1994938/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16848931/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Quarterly%20Reviews%20of%20Biophysics&amp;title=Computational%20biology%20in%20the%20study%20of%20cardiac%20ion%20channels%20and%20cell%20electrophysiology&amp;author=Y%20Rudy&amp;author=JR%20Silva&amp;volume=39&amp;issue=1&amp;publication_year=2006&amp;pages=57-116&amp;pmid=16848931&amp;doi=10.1017/S0033583506004227&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref059">
<span class="label">59.</span><cite>
Fink M, Noble D. Markov models for ion channels: versatility versus identifiability and speed. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences. 2009;367(1896):2161–2179. 10.1098/rsta.2008.0301
</cite> [<a href="https://doi.org/10.1098/rsta.2008.0301" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19414451/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Philosophical%20Transactions%20of%20the%20Royal%20Society%20A:%20Mathematical,%20Physical%20and%20Engineering%20Sciences&amp;title=Markov%20models%20for%20ion%20channels:%20versatility%20versus%20identifiability%20and%20speed&amp;author=M%20Fink&amp;author=D%20Noble&amp;volume=367&amp;issue=1896&amp;publication_year=2009&amp;pages=2161-2179&amp;pmid=19414451&amp;doi=10.1098/rsta.2008.0301&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref060">
<span class="label">60.</span><cite>
Clancy CE, Zhu ZI, Rudy Y. Pharmacogenetics and anti-arrhythmic drug therapy: A theoretical investigation. AJP: Heart and Circulatory Physiology. 2007;292(1):H66–H75. 10.1152/ajpheart.00312.2006
</cite> [<a href="https://doi.org/10.1152/ajpheart.00312.2006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2034498/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16997895/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=AJP:%20Heart%20and%20Circulatory%20Physiology&amp;title=Pharmacogenetics%20and%20anti-arrhythmic%20drug%20therapy:%20A%20theoretical%20investigation&amp;author=CE%20Clancy&amp;author=ZI%20Zhu&amp;author=Y%20Rudy&amp;volume=292&amp;issue=1&amp;publication_year=2007&amp;pages=H66-H75&amp;pmid=16997895&amp;doi=10.1152/ajpheart.00312.2006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref061">
<span class="label">61.</span><cite>
Tveito A, Lines GT, Li P, McCulloch A. Defining candidate drug characteristics for Long-QT (LQT3) syndrome. Mathematical Biosciences and Engineering. 2011;8(3):861–73. 10.3934/mbe.2011.8.861
</cite> [<a href="https://doi.org/10.3934/mbe.2011.8.861" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21675815/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mathematical%20Biosciences%20and%20Engineering&amp;title=Defining%20candidate%20drug%20characteristics%20for%20Long-QT%20(LQT3)%20syndrome&amp;author=A%20Tveito&amp;author=GT%20Lines&amp;author=P%20Li&amp;author=A%20McCulloch&amp;volume=8&amp;issue=3&amp;publication_year=2011&amp;pages=861-73&amp;pmid=21675815&amp;doi=10.3934/mbe.2011.8.861&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref062">
<span class="label">62.</span><cite>Tveito A, Lines GT. Computing Characterizations of Drugs for Ion Channels and Receptors Using Markov Models. Springer-Verlag, Lecture Notes, vol. 111; 2016.</cite>
</li>
<li id="pcbi.1008089.ref063">
<span class="label">63.</span><cite>
Whittaker DG, Ni H, Benson AP, Hancox JC, Zhang H. Computational analysis of the mode of action of disopyramide and quinidine on hERG-linked short QT syndrome in human ventricles. Frontiers in Physiology. 2017;8:759. 10.3389/fphys.2017.00759
</cite> [<a href="https://doi.org/10.3389/fphys.2017.00759" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5649182/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29085299/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Physiology&amp;title=Computational%20analysis%20of%20the%20mode%20of%20action%20of%20disopyramide%20and%20quinidine%20on%20hERG-linked%20short%20QT%20syndrome%20in%20human%20ventricles&amp;author=DG%20Whittaker&amp;author=H%20Ni&amp;author=AP%20Benson&amp;author=JC%20Hancox&amp;author=H%20Zhang&amp;volume=8&amp;publication_year=2017&amp;pages=759&amp;pmid=29085299&amp;doi=10.3389/fphys.2017.00759&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref064">
<span class="label">64.</span><cite>Luo C, Wang K, Liu T, Zhang H. Computational Analysis of the Action of Chloroquine on Short QT Syndrome Variant 1 and Variant 3 in Human Ventricles. In: 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE; 2018:5462–5465.</cite> [<a href="https://doi.org/10.1109/EMBC.2018.8513572" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30441573/" class="usa-link">PubMed</a>]</li>
<li id="pcbi.1008089.ref065">
<span class="label">65.</span><cite>
Adeniran I, Whittaker DG, El Harchi A, Hancox JC, Zhang H. In silico investigation of a KCNQ1 mutation associated with short QT syndrome. Scientific Reports. 2017;7(1):1–14. 10.1038/s41598-017-08367-2
</cite> [<a href="https://doi.org/10.1038/s41598-017-08367-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5559555/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28814790/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=In%20silico%20investigation%20of%20a%20KCNQ1%20mutation%20associated%20with%20short%20QT%20syndrome&amp;author=I%20Adeniran&amp;author=DG%20Whittaker&amp;author=A%20El%20Harchi&amp;author=JC%20Hancox&amp;author=H%20Zhang&amp;volume=7&amp;issue=1&amp;publication_year=2017&amp;pages=1-14&amp;pmid=28814790&amp;doi=10.1038/s41598-017-08367-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref066">
<span class="label">66.</span><cite>
Mathur A, Loskill P, Shao K, Huebsch N, Hong S, Marcus SG, et al. Human iPSC-based cardiac microphysiological system for drug screening applications. Scientific Reports. 2015;5:8883. 10.1038/srep08883
</cite> [<a href="https://doi.org/10.1038/srep08883" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4352848/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25748532/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=Human%20iPSC-based%20cardiac%20microphysiological%20system%20for%20drug%20screening%20applications&amp;author=A%20Mathur&amp;author=P%20Loskill&amp;author=K%20Shao&amp;author=N%20Huebsch&amp;author=S%20Hong&amp;volume=5&amp;publication_year=2015&amp;pages=8883&amp;pmid=25748532&amp;doi=10.1038/srep08883&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref067">
<span class="label">67.</span><cite>
Rees CM, Yang JH, Santolini M, Lusis AJ, Weiss JN, Karma A. The Ca<sup>2+</sup> transient as a feedback sensor controlling cardiomyocyte ionic conductances in mouse populations. eLife. 2018;7:e36717. 10.7554/eLife.36717
</cite> [<a href="https://doi.org/10.7554/eLife.36717" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6205808/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30251624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=eLife&amp;title=The%20Ca2+%20transient%20as%20a%20feedback%20sensor%20controlling%20cardiomyocyte%20ionic%20conductances%20in%20mouse%20populations&amp;author=CM%20Rees&amp;author=JH%20Yang&amp;author=M%20Santolini&amp;author=AJ%20Lusis&amp;author=JN%20Weiss&amp;volume=7&amp;publication_year=2018&amp;pages=e36717&amp;pmid=30251624&amp;doi=10.7554/eLife.36717&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref068">
<span class="label">68.</span><cite>
Sarkar AX, Sobie EA. Regression analysis for constraining free parameters in electrophysiological models of cardiac cells. PLoS Computational Biology. 2010;6(9). 10.1371/journal.pcbi.1000914
</cite> [<a href="https://doi.org/10.1371/journal.pcbi.1000914" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2932676/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20824123/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Computational%20Biology&amp;title=Regression%20analysis%20for%20constraining%20free%20parameters%20in%20electrophysiological%20models%20of%20cardiac%20cells&amp;author=AX%20Sarkar&amp;author=EA%20Sobie&amp;volume=6&amp;issue=9&amp;publication_year=2010&amp;pmid=20824123&amp;doi=10.1371/journal.pcbi.1000914&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref069">
<span class="label">69.</span><cite>
Jæger KH, Charwat V, Wall S, Healy K, Tveito A. Identifying drug response by combining measurements of the membrane potential, the cytosolic calcium concentration, and the extracellular potential in microphysiological systems. Frontiers in Pharmacology. 2021; 11:569489. 10.3389/fphar.2020.569489</cite> [<a href="https://doi.org/10.3389/fphar.2020.569489" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7898238/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33628168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Pharmacology&amp;title=Identifying%20drug%20response%20by%20combining%20measurements%20of%20the%20membrane%20potential,%20the%20cytosolic%20calcium%20concentration,%20and%20the%20extracellular%20potential%20in%20microphysiological%20systems&amp;author=KH%20J%C3%A6ger&amp;author=V%20Charwat&amp;author=S%20Wall&amp;author=K%20Healy&amp;author=A%20Tveito&amp;volume=11&amp;publication_year=2021&amp;pmid=33628168&amp;doi=10.3389/fphar.2020.569489&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref070">
<span class="label">70.</span><cite>
Wen-ning Q, Shao-ru L. Effect of tetrodotoxin on the transmembrane potential of the pacemaker cell in the sinus venosus of toad. Journal of Tongji Medical University. 1988;8(2):101–105. 10.1007/BF02887804</cite> [<a href="https://doi.org/10.1007/BF02887804" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3150465/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Tongji%20Medical%20University&amp;title=Effect%20of%20tetrodotoxin%20on%20the%20transmembrane%20potential%20of%20the%20pacemaker%20cell%20in%20the%20sinus%20venosus%20of%20toad&amp;author=Q%20Wen-ning&amp;author=L%20Shao-ru&amp;volume=8&amp;issue=2&amp;publication_year=1988&amp;pages=101-105&amp;pmid=3150465&amp;doi=10.1007/BF02887804&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref071">
<span class="label">71.</span><cite>
Sarkar AX, Christini DJ, Sobie EA. Exploiting mathematical models to illuminate electrophysiological variability between individuals. The Journal of Physiology. 2012;590(11):2555–2567. 10.1113/jphysiol.2011.223313
</cite> [<a href="https://doi.org/10.1113/jphysiol.2011.223313" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3424714/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22495591/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20Journal%20of%20Physiology&amp;title=Exploiting%20mathematical%20models%20to%20illuminate%20electrophysiological%20variability%20between%20individuals&amp;author=AX%20Sarkar&amp;author=DJ%20Christini&amp;author=EA%20Sobie&amp;volume=590&amp;issue=11&amp;publication_year=2012&amp;pages=2555-2567&amp;pmid=22495591&amp;doi=10.1113/jphysiol.2011.223313&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref072">
<span class="label">72.</span><cite>
Dokos S, Lovell NH. Parameter estimation in cardiac ionic models. Progress in Biophysics and Molecular Biology. 2004;85(2-3):407–431. 10.1016/j.pbiomolbio.2004.02.002
</cite> [<a href="https://doi.org/10.1016/j.pbiomolbio.2004.02.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15142755/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Progress%20in%20Biophysics%20and%20Molecular%20Biology&amp;title=Parameter%20estimation%20in%20cardiac%20ionic%20models&amp;author=S%20Dokos&amp;author=NH%20Lovell&amp;volume=85&amp;issue=2-3&amp;publication_year=2004&amp;pages=407-431&amp;pmid=15142755&amp;doi=10.1016/j.pbiomolbio.2004.02.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref073">
<span class="label">73.</span><cite>
Jæger KH, Wall S, Tveito A. Detecting undetectables: Can conductances of action potential models be changed without appreciable change in the transmembrane potential?
Chaos: An Interdisciplinary Journal of Nonlinear Science. 2019;29(7):073102. 10.1063/1.5087629
</cite> [<a href="https://doi.org/10.1063/1.5087629" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31370420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chaos:%20An%20Interdisciplinary%20Journal%20of%20Nonlinear%20Science&amp;title=Detecting%20undetectables:%20Can%20conductances%20of%20action%20potential%20models%20be%20changed%20without%20appreciable%20change%20in%20the%20transmembrane%20potential?&amp;author=KH%20J%C3%A6ger&amp;author=S%20Wall&amp;author=A%20Tveito&amp;volume=29&amp;issue=7&amp;publication_year=2019&amp;pages=073102&amp;pmid=31370420&amp;doi=10.1063/1.5087629&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref074">
<span class="label">74.</span><cite>
Melgari D, Brack KE, Zhang C, Zhang Y, El Harchi A, Mitcheson JS, et al. hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine. Journal of the American Heart Association. 2015;4(4):e001813. 10.1161/JAHA.115.001813
</cite> [<a href="https://doi.org/10.1161/JAHA.115.001813" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4579960/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25911606/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Heart%20Association&amp;title=hERG%20potassium%20channel%20blockade%20by%20the%20HCN%20channel%20inhibitor%20bradycardic%20agent%20ivabradine&amp;author=D%20Melgari&amp;author=KE%20Brack&amp;author=C%20Zhang&amp;author=Y%20Zhang&amp;author=A%20El%20Harchi&amp;volume=4&amp;issue=4&amp;publication_year=2015&amp;pages=e001813&amp;pmid=25911606&amp;doi=10.1161/JAHA.115.001813&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref075">
<span class="label">75.</span><cite>
Bucchi A, Tognati A, Milanesi R, Baruscotti M, DiFrancesco D. Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels. The Journal of Physiology. 2006;572(2):335–346. 10.1113/jphysiol.2005.100776
</cite> [<a href="https://doi.org/10.1113/jphysiol.2005.100776" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1779671/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16484306/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20Journal%20of%20Physiology&amp;title=Properties%20of%20ivabradine-induced%20block%20of%20HCN1%20and%20HCN4%20pacemaker%20channels&amp;author=A%20Bucchi&amp;author=A%20Tognati&amp;author=R%20Milanesi&amp;author=M%20Baruscotti&amp;author=D%20DiFrancesco&amp;volume=572&amp;issue=2&amp;publication_year=2006&amp;pages=335-346&amp;pmid=16484306&amp;doi=10.1113/jphysiol.2005.100776&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref076">
<span class="label">76.</span><cite>
Haechl N, Ebner J, Hilber K, Todt H, Koenig X. Pharmacological Profile of the Bradycardic Agent Ivabradine on Human Cardiac Ion Channels. Cellular Physiology and Biochemistry. 2019;53:36–48. 10.33594/000000119
</cite> [<a href="https://doi.org/10.33594/000000119" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31169990/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cellular%20Physiology%20and%20Biochemistry&amp;title=Pharmacological%20Profile%20of%20the%20Bradycardic%20Agent%20Ivabradine%20on%20Human%20Cardiac%20Ion%20Channels&amp;author=N%20Haechl&amp;author=J%20Ebner&amp;author=K%20Hilber&amp;author=H%20Todt&amp;author=X%20Koenig&amp;volume=53&amp;publication_year=2019&amp;pages=36-48&amp;pmid=31169990&amp;doi=10.33594/000000119&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref077">
<span class="label">77.</span><cite>
McPate M, Duncan R, Hancox J, Witchel H. Pharmacology of the short QT syndrome N588K-hERG K<sup>+</sup> channel mutation: differential impact on selected class I and class III antiarrhythmic drugs. British Journal of Pharmacology. 2008;155(6):957–966. 10.1038/bjp.2008.325
</cite> [<a href="https://doi.org/10.1038/bjp.2008.325" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2597231/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18724381/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=Pharmacology%20of%20the%20short%20QT%20syndrome%20N588K-hERG%20K+%20channel%20mutation:%20differential%20impact%20on%20selected%20class%20I%20and%20class%20III%20antiarrhythmic%20drugs&amp;author=M%20McPate&amp;author=R%20Duncan&amp;author=J%20Hancox&amp;author=H%20Witchel&amp;volume=155&amp;issue=6&amp;publication_year=2008&amp;pages=957-966&amp;pmid=18724381&amp;doi=10.1038/bjp.2008.325&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref078">
<span class="label">78.</span><cite>
Melgari D, El Harchi A, Dempsey CE, Hancox JC. Sensitivity of Flecainide Inhibition of hERG Channels to Channel Inactivation. Biophysical Journal. 2014;106(2):138a. 10.1016/j.bpj.2013.11.807</cite> [<a href="https://doi.org/10.1016/j.bpj.2013.11.807" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biophysical%20Journal&amp;title=Sensitivity%20of%20Flecainide%20Inhibition%20of%20hERG%20Channels%20to%20Channel%20Inactivation&amp;author=D%20Melgari&amp;author=A%20El%20Harchi&amp;author=CE%20Dempsey&amp;author=JC%20Hancox&amp;volume=106&amp;issue=2&amp;publication_year=2014&amp;pages=138a&amp;doi=10.1016/j.bpj.2013.11.807&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref079">
<span class="label">79.</span><cite>
Bébarová M, Matejovic P, Pásek M, Simurdova M, Simurda J. Effect of ajmaline on action potential and ionic currents in rat ventricular myocytes. General Physiology and Biophysics. 2005;24(3):311. </cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/16308426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=General%20Physiology%20and%20Biophysics&amp;title=Effect%20of%20ajmaline%20on%20action%20potential%20and%20ionic%20currents%20in%20rat%20ventricular%20myocytes&amp;author=M%20B%C3%A9barov%C3%A1&amp;author=P%20Matejovic&amp;author=M%20P%C3%A1sek&amp;author=M%20Simurdova&amp;author=J%20Simurda&amp;volume=24&amp;issue=3&amp;publication_year=2005&amp;pages=311&amp;pmid=16308426&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref080">
<span class="label">80.</span><cite>
Courney KR. Comparatibe actions of mexiletine on sodium channels in nerve, skeletal and cardiac muscle. European Journal of Pharmacology. 1981;74(1):9–18. 10.1016/0014-2999(81)90317-4</cite> [<a href="https://doi.org/10.1016/0014-2999(81)90317-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6274652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Pharmacology&amp;title=Comparatibe%20actions%20of%20mexiletine%20on%20sodium%20channels%20in%20nerve,%20skeletal%20and%20cardiac%20muscle&amp;author=KR%20Courney&amp;volume=74&amp;issue=1&amp;publication_year=1981&amp;pages=9-18&amp;pmid=6274652&amp;doi=10.1016/0014-2999(81)90317-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref081">
<span class="label">81.</span><cite>
Qu Y, Vargas HM. Proarrhythmia risk assessment in human induced pluripotent stem cell-derived cardiomyocytes using the maestro MEA platform. Toxicological Sciences. 2015;147(1):286–295. 10.1093/toxsci/kfv128
</cite> [<a href="https://doi.org/10.1093/toxsci/kfv128" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26117837/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicological%20Sciences&amp;title=Proarrhythmia%20risk%20assessment%20in%20human%20induced%20pluripotent%20stem%20cell-derived%20cardiomyocytes%20using%20the%20maestro%20MEA%20platform&amp;author=Y%20Qu&amp;author=HM%20Vargas&amp;volume=147&amp;issue=1&amp;publication_year=2015&amp;pages=286-295&amp;pmid=26117837&amp;doi=10.1093/toxsci/kfv128&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref082">
<span class="label">82.</span><cite>
Hu XD, Qian JQ. DDPH inhibited L-type calcium current and sodium current in single ventricular myocyte of guinea pig. Acta pharmacologica Sinica. 2001;22(5):415–419. </cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/11743888/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20pharmacologica%20Sinica&amp;title=DDPH%20inhibited%20L-type%20calcium%20current%20and%20sodium%20current%20in%20single%20ventricular%20myocyte%20of%20guinea%20pig&amp;author=XD%20Hu&amp;author=JQ%20Qian&amp;volume=22&amp;issue=5&amp;publication_year=2001&amp;pages=415-419&amp;pmid=11743888&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref083">
<span class="label">83.</span><cite>
Mirams GR, Cui Y, Sher A, Fink M, Cooper J, Heath BM, et al. Simulation of multiple ion channel block provides improved early prediction of compounds’ clinical torsadogenic risk. Cardiovascular Research. 2011;91(1):53–61. 10.1093/cvr/cvr044
</cite> [<a href="https://doi.org/10.1093/cvr/cvr044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3112019/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21300721/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=Simulation%20of%20multiple%20ion%20channel%20block%20provides%20improved%20early%20prediction%20of%20compounds%E2%80%99%20clinical%20torsadogenic%20risk&amp;author=GR%20Mirams&amp;author=Y%20Cui&amp;author=A%20Sher&amp;author=M%20Fink&amp;author=J%20Cooper&amp;volume=91&amp;issue=1&amp;publication_year=2011&amp;pages=53-61&amp;pmid=21300721&amp;doi=10.1093/cvr/cvr044&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref084">
<span class="label">84.</span><cite>
Ming T, Guang-lan Z, Xiao-rong Z, Jun-yuan Z, Yi Z, Shao-ru L. Relationship between action potential duration of ventricular cells and heart rate in dog under natural breathing. Journal of Tongji Medical University. 1987;7(3):148–152. 10.1007/BF02888208</cite> [<a href="https://doi.org/10.1007/BF02888208" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3448239/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Tongji%20Medical%20University&amp;title=Relationship%20between%20action%20potential%20duration%20of%20ventricular%20cells%20and%20heart%20rate%20in%20dog%20under%20natural%20breathing&amp;author=T%20Ming&amp;author=Z%20Guang-lan&amp;author=Z%20Xiao-rong&amp;author=Z%20Jun-yuan&amp;author=Z%20Yi&amp;volume=7&amp;issue=3&amp;publication_year=1987&amp;pages=148-152&amp;pmid=3448239&amp;doi=10.1007/BF02888208&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref085">
<span class="label">85.</span><cite>
Zemzemi N, Bernabeu MO, Saiz J, Cooper J, Pathmanathan P, Mirams GR, et al. Computational assessment of drug-induced effects on the electrocardiogram: from ion channel to body surface potentials. British Journal of Pharmacology. 2013;168(3):718–733. 10.1111/j.1476-5381.2012.02200.x
</cite> [<a href="https://doi.org/10.1111/j.1476-5381.2012.02200.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3579290/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22946617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=Computational%20assessment%20of%20drug-induced%20effects%20on%20the%20electrocardiogram:%20from%20ion%20channel%20to%20body%20surface%20potentials&amp;author=N%20Zemzemi&amp;author=MO%20Bernabeu&amp;author=J%20Saiz&amp;author=J%20Cooper&amp;author=P%20Pathmanathan&amp;volume=168&amp;issue=3&amp;publication_year=2013&amp;pages=718-733&amp;pmid=22946617&amp;doi=10.1111/j.1476-5381.2012.02200.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref086">
<span class="label">86.</span><cite>
Lines GT, Grottum P, Tveito A. Modeling the electrical activity of the heart: a bidomain model of the ventricles embedded in a torso. Computing and Visualization in Science. 2003;5(4):195–213. 10.1007/s00791-003-0100-5</cite> [<a href="https://doi.org/10.1007/s00791-003-0100-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Computing%20and%20Visualization%20in%20Science&amp;title=Modeling%20the%20electrical%20activity%20of%20the%20heart:%20a%20bidomain%20model%20of%20the%20ventricles%20embedded%20in%20a%20torso&amp;author=GT%20Lines&amp;author=P%20Grottum&amp;author=A%20Tveito&amp;volume=5&amp;issue=4&amp;publication_year=2003&amp;pages=195-213&amp;doi=10.1007/s00791-003-0100-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref087">
<span class="label">87.</span><cite>
Potse M, Dubé B, Vinet A. Cardiac anisotropy in boundary-element models for the electrocardiogram. Medical &amp; Biological Engineering &amp; Computing. 2009;47(7):719–729. 10.1007/s11517-009-0472-x
</cite> [<a href="https://doi.org/10.1007/s11517-009-0472-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2688616/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19306030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Medical%20&amp;%20Biological%20Engineering%20&amp;%20Computing&amp;title=Cardiac%20anisotropy%20in%20boundary-element%20models%20for%20the%20electrocardiogram&amp;author=M%20Potse&amp;author=B%20Dub%C3%A9&amp;author=A%20Vinet&amp;volume=47&amp;issue=7&amp;publication_year=2009&amp;pages=719-729&amp;pmid=19306030&amp;doi=10.1007/s11517-009-0472-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref088">
<span class="label">88.</span><cite>
Boulakia M, Cazeau S, Fernández MA, Gerbeau JF, Zemzemi N. Mathematical modeling of electrocardiograms: a numerical study. Annals of Biomedical Engineering. 2010;38(3):1071–1097. 10.1007/s10439-009-9873-0
</cite> [<a href="https://doi.org/10.1007/s10439-009-9873-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20033779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Biomedical%20Engineering&amp;title=Mathematical%20modeling%20of%20electrocardiograms:%20a%20numerical%20study&amp;author=M%20Boulakia&amp;author=S%20Cazeau&amp;author=MA%20Fern%C3%A1ndez&amp;author=JF%20Gerbeau&amp;author=N%20Zemzemi&amp;volume=38&amp;issue=3&amp;publication_year=2010&amp;pages=1071-1097&amp;pmid=20033779&amp;doi=10.1007/s10439-009-9873-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref089">
<span class="label">89.</span><cite>
Zhang S. Isolation and characterization of <em>I</em><sub>Kr</sub> in cardiac myocytes by Cs<sup>+</sup> permeation. American Journal of Physiology-Heart and Circulatory Physiology. 2006;290(3):H1038–H1049. 10.1152/ajpheart.00679.2005
</cite> [<a href="https://doi.org/10.1152/ajpheart.00679.2005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16227343/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology-Heart%20and%20Circulatory%20Physiology&amp;title=Isolation%20and%20characterization%20of%20IKr%20in%20cardiac%20myocytes%20by%20Cs+%20permeation&amp;author=S%20Zhang&amp;volume=290&amp;issue=3&amp;publication_year=2006&amp;pages=H1038-H1049&amp;pmid=16227343&amp;doi=10.1152/ajpheart.00679.2005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pcbi.1008089.ref090">
<span class="label">90.</span><cite>
O’Hara T, Virág L, Varró A, Rudy Y. Simulation of the undiseased human cardiac ventricular action potential: Model formulation and experimental validation. PLoS Computational Biology. 2011;7(5):e1002061. 10.1371/journal.pcbi.1002061
</cite> [<a href="https://doi.org/10.1371/journal.pcbi.1002061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3102752/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21637795/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Computational%20Biology&amp;title=Simulation%20of%20the%20undiseased%20human%20cardiac%20ventricular%20action%20potential:%20Model%20formulation%20and%20experimental%20validation&amp;author=T%20O%E2%80%99Hara&amp;author=L%20Vir%C3%A1g&amp;author=A%20Varr%C3%B3&amp;author=Y%20Rudy&amp;volume=7&amp;issue=5&amp;publication_year=2011&amp;pages=e1002061&amp;pmid=21637795&amp;doi=10.1371/journal.pcbi.1002061&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>S1 Appendix. Base model formulation.</span><p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7909705/bin/pcbi.1008089.s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (237KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>S2 Appendix. A note on the sign of the pseudo-ECG.</span><p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7909705/bin/pcbi.1008089.s002.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (176.5KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p">
<span>S1 Code. MATLAB code for the different versions of the base model used in this study.</span><p>(ZIP)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7909705/bin/pcbi.1008089.s003.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (18.1KB, zip) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p">
<span>S1 Data. Underlying numerical data for figures.</span><p>Excel spreadsheet containing the underlying numerical data of Figs <a href="#pcbi.1008089.g005" class="usa-link">5</a>, <a href="#pcbi.1008089.g006" class="usa-link">6</a>, <a href="#pcbi.1008089.g007" class="usa-link">7</a>, <a href="#pcbi.1008089.g008" class="usa-link">8</a>, <a href="#pcbi.1008089.g009" class="usa-link">9</a>, <a href="#pcbi.1008089.g010" class="usa-link">10</a> and <a href="#pcbi.1008089.g011" class="usa-link">11</a>.</p>
<p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7909705/bin/pcbi.1008089.s004.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (482KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="caption p">
<span>S1 Fig. Comparison of the hiPSC-CM base model to data.</span><p>Comparison of data from [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>] for WT and SQT1 hiPSC-CMs to properties of the hiPSC-CM base model for WT and SQT1 used as a starting point for the inversions. The upper two rows compare the resting membrane potential (RMP), action potential amplitude (APA), maximal upstroke velocity (dvdt<sub>max</sub>) and action potential durations at 50% and 90% repolarization (APD50 and APD90). The lower two rows compare the current densities of <em>I</em><sub>Ks</sub>, <em>I</em><sub>to</sub>, <em>I</em><sub>K1</sub>, <em>I</em><sub>CaL</sub> and <em>I</em><sub>NaL</sub> at specific voltages using the voltage clamp procedures described in [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>]. Note that two different WT hiPSC lines (D1 and D2) were considered in [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>]. Note also that the <em>I</em><sub>Kr</sub> current reported in [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>] was not compared to the model because the measurements of <em>I</em><sub>Kr</sub> in [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>] were conducted using Cs<sup>+</sup> ions instead of K<sup>+</sup> ions, which could influence the properties of the current, making the measurements less appropriate for direct comparison to the model current [<a href="#pcbi.1008089.ref009" class="usa-link" aria-describedby="pcbi.1008089.ref009">9</a>, <a href="#pcbi.1008089.ref089" class="usa-link" aria-describedby="pcbi.1008089.ref089">89</a>].</p>
<p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7909705/bin/pcbi.1008089.s005.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (8.1KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material6_reqid_"><div class="caption p">
<span>S2 Fig. Comparison the adult base model to other AP models.</span><p>Comparison of the action potential and some of the main currents in the adult WT base model used in this study against the action potential and currents from the Grandi et al. and O’Hara et al. models [<a href="#pcbi.1008089.ref027" class="usa-link" aria-describedby="pcbi.1008089.ref027">27</a>, <a href="#pcbi.1008089.ref090" class="usa-link" aria-describedby="pcbi.1008089.ref090">90</a>]. The currents and action potentials are computed in a simulation using 1 Hz pacing, and the epicardial version of the models are used for all three models.</p>
<p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7909705/bin/pcbi.1008089.s006.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (133.1KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material7_reqid_"><div class="caption p">
<span>S3 Fig. Singular value decomposition analysis.</span><p>Singular value decomposition analysis of the SQT1 hiPSC-CM base model, using the method from [<a href="#pcbi.1008089.ref073" class="usa-link" aria-describedby="pcbi.1008089.ref073">73</a>]. The identifiability of each current is indicated in the orange panel, and a value close to 1 indicates a high degree of identifiability. The cost function used to define the unidentifiable space is the same as that used in the inversions. The identifiability threshold, <em>δ</em>, was set to 0.1. For details on the analysis, we refer to [<a href="#pcbi.1008089.ref073" class="usa-link" aria-describedby="pcbi.1008089.ref073">73</a>].</p>
<p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7909705/bin/pcbi.1008089.s007.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (159.1KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material8_reqid_"><div class="caption p">
<span>S4 Fig. Comparison of optimization methods.</span><p>Comparison of the continuation method and a number of other optimization methods from MATLAB’s Global Optimization Toolbox [<a href="#pcbi.1008089.ref045" class="usa-link" aria-describedby="pcbi.1008089.ref045">45</a>]. We use the same cost function as in the inversions of the paper, except that we include no regularization terms and only consider a single AP (not several doses). The data is defined by simulated solutions generated using λ = −0.5 for all considered currents (see the legends). The titles above each column specify the considered number of free parameters, and the plots show the evolution of the optimal parameter values during the iterations of the algorithms. We impose the bounds −1 ≤ λ ≤ 0 and a maximum time limit of 5 hours for all methods, except that the bounds are adjusted to −0.7 ≤ λ ≤ 0.3 for the surrogate optimization algorithm, to avoid automatically finding the correct solution, λ = −0.5, in the first iteration of the algorithm.</p>
<p>(PDF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/7909705/bin/pcbi.1008089.s008.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (117KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All relevant data are within the manuscript and its <a href="#sec034" class="usa-link">Supporting information</a> files.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLoS Computational Biology are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pcbi.1008089"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pcbi.1008089.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.7 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/7909705/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/7909705/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC7909705%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC7909705/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC7909705/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC7909705/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/33591962/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC7909705/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/33591962/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC7909705/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/7909705/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="jbm0ZVld9stM9DVbUVk773rTSxtJCY1oemUPdbuPePpAAse6J0vs1LKms3yab7E0">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-574fdcc6.js"></script>
    
    

    </body>
</html>
